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Summary 
As our knowledge of the genome expands, so does our understanding of the 
characteristics of what we define as genes. Small Open Reading Frame (smORF) genes 
have eluded gene annotation until very recently, and evidence is mounting that these 
very short nucleotide sequences encode functional peptides that are ≤100 amino acids in 
size. From work conducted in the fruit fly, our lab has successfully characterised three 
Drosophila smORFs, of which two have been shown to have a function in higher 
vertebrates, including humans. The functional characterisation of one of these conserved 
smORF encoded peptides (SEPs), Hemotin, is presented in this thesis. Though the 
overall number is still low compared to the abundance of potential smORF-encoding 
genes in Drosophila, the information gathered here allows us to speculate on the wider 
role of smORF peptides through cell-based imaging studies conducted on Drosophila 
cells. Here, I will discuss the various techniques that can and should be employed in 
order to study the functions of SEPs. Chapter III describes the various phenotypic 
studies conducted on the Hemotin smORF which is expressed in Drosophila 
haemocytes, and are integral to the fruit fly immune system. This study showed that 
connecting subcellular localisation of an SEP to a direct functional assay in cells can 
reveal functional characteristics of the peptide for further study. Chapter IV details the 
results from a tagging-transfection assay, which began initially as a way to 
independently corroborate the translation of smORF mRNAs that were assessed as such 
by Ribosome Profiling. This experiment resulted in the discovery of several 
mitochondrial-localised SEPs in Drosophila S2 cells, opening the door for the direct 
functional assay described in Chapter V. The results from a small-scale RNAi screen 
conducted on the mitochondria of S2 cells provided a reliable read-out for functionality 
of a large proportion of the smORFs that were screened. This assay can potentially be 
used as a phenotypic read-out of mitochondrial-SEP function in any cell or tissue type. 
Elucidation of smORFs and the functions of the peptides that they encode will help us 
to expand the Drosophila proteome, along with providing evidence of their functionality 
across every organism in which they are found. Considering that characterised SEPs 
play very important roles in physiology and health, it is time for smORFs to be 
acknowledged as the important genomic elements that they are.  
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Chapter I - General Introduction
Our lab has been focused on identifying and characterising smORF genes since the 
serendipitous discovery of tarsal-less (tal) (Galindo et al. 2007). An open reading frame 
(ORF) is defined as a potentially protein coding stretch of DNA or RNA that contains a 
start codon (ATG) and ends in a stop codon (TAG, TAA, TGA). A small-Open Reading 
Frame (smORF) gene is identified by the presence of an ORF that encodes a peptide 
which is less than or equal to 100 amino acids in length (Basrai 1997). tal is a smORF 
gene that was found by our lab while studying the developmental patterning of 
Drosophila melanogaster leg morphology (Galindo et al. 2000; Galindo et al. 2005 
Galindo et al. 2002; Couso et al. 1998) and had previously been classified as a non-
coding RNA gene. However, our lab demonstrated that four of the five tandemly 
arrayed smORFs in the Tal transcript give rise to smORF-encoded peptides (SEPs) of 
11, 12 and 32 amino acids in length. These peptides are the shortest peptides ever 
discovered in metazoans (Galindo et al. 2007). Since then, it has been shown that Tal is 
involved in the differentiation of the second, third and fourth tarsal subsegments in the 
legs of the fruit fly, and is required for embryonic development (Galindo et al. 2007; 
Pueyo and Couso 2008). This study was one of the first to highlight the fact that SEPs 
are translated and perform important functions in the fruit fly (Kondo et al. 2007; 
Galindo et al. 2007). If such a small peptide could determine vital structures of the adult 
fly morphology, as well as embryonic viability, it could be possible that there are other 
previously overlooked small peptides encoded in the Drosophila genome. 
The challenge of identifying smORFs 
In order to begin characterising smORFs, we must be able to determine other potential 
candidates for functional studies. The most logical place to look for further smORF 
genes to study would be the genome. The challenges of identifying smORFs begin with 
the first full genome to be sequenced, which was that of the budding yeast 
(Saccharomyces cerevisiae) (Goffeau et al. 1996). In the two decades since, mass 
sequencing projects have enabled a vast amount of genomic data to be generated. These 
data have revealed that there is a huge amount of information encoded within genomes, 
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and led to the subsequent annotation of thousands of genes. These annotation 
approaches struggle to cope with the sheer volume of data that has been generated, and 
it is only natural that there is some exclusivity generated by the annotation exercises. In 
the S. cerevisiae genome, hundreds of thousands of ORFs were identified across a large 
size range, encoding for peptides across a range of hundreds to thousands of amino 
acids. During this time, the presence of a large number of putative smORFs was shown 
as an outlier to this distribution, as they amounted to a total of ~260,000 ORFs that were 
2-99 codons in length (Basrai et al. 1997). Of these hundreds of thousands of smORFs, 
only four hundred showed clear homology to known proteins and almost one hundred 
functional SEPs had already been verified in yeast through genetic and biochemical 
experiments (Basrai et al. 1997). This highlighted the importance of retaining some, if 
not all smORF encoding genes in genome annotations. However, the remaining 
~259,000 smORFs were initially left out of S. cerevisiae genome annotation by 
imposing a minimum 300 nucleotide (nt) ORF length cut-off (Fickett 1995) due to their 
sheer abundance (Fickett 1995; Das et al. 1997). Despite the discovery of smORFs and 
evidence of functionality of peptide products, the smORF genes being largely excluded 
from yeast genome annotations set a precedent for subsequent genome annotation 
exercises in other organisms. 
When smORF discovery is approached at a genome-wide scale in Drosophila, smORFs 
fail to obtain high conservation scores in relation to controls designed for canonical 
genes, and must be treated differently due to their small size (Ladoukakis et al. 2011). 
Most systematic bioinformatic searches have relied on evolutionary conservation of 
DNA sequences as a criterion to identify novel genes, which is based upon the theory 
that conservation of gene sequences implies functionality (Das et al. 1997; Clark et al. 
2003). Searches for novel protein coding genes have also been targeted to highly 
transcribed (euchromatic) regions of the genome, based on the assumption that essential 
genes must be undergoing active transcription (Misra et al. 2002; Consortium 2004; 
Stein 2004). Typically, the presence of a start and stop codon and some sort of sequence 
conservation and homology would be enough to predict the coding potential of an ORF. 
However, analyses of the human and mouse transcriptomes have shown that large 
proportions of the mammalian genomes is transcribed into RNA without any further 
 3
translation of the RNA into a peptide (Dinger et al. 2008). Experimental evidence also 
exists for conserved developmental genes that have been found to employ the RNA 
rather than the peptide as the functional product of the gene. (Pollard et al. 2006). The 
transcripts from these kinds of genes have generally been classified as non-protein 
coding, or non-coding RNAs (ncRNAs).  
Potentially, twenty-six percent of human and thirteen percent of mouse RNA is 
polyadenylated ncRNA (Okazaki et al. 2002; Ota et al. 2004). This means that 
polyadenylation cannot be used as an exclusive marker to identify protein-coding 
transcripts. ncRNA transcripts can be classified into short or long ncRNA. Short 
ncRNAs include microRNA (miRNA) and small-interfering RNA (siRNA), which have 
been increasingly shown to be involved in the regulation of gene expression 
(Aboobaker et al. 2005; Nguyen et al. 2006; Haley et al. 2008). The very abundant 
‘long’ non-coding RNAs (lncRNA) transcripts undergo post-transcriptional processing 
such as polyadenylation and splicing, and fall in the same size range as smORF 
transcripts. Therefore, due to the 300 nucleotide minimum ORF length cut-off discussed 
previously, many smORF-containing transcripts are annotated as putative non-coding 
RNAs as there is no way to differentiate between them.  
In order to identify other smORFs in D. melanogaster, our lab conducted a systematic 
bioinformatics search for putative smORFs in traditionally non-coding regions of the 
Drosophila genome. The bioinformatics pipeline included filters for size (ORFs coding 
<100aa), the presence of both start (ATG) and stop codons and conservation between D. 
melanogaster and D. pseudoobscura (divergence of 25-55mya) (Ladoukakis et al. 2011) 
to identify 4,561 putative smORF candidates. This study used two further evolutionary 
conservation criteria: 1) the ratio of synonymous to non-synonymous amino acid 
substitutions of the codons in the smORF and 2) the conservation of sequences around 
the smORF in syntenic regions of the D. pseudoobscura and D. melanogaster genomes, 
to narrow this number down to 401 ‘high confidence’ smORFs. Together, this data 
would imply that these identified smORFs have functional, protein-coding potential.  
By combining information obtained from other functional studies and bioinformatics 
predictions, this study places the potential number of D. melanogaster smORFs within 
the range of predicted smORFs found by similar studies in S. cerevisiae, M. musculus, 
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and A. thaliana (Kastenmayer et al. 2006; Frith et al. 2006; Hanada et al. 2007; 
Ladoukakis et al. 2011). smORFs have also been found in rice (Oryza sativa) by 
comparing the genome to that of A. thaliana and using smORF nucleotide sequence 
conservation between the diverged plant species to predict that they are ‘real’ smORFs 
(Okamoto et al. 2014). Analysis of conserved amino-acid sequences (as opposed to 
nucleotide sequences) resulted in the identification of almost 2000 smORFs in the 
untranslated regions (UTR) of both canonical mRNAs and within non-coding RNAs in 
humans, mice, zebrafish, fruit flies and the nematode C. elegans (Mackowiak et al. 
2015).  
Of these bioinformatically predicted smORFs, published ribosome profiling data 
predicts putative translation of more than 100 novel smORFs, and mass spectrometry 
data further corroborates 70 novel SEPs. This leads to the conclusion that a significant 
proportion of smORFs may be translated and encode functional peptides, with evidence 
for their putative functions demonstrated by their conservation across phyla and 
between species. The 401 smORFs identified by our bioinformatics study are very 
strong candidates for functionality as they have evidence of transcription and 
conservation (Ladoukakis et al. 2011), but so far only two of these smORFs have been 
proven to be translated into SEPs and are functional peptides in Drosophila (Magny et 
al. 2013; Pueyo et al. 2016, in print). The general lack of peptide level evidence and 
homology to known protein coding genes has compounded the ambiguity around the 
question of whether or not smORFs are translated into functional peptides. It is clear 
that without proof of translation, we cannot determine smORF function, therefore other 
ways have been sought to circumvent the issue of bioinformatically predicting the 
coding potential of smORFs. 
Assessing smORF translation 
Of the 21,780 total annotated protein coding ORFs in the D. melanogaster genome, 829 
are coding for peptides <100aa (3.8%) (Flybase (FB), http://flybase.org/), which is 
similar to the total proportion of annotated smORFs in zebrafish (2%), mice (2.2%) and 
humans (1.9%) (Aspden et al. 2014). Even though these smORF genes are annotated as 
putatively protein coding, there is very little experimental evidence of their translation, 
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therefore these can fluctuate between protein-coding and non-coding between different 
releases of the genome. Thus in order to study them any further; it becomes essential to 
somehow assess the translation of these smORFs, especially in the absence of a detected 
peptide. Standard Mass Spectrometry techniques have generally not been successful at 
the detection of SEPs and genome-wide studies have only revealed the translation of a 
few SEPs in Drosophila (Brunner et al. 2007).  
Ribosome profiling involves the deep sequencing of  ribosome footprints, which are 
fragments of mRNA that are protected from nuclease digestion by binding of ribosomes 
(Ingolia et al. 2009). These sequenced Ribosome-bound mRNA fragments (RBFs) are 
mapped to the transcriptome to highlight transcripts that are undergoing translation in 
vivo. This technique has allowed the identification of which regions within the mRNA 
are being translated and also reveals the abundance of these translated regions, which 
can be an indicator of cellular or tissue requirement of the product. Several ribosome 
profiling studies performed by other research groups have demonstrated the translation 
of a variety of novel ORFs in various organisms (Ingolia et al. 2009; Vanderperre et al. 
2013; Duncan et al. 2014; Aspden et al. 2014; Bazzini et al. 2014). These novel ORFs 
occur outside of annotated protein coding regions, such as in 5’ (upstream-ORFs) and 3’ 
untranslated regions as well as in non-coding RNAs (ncr_ORFs) and alternative reading 
frames of known protein coding sequences (AltORFs) and have been reviewed in 
(Ingolia et al. 2014).  
By using an assessment of ribosome footprint periodicity through ribosome profiling 
methods, Bazzini et al. (2014) have identified several hundred translated smORFs in 
both zebrafish and human cell lines. Evolutionary conservation of these novel smORFs 
between organisms helps to corroborate these results (Vanderperre et al. 2013), 
especially for those smORFs which are believed to be important regulators of 
development and physiology in higher vertebrates (Bazzini et al. 2014). Ribosome 
profiling studies in yeast show that 24% of previously considered ncRNAs could 
potentially be undergoing translation (Duncan et al. 2014). This study also showed the 
translation of almost two thousand upstream-ORFs (uORFs), which are smORFs that 
occur in the 5’UTR of a longer, canonical transcript. Some uORFs have been 
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experimentally shown to affect the translational regulation of the longer downstream 
ORFs (Zhang et al. 2005). 
Using the relatively new technique of ribosome profiling, our lab attempted a genome-
wide assessment of smORF translation in order to determine how many and which D. 
melanogaster smORFs are translated. For our Ribo-Seq experiment, the technique was 
applied to S2 cells, which are derived from a spontaneously immortalised embryonic 
cell line obtained from late-stage D. melanogaster embryos (Schneider 1972). smORF 
coding sequences are by definition shorter than those of canonical protein coding genes, 
hence they present a smaller target for ribosome binding. This means there are relatively 
fewer RBFs that can arise from a  smORF mRNA in the sequencing data, which creates 
a challenge for classifying smORFs as translated when compared to the  number of 
footprints derived from longer transcripts. This experimental limitation was overcome 
by developing a modified version of ribosomal profiling called Polysomal Ribosome 
Profiling (Poly-Ribo-Seq)., which incorporates polysome fractionation into the initial 
stages of the technique. By limiting the starting material to transcripts bound by 2-6 
ribosomes, we hoped to increase the proportion of RBFs in the library arising from 
smORF transcripts. The Poly-Ribo-Seq experiments revealed the translation of ~230 
annotated smORFs in Drosophila S2 cells (Aspden et al. 2014). Our Ribosome profiling 
study also revealed the translation of 2,708 uORFs and 313 smORFs in non-coding 
RNAs in Drosophila S2 cells (Aspden 2014).  
Ribosomal profiling is gradually becoming an accepted high-throughput assessment of 
genome-wide translation for annotated protein coding regions but significant debate 
remains with regards to the real translation and function of these novel ORFs. It has 
been argued that even though RBFs align to many smORF sequences within various 
transcripts, this association does not constitute proof of translation of these smORFs, 
until a peptide product is detected (Chew et al. 2013). A number of bioinformatic 
approaches have been developed to try and identify translated ORFs by using 
confidence scoring, but these studies have their own challenges (reviewed in Mumtaz 
and Couso 2015). Therefore, until a much larger proportion of smORFs have proof of 
translation at the peptide level, there still exists a need to corroborate some, if not all, of 
the SEPs from smORFs discovered by ribosome profiling. However, few techniques 
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match the scope and sensitivity of ribosome profiling. Mass spectrometry conducted on 
a small protein fraction from S2 cells could only corroborate about 25% of the total 
annotated smORFs that are found to be translated by Poly-Ribo-Seq (Aspden et al. 
2014).  
Some research groups are choosing to approach characterisation of smORFs by 
detecting SEPs directly through Mass Spectrometry and one such study resulted in the 
discovery of 90 SEPs, of which the majority are encoded by novel, previously 
uncharacterised smORFs in human cells (Slavoff et al. 2012). As the pool of 
corroborative information grows, so does the confidence in the data obtained from 
Ribosome Profiling experiments. This has resulted in the general consensus that 
smORFs are translated, despite the low rates of SEP detection and lack of functional 
characterisation (Ingolia 2014; Andrews et al. 2014; Mumtaz and Couso 2015; Brar et 
al. 2015;). However, there are still some doubts and it could be considered that the low 
numbers of SEP-encoding ORFs are actually contaminants in the larger pool of genuine 
ncRNAs (Chew et al. 2013). Therefore further work must be done to differentiate the 
coding-features of smORFs to support their existence as proteins. One of the ways to do 
this is to prove that SEPs are functional at the peptide level. 
The functions of smORF-encoded peptides 
There is significant evidence that some smORFs can have homologues across vast 
evolutionary distances (Ladoukakis et al. 2011; Slavoff et al. 2012; Aspden et al. 2014; 
Bazzini et al. 2014). This means that the functional characterisation of more SEPs could 
open the door for hundreds of previously uncharacterised peptides across animal phyla. 
Known SEP functions range across various biological processes, such as development, 
regulation of metabolism, transcriptional regulation and ion transport across 
membranes. These type of functions are not distinct to SEPs, or exclusive from the 
function and regulation of longer, canonical proteins. There are a few smORFs that have 
been functionally characterised in humans, such as the smORF found in mitochondrial 
16S RNA, which produces a 24aa SEP called Humanin. Expression of Humanin 
protects cells from amyloid-beta mediated apoptosis and inhibits proteins of the pro-
apoptotic cascade (Lee et al. 2013). Another human smORF encodes the 16aa MOTS-c 
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SEP, which is localised to the mitochondria of muscles and regulates cellular 
metabolism. It inhibits the folate cycle and increases the sensitivity of muscles to 
insulin, preventing weight gain and metabolic disease in mice (Lee et al. 2015). MRI-2 
is a 69aa long SEP discovered in human cells, which mediates DNA double-strand 
break ligation by non-homologous end joining, therefore playing a role in DNA repair 
(Slavoff et al. 2014).  
In Drosophila, The 65 amino acid long SEP Reaper is a regulator of the apoptotic 
pathway (White et al. 1994). This is perhaps one of the most important SEPs that has 
been found in Drosophila, as the function of Reaper sits at the convergence point of the 
different signals that lead to the induction of the cell death program. Reaper has also 
been shown to induce apoptosis in Xenopus egg extracts, showing that it can perform its 
biological function in vertebrates systems as well (Evans et al. 1997). This is one 
example of an unavoidable smORF discovery, leading from the investigation of a major 
cellular process, but other smORFs may not be playing such an overt role. Other 
previously characterised Drosophila smORFs show a broad range of functions that 
could be very important for fly life and health. Spargel is a 71aa SEP which was 
discovered in Drosophila S2 cells upon treatment with the insulin-regulated 
transcription factor dFoxo (Tiefenböck et al. 2010). Spargel functions in parallel to this 
transcription factor to help fine-tune insulin signalling. Spargel is a novel homolog of 
mammalian peroxisome proliferator coactivator-1 (PGC-1) (Gershman et al. 2007), 
which has been found to control mitochondrial gene expression in mammals. In 
Drosophila, over expression of Spargel leads to increased mitochondrial activity which 
extends the adult fly life-span (Rera et al. 2011); thus Spargel plays a significant role in 
the integration of mitochondrial activity, gene expression and metabolism. Another 
Drosophila SEP, HSPC300 (75aa), acts as a regulator of actin in the WAVE/SCAR 
complex, which is involved in the downstream effects of the cytoskeletal Rac1 GTPase 
signal transduction pathways (Qurashi et al. 2007). These signals dictate cellular 
movements through the regulation of actin and HSPC300 is particularly important in the 
nervous system, where it helps to control embryonic CNS axon and synaptic 
morphologies via these pathways. 
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The 11aa Tarsal-less peptide can perform the entire range of the functions of this 
polcistronic smORF gene as long as the peptide contains the LDPTGXY motif, which is 
phylogenetically conserved across insects, indicating its importance (Kondo et al. 2007; 
Galindo et al. 2007). In addition to Tal, which functions as a cell signal, our lab has also 
characterised the function of sarcolamban (scl), which encodes two SEPs of 28 and 29 
amino acids in length. Scl was shown to be a homologue of the vertebrate Sarcolipin 
and Phospholamban peptides (Magny et al. 2013). These peptides are structurally and 
functionally shown to be playing a role in the regulation of the Ca2+ SERCA pump in 
both vertebrates and flies. The SERCA pump is found in the sarcoplasmic reticulum of 
heart muscles in most mammals and also in mouse skeletal muscle (Anderson et al. 
2015). Changes in the expression of sarcolamban and its homologues have an effect on 
the rhythmic beating of the heart, which lowers the overall health of the fly (Magny et 
al. 2013). The functional homology of Scl in higher eukaryotes, as well as of some of 
the other SEP examples given here, can be considered further evidence for why the 
study of smORFs in Drosophila is a subject of wider relevance, not just for Drosophila 
development and physiology, but for vertebrates as well.  
Approaching the question of smORF function using the fruit fly as a model has 
uncovered the vital functions of some novel smORF encoded peptides. However, 
research on SEP functions has been serendipitous, and follows smORF gene discovery. 
This illustrates a need for a more targeted approach in the detection of SEPs and their 
functions. Studying SEP function at the organism-level is vital to giving relevance to the 
wider function of smORFs, and for this purpose, Drosophila is probably one of the best 
eukaryote models for the functional characterisation of these novel genes, because of its 
ease of genetic manipulation and extremely well annotated genome. However, the 
methods employed by these single gene studies cannot currently be extended to a 
genome-wide smORF functional study due to the various challenges of assessing very 
small proteins. Therefore, each smORF that has been characterised so far, requires years 
of research on a particular pathway or system while breaking new ground with a range 
of diverse techniques. If it becomes possible to unravel the functions of smORFs in a 
high-throughput manner in Drosophila, this would open the door for similar studies in 
vertebrates, where time and experimental limitations are even bigger concerns.  
 10
The only genome-wide study conducted specifically on smORF function, has been 
conducted in S. cerevisiae, in which less than 10% of the smORFs tested led to a mutant 
phenotype in relation to the growth of yeast cells (Kastenmayer et al. 2006). This could 
be because not all smORFs in yeast are involved in growth, but also because growth can 
be attributed to several processes occurring in the cell. This highlights the need for 
establishing a higher-throughput approach to characterise smORFs by gathering more 
data on specific functions in which SEPs are directly involved, in order to characterise 
their functions. Genome-wide Ribosome Profiling and Mass Spectrometry experiments 
have provided us with data about which smORFs are being translated, but only a small 
minority of these SEPs have any specific localisation data or experimentally 
corroborated functions. The direct detection of SEPs can be considered vital to 
understanding smORFs on a broader scale, as they are likely to function where the are 
found. The ability to label and knock-down smORF gene products would aid in 
understanding their functional phenotypes. 
The main question addressed in this thesis is how to assess the function of smORFs and 
SEPs in a high or medium-throughput manner in Drosophila. This question has been 
addressed by approaching smORF functions at the cellular level, which provide an 
experimental system that can be manipulated at a more rapid and wider scale than 
studies conducted in vivo. Most important mechanisms of cellular function remain 
unchanged across eukaryotic cells, providing a broader scope for this study in higher 
eukaryotes as well, especially for SEPs conserved in vertebrates, therefore in this thesis, 
I use Drosophila haemocytes and S2 cells to study the localisation and function of 
smORF-encoded peptides. Like several other Drosophila embryonic cell lines, S2 cells 
display gene expression similar to that of haemocytes (Cherbas et al. 2011) and some 
cell lines also display haemocyte-like motility (Baum and Cherbas 2008). S2 cells are 
also phagocytic, which is a characteristic behaviour of macrophage-like cells (Elwell 
and Engel 2005). After pursuing an in-depth study on a single smORF expressed in 
haemocytes in vivo (Hemotin; Chapter III). The results from this study were used as 
groundwork to create a pipeline for the cell based assessment of SEP functions in S2 
cells. This pipeline allows us to provide novel insight into the characterisation of several 
SEPs, which localise to and function within the mitochondria (Chapters IV and V). 
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Chapter II - Materials and Methods 
A. Animal rearing 
All experimental fly stocks were kept in vials or bottles at 25ºC on a standard cornmeal 
diet. 
B. Embryo collection   
Flies expressing GFP in haemocytes: w; srpGAL4-UASGFP; crqGAL4-UASGFP were 
crossed with Hemotin null flies (w;;Df A4/TM3-YFP) to establish the stable line: w; 
srpGAL4-UASGFP; Df A4/Tm3-YFP. The TM3-YFP chromosome III balancer was used 
to maintain this line, as male Df A4 flies are sterile. The embryos and larvae could be 
differentiated from Df A4 homozygous flies due to the presence of the strong YFP in the 
presumptive eye region. These flies were transferred from vials into egg-laying ‘cages’ 
supplemented with apple juice agar plates with yeast paste to collect embryos. After 
discarding embryos from the first 24 hours, plates were changed at 12-hour intervals, 
resulting in the collection of a mixed population of embryos between Stage 1 to Stage 
14 of embryonic development (Hartenstein 1985). Embryos were collected from the 
apple juice agar plate with a paintbrush into a basket and washed using distilled-H2O 
(dH2O) to prepare for dechorionation. Embryos were dechorionated by adding a few 
drops of bleach to the collection basket and rocked for ~2-3 min, until the chorion 
dissolved and embryos appeared shiny; the bleach was washed out using dH2O and the 
embryos were blotted to dry.  
C. Embryo fixation and removal of vitelline membrane  
Paraformaldehyde (PFA) was used as a fixative to crosslink molecules of the embryo in 
situ. One millilitre of 4% PFA and 1ml of Heptane were added to a 2ml Eppendorf tube. 
The dechorionated embryos were added to the vial using a paintbrush.The Eppendorf 
was taped to an agitator at the lowest settings for 20 minutes to allow fixation to occur. 
After this time, the bottom PFA phase was removed, taking care to ensure that embryos 
remain in the Eppendorf. One millilitre of 100% methanol (MeOH) was added to the 
tube and the vials were shook hard for several minutes, until almost all the embryos 
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sunk to the bottom of the tube, indicative of vitelline membrane removal. The heptane 
was aspirated from the sample, and after 2–3 washes with methanol, the embryos were 
stored at –20ºC in fresh 100% MeOH. 
D. Embryo immunohistochemistry 
The Hemotin antibody (Eurogentec) was raised against the N-terminal peptide sequence 
of Hemotin: RISITPGCSMVATTKLTHSRNSVDIY. Fixed embryos were washed in 1X 
Phosphate Buffered Saline (PBS), and then 1X PBT (1X PBS + 0.1% Triton X-100). 
Embryos were then prepared for antibody staining by blocking in 1X PBT-BSA (0.3% 
Triton X-100, 0.2% Bovine Serum Albumin). Rabbit anti-Hemotin Serum and 
Immunopurified antibodies were diluted to 1:200, along with 1:500 mouse anti-GFP 
(Roche) in PBT and incubated overnight overnight at 4ºC. The next day, embryos were 
incubated for two hours at room temperature with anti-mouse FITC and anti-rabbit 
Biotin (each at 1:200). Embryos were then mounted on glass slides in Vectashield 
(Vector). Fluorescent antibody stained embryos were analysed and images were 
captured using a Zeiss LSM510 Meta point scanning confocal microscope and the Zeiss 
LSM software (Sussex Centre for Advanced Microscopy, University of Sussex; 
Brighton, UK). LSM Image Browser and ImageJ softwares were used for image 
processing.  
E. Primary haemocyte immunohistochemistry  
Hemolectin_GAL4 (Hml_GAL4) (Goto 2003) flies were crossed to the UAS-Hemotin-
GFP fly line. The w;;Df A4/Tm3-YFP balanced stocks were used to obtain Hemotin null 
animals, which do not have the Tm3-YFP marker. Oregon-R flies were used as wild 
type controls. From the tubes of these flies, 6 animals at wandering third instar larval 
stage (L3) or white prepupal (WPP) stages were collected for each genotype, washed 
with dH2O and blotted to dry. Animals were sorted on a fluorescent dissection 
microscope to differentiate the Df A4 L3 and WPP. The animals were bled using a sterile 
needle and forceps in 200µl DHIM (25% FBS v/v Schneider’s media: Drosophila 
Haemocyte Isolation Medium (Sampson and Williams 2012)), which consists of filtered 
Schneider’s Drosophila medium supplemented with 25% Fetal Bovine Serum (FBS). 
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The staining protocol is adapted from Zettervall et al. (Zettervall et al. 2004), in which 
haemocytes are fixed and stained ex vivo. After removal of the carcasses, the remaining 
200µl was transferred to collagen IV-coated coverslips in circular culture dishes to settle 
for 30 minutes before further staining. After this stage, in the case of organelle dye 
Lysotracker-RED DND-99 (Life Technologies), the dye was diluted to 1:1000 in DHIM 
and 200µl of this was incubated with the cells for 15 minutes after removal of plating 
media. As further fixation would remove the Lyostracker staining, these samples were 
imaged live Imaging was conducted on a Zeiss LSM 510 confocal microscope with 
automated prior stage. LSM Image Browser, ImageJ v1.46r softwares were used for 
image processing.
If samples were to be used for antibody staining, plating media was removed and 200µl 
of 4% PFA fixative was added to the culture dish for 10 minutes and then the cells were 
washed with 1X PBT. After this, cells were blocked with 1X PBT-BSA for 1 hour. The 
primary antibodies used for immunohistochemistry are: rabbit anti-Hemotin (1:200), 
rabbit anti-KDEL (DSHB) (1:50), mouse anti-GRP75 (Santa Cruz) (1:200), rabbit 
anti-14-3-3 pan (Santa Cruz) (1:400), mouse anti-beta tubulin (DSHB) (1:500). Cells 
were incubated with primary antibodies either overnight at 4ºC or for 2 hours at room 
temperature. After washing with 1X PBT, samples were incubated with anti-rabbit 
Rhodamine (1:200), anti-mouse Biotin (1:200) or anti-rabbit Biotin (1:200) from all 
from Jackson laboratories. In the case of Hemotin staining, with biotin labelling 
followed by Avidin Rhodamine (Jackson) tertiary antibody (1:1000). For F-actin 
staining, 1:500 Phalloidin-FITC (Life Technologies) dye was added after antibody 
incubations for 30 minutes at room temperature. After 1X PBT washes, Hoechst nuclear 
stain (Sigma) was used at a concentration of 1:500 for 10 minutes. Samples were then 
washed with 1X PBS, covered with Vectashield and stored at 4ºC. Imaging was 
conducted on a Zeiss LSM 510 confocal microscope with automated prior stage. LSM 
Image Browser, ImageJ v1.46r softwares were used for image processing. The ImageJ 
plugin ‘Manders Coefficients’ was used to calculate correlation coefficients of Hemotin-
GFP to signal from the various organelle markers.  
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F. Mander’s Coefficients for colocalisation of markers  
Mander’s coefficient is used to quantify the amount of overlap between pixels of 
different channels that detect signal from different fluorescent markers (Dunn et al. 
2011). All sample images were quantified by cropping the cells from the main image in 
order to isolate individual scores for each cell. The R-value for each measurement of 
colocalisation was then averaged for all the cells of each sample imaged.  
G. Fly Survival Assay  
The fly viability assay was conducted on male and female virgins 0–2 days old from the 
following lines: Hemotin mutant (Df A4), wild type Oregon-R (Or-R) and positive 
control fob1 allele flies (Akber et al. 2011). In order to verify the specificity of viability 
to the Hemotin gene, a fly line that rescues the deletion of CG7691 in a Df A4 
background (made by J.I. Pueyo) was used. The collected flies were kept at a maximum 
density of 20 flies per vial. For each strain, we kept three classes: untreated, wounded 
and infected. Bacteria were grown from stock cultures stored at –80ºC. A toothpick 
amount of each bacterial strain was placed in culture flasks containing 10ml of 
Lysogeny Broth (LB) medium and cultures were grown overnight at 37ºC. The next day, 
1ml of the starter culture was placed in Erlenmeyer flasks containing 50ml of LB media 
and allowed to grow at 37ºC; bacterial concentrations were checked every hour after an 
initial 2-hour growth phase. The Gram-positive, pathogenic bacteria Micrococcus 
luteus, and the Gram-negative pathogenic bacteria Enterobacter cloacae were used at a 
final concentration of optical density (OD) 0.75 and 0.84, respectively, in LB medium. 
The non-pathogenic DH5α Escherichia coli was grown to an OD of 0.95 and then spun 
down in a cooled centrifuge (5000g) to pellet the bacteria. The pellet was then 
resuspended in 0.5ml of PBS for a final concentration of approximately OD 0.95, which 
is theoretically impossible, but in relative terms, this would be a very high concentration 
of DH5α E. coli. Fly infections were conducted by pricking the flies in the ventrolateral 
abdomen, under the haltere, with a sterile 0.25 gauge tungsten needle dipped into the 
bacterial cultures. As a control, flies of each strain were wounded in the abdomen with a 
tungsten needle dipped in sterile 1X PBS. The flies that remained alive were then 
counted over the next 60 days.  
 15
H. In vivo imaging of embryonic haemocytes 
w; srpGAL4-UASGFP; Df A4/Tm3-YFP heterozygous flies were allowed to lay 
embryos on apple juice agar plates. These embryos laid by these flies were sorted for 
homozygous and heterozygous conditions based upon the presence of the TM3-YFP 
marker. After dechorionation, embryos were mounted on double-sided tape stuck to a 
glass slide, with the ventral side towards the coverslip and covered in 10S Voltalef Oil 
(SIGMA); a coverslip was applied to the slide and affixed using nail varnish. This is 
similar to the protocol used by the Wood Lab (University of Bath) (Evans 2010) (Evans 
2010a). Imaging was conducted on the Zeiss LSM 510 confocal microscope. In vivo 
time lapses were obtained as well as stills, using a Z-stack taken every 2–4 minutes for 
30 min to 1.5 h. Image analysis was conducted with Freeware software, ImageJ. The 
ImageJ Plug-in ‘Grouped ZProjector’ was used to make projections of each frame. 
I. In vivo imaging of pupal haemocytes 
w; srpGAL4-UASGFP; Df A4/Tm3-YFP flies were allowed to lay eggs in tubes and 
adults were removed frequently to prevent crowding. Brown pupae (40–50h after 
puparium formation) were recovered and sorted for homozygous and heterozygous 
conditions. The selected pupae were washed with dH2O and blotted dry. Pupae were 
mounted ventral-side down on double-sided tape applied to a glass slide. The pupal 
cases were dissected in a manner similar to that of Moreira et al. (2011) (Moreira et al. 
2011), by removing a window in the pupal case over the thorax. After application of 10S 
Voltalef Oil on the thorax region, a ring of petroleum jelly was made around the 
samples, a coverslip was rested on this ring and pressed down on the sample. The slide 
was raised on the microscope stage by adding additional pieces of glass slide to the 
edges to allow deeper focal length. Imaging of live haemocytes was conducted on an 
inverted Zeiss LSM 510 with automated prior stage, using a Hamamatsu ORCA-ER 
C4742-95 digital camera. A Z-stack was taken every 2–4 minutes for 30 min to 1.5 
hours. Image analysis was conducted with ImageJ. 
J. Measuring Occupied Area Index of haemocyte vacuoles 
Cell and vacuole sizes were measured using ImageJ. Lines were drawn around GFP-
labeled haemocytes and the dark vacuoles in the cytoplasm with the drawing tool used 
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to label ROIs and then measured using the Measure tool to show the area of the ROI of 
the cells and vacuolated areas. The sum of the vacuolated areas of each cell was divided 
by the overall cell area to calculate the vacuolar Occupied Area Index (OAI) for each 
cell, and averaged. 
K. Primary haemocyte culture ex vivo  
Flies were allowed to grow in stock tubes; L3 and WPP were collected and bled with a 
0.25mm gauge needle in DHIM. These were plated on collagen-coated coverslips and 
allowed to adhere for 30 minutes. Ex vivo imaging and image analysis was conducted 
using an inverted Zeiss Axiovert 200M microscope with automated prior stage with a 
Hamamatsu ORCA-ER C4742-95 camera. Ex vivo time lapses were 20 minutes at 15 
seconds/frame, as conducted by Sampson et al. (Sampson et al. 2013). All ex vivo 
experiments consisted of haemocytes excised and isolated from a minimum of 6 L3 or 
WPP, which was repeated a minimum of two to three times per life stage/experimental 
group. ImageJ v1.46r was used to make time-lapse movies for subsequent analysis of 
morpho-behavioral haemocyte types. 
L. S2 cell culture, transfection and imaging   
S2 cells were cultured in 10% FBS (v/v) Schneider’s media. The cells were grown to a 
confluent stage (2 days after splitting) and then resuspended in fresh media and diluted 
at lower dilutions in new flasks. For imaging and transfections, 1ml of S2 cells at a 
concentration of 250,000 cells/mL were plated on acid-treated coverslips in 6-well 
plates. The smORF transfections were conducted by combining 1µg of plasmid DNA of 
each transfection in order to have consistent levels of DNA in the S2 cells. The smORF 
fusion constructs were combined with a lipid-based transfection reagent, Xtreme Gene 
HP (Roche). The plasmid and transfection reagent mix was added to the cells and then 
left for 48 hours in order to allow the plasmid to be expressed by the host cells 
translation machinery. The cells were then fixed for 20 min with 4% PFA, washed with 
1X PBS and 1X PBT, then blocked with PBT + 2% BSA (wt/vol), before IHC with 
primary mouse anti-FLAG M2 antibody (1:1000; Sigma) and secondary anti-mouse 
FITC (1:400; Jackson). For subcellular localisation experiments, cells were incubated 
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for 30 min with 1:500 Rhodamine-Phalloidin (Life Technologies) to highlight F-actin. 
All transfections were incubated for 10 min with Hoechst (Sigma) according to 
manufacturer's instructions for nuclei staining and mounted with Vectashield (Vector 
Labs). For Mitotracker experiments, cells were incubated in 500 nM Mitotracker Red 
CMXRos (Life Technologies) for 45 min. Cells were then fixed and the 
immunohistochemistry protocol for anti-FLAG was conducted as above, followed by 
DAPI to stain the nuclei. Imaging was conducted using a Zeiss 63X Plan Apochromat 
Oil Immersion lens on the LSM510 Axioskop 2. For colocalisation analysis Z-stack 
images were taken with slice interval of 0.15 µm, and the ImageJ plugin ‘Mander's 
Coefficients’ was used to calculate correlation coefficient of FLAG to Mitotracker 
signal with at least 15 cells per replicate, with three replicate transfections.  
M. Alamar Blue Assay 
Confluent S2 cells were resuspended in Serum-Free Schneider’s media and counted on 
the haemocytometer, after which they were diluted by volume to required densities. The 
dsRNAs used in this assay were made at the RNAi screening facility at the University 
of Sheffield (Sheffield, UK). One micro litre of 0.1µg/µl dsRNA was added to the 
bottom of the wells and 100µl of cells were quickly added. One hour after the addition 
of cells, the wells were supplemented with 20% FBS Schneider’s media for the normal 
amount of FBS used to culture S2 cells. The plates were sealed with ParaFilm and 
incubated at 25ºC for 48-96 hours, depending on the experiment. The growth media was 
then aspirated from the wells and 200uL of fresh Serum-Free media containing 10% 
Alamar Blue (ThermoFisher) was added to each well. The plates were incubated at 25ºC 
for up to 6 hours and triple fluorescent readings were obtained for the samples at hourly 
intervals in the GloMax Plate Reader (Promega)  
N. Verification of positive control dsRNAs by RT-PCR 
Total RNA was extracted from S2 cells transfected with dsRNA against the controls 
DIAP1, cdc2 and BlueScript in the following way. 2x106 cells were plated in 1ml of 
Serum-Free media in each sample well to which 8µg of dsRNA was added; after 1 hour, 
1ml of 20% FBS Schneider’s media was added. The plate was sealed and incubated for 
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48 hours at 25ºC. After this time, cells were resuspended in the growth media and 
transferred to 2ml Eppendorf tubes. The samples were spun at 5000g for 10 minutes in a 
chilled centrifuge (4ºC) to pellet the cells. After pelleting, the media was removed and 
cells were washed with ice-cold 1X PBS and spun down twice. After removal of PBS, 
800µl of the TRIzol reagent (Invitrogen), which contains a mixture of phenol, 
guanidium thiocynate, and ammonium thiocynate, was added to the cell pellet. The 
samples were homogenised by pipetting and stored at -80ºC. After the addition of 
chloroform:isoamyl (24:1) the tubes were incubated for 5 minutes at room temperature, 
spun to separate phases and the resulting supernatant was transferred to a sterile, 
nuclease-free tube.  
In subsequent steps, the RNA was precipitated with isopropanol and washed with 
ethanol before being resuspended in nuclease-free H2O and quantified using a 
NanoDrop Spectrophotometer. cDNA was synthesised using the RETROscript Reverse 
Transcription Kit (Ambion), following the protocol for the ‘Two-step RT-PCR with heat 
denaturation of RNA’ procedure provided by the manufacturer. One microgram total 
RNA was combined with either random decamers or oligo(dT) primers and nuclease-
free water, then denatured at 80ºC before the addition of the remaining RT reagents: 
10X RT buffer, dNTPs, RNase inhibitor, and the M-MLV Reverse Transcriptase. 
Reverse transcription of cDNA was done at 42ºC for 1–2 hours. The reaction was 
stopped by inactivating the reverse transcriptase at 92ºC for 10 minutes. Newly 
synthesised cDNA was stored at -80ºC until ready to use in PCR reactions. 
 
O. PCR Primer design 
Primers were designed by hand towards the sequences of DIAP1 and cdc2 and prepared 
by Invitrogen Custom Primers (http://www.invitrogen.com). Primers were resuspended 
in sterile water to a stock concentration of 100µM, from which a 10µM working 
solution was prepared; both were stored at -20ºC. Primer design targeted areas of the 
DNA which were exclusive to the dsRNA sequence, so to observe only the priming of 
the target and not accidentally quantify the dsRNA which had been added to the cells. 
The list of specific primers used for each gene can be found in Appendix 1.   
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P. Polymerase Chain Reaction 
 
PCR reactions were conducted using reagents provided in the Taq PCR Core Kit 
(QIAGEN). PCR reactions were prepared on ice to a total volume of 100µl as follows: 
5µl 10X PCR buffer; 10µl 5X Q-Solution; 2–4µl MgCl2 (25mM); 2µl dNTP mix 
(10mM each); 2µl each specific forward/reverse specific primer (5µl degenerate 
primers); 2µl template cDNA; 0.5µl Taq DNA polymerase (5U/µl); H20 up to 100µl. 
PCRs were conducted using the Master-cycler Gradient Thermocycler (Eppendorf). 
Cycling conditions were kept constant for both PCRs. Initial DNA denaturation at 94°C 
(4 minutes), then 31 cycles of: Denaturation at 94°C (30 seconds), Annealing at 59°C 
(30 seconds), Extension at 72ºC (45 seconds) and the final extension at 72°C (5 
minutes). Visualisation of the various PCR products was done via agarose gel 
electrophoresis. Gels were prepared by combining 1.5% agarose with 1X TBE (89mM 
Tris, 89mM boric acid, 2mM EDTA) and heated in a microwave to dissolve. For 
visualisation, 0.5µg/ml ethidium bromide was added to the liquid agarose before 
pouring into the gel cast. The DNA or RNA product was combined with 
MassRulerDNA Loading Dye (Fermentas) at a proportion of 1µl dye for every 5µl 
product and loaded into the wells of the agarose gel alongside the MassRulerDNA 
Ladder Mix (80–10,000bp fragments; Fermentas) to assess product length and to 
calculate approximate sample concentration. Gel pictures were taken using an Uvidoc 
gel documentation system and UviPhotoMW image analysis software. 
Q. Mitochondrial morphology assay 
Cultured S2 cells were resuspended in Serum-Free media and counted for dilution using 
a haemocytometer. Cells were to be plated at a concentration of 250,000 cells, which is 
a standard number for imaging. Six-well culture plates were prepared to contain an acid-
treated coverslip upon which 2µg of 1µg/µl dsRNA working solution were pipetted. 
These dsRNAs were designed in-house by myself or J.L. Aspden and made by R.J. 
Phillips. In untreated cells, 2µl of milliQ H2O was pipetted instead of dsRNA. One 
millilitre of cells (250,000 cells/ml) were added to the coverslip and allowed to mix 
with the dsRNA by gentle swirling of the plate. After a 45 minute incubation at room 
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temperature, the cells + dsRNA were supplemented with Schneider’s media containing 
20% FBS and allowed to grow for 48 hours on the coverslip. After this time, 
MitoTracker-Red, diluted to 500nM in 10% FBS Schneider’s media, was added to the 
wells for 1h. After removal of media, cells were fixed with 4% PFA, stained with DAPI 
for 10 minutes to label the nuclei and the coverslip was mounted on glass slides 
containing a drop of Vectashield. 
R. Bioinformatics Software 
Peptide Atlas (Desiere et al. 2006) Lists of peptide CDS coordinates with protein 
identifiers (FlyBase peptide ID) were downloaded from the Peptide Atlas database 
(http://www.peptideatlas.org).  (Desiere et al. 2006) Peptide Sequences of smORFs 
were obtained from Ensembl (http://www.ensembl.org/biomart/martview). Prediction of 
transmembrane alpha-helices was performed using TMHMM (http://www.cbs.dtu.dk/
services/TMHMM). Prediction of peptide-localisation motifs was conducted by TargetP 
(http://www.cbs.dtu.dk/services/TargetP/) 
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Chapter III - Cellular characterisation of Hemotin
Introduction
In proving the existence of small functional peptides, the detection of a peptide product 
encoded by a putative open reading frame is a crucial step in differentiating smORF 
transcripts from genuine non-coding RNA’s. After the success of smORF gene 
characterisation with tarsal-less and Sarcolamban, a potential candidate was found on 
the Drosophila chromosome 3R. We named this gene Swiss-smORF, in homage to the 
detection of this putative peptide by a Swiss group in a genome-wide proteomics study 
of Drosophila melanogaster. The ‘Swiss-prot' database was the result of one of the first 
genome-wide Mass Spectrometry studies conducted in the fruit fly (Brunner et al. 
2007). With the promise of a detected protein, we began to map the various open-
access data that is available regarding this stretch of DNA. CG43194 and CG43210 are 
now annotated as two individual gene models, but are actually a dicistronic smORF 
gene. There is evidence of a processed transcript for these genes, FBtr0346523, which 
contains two non-overlapping ORFs. The Swiss-smORF gene is approximately 1kb 
long, and encodes for two peptides of 88 and 59 amino acids in length (Figure 3.1A). 
The ‘model organism Encyclopaedia of DNA Elements’ (modENCODE) project has 
compiled RNA-Sequencing data for several Drosophila experimental models, including 
various stages of animal development, tissue types, cell lines, and treatments. These 
experiments allowed for sequenced mRNA transcripts to be mapped to the genome in 
terms of their relative abundance in each of the conditions (Roy et al. 2010) (Li et al. 
2014). Using the compiled data from various conditions, we are able to see that the 
transcript levels of Swiss-smORF are quite low overall (Figure 3.1B).  
N.B. Portions of this chapter have been published in Pueyo et al., (2016) PLoS 
Biology (in print) and Sampson et al., (2013) Biology Open.  
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Figure 3.1: Hemotin gene models and the expression of Hemotin in Drosophila  
A) Hemotin is made of two smORFs that are transcribed as a dicistronic transcript 
encoding for 88aa (ORF1) and 59aa (ORF2) peptides. B) Semi-quantitative RT-PCR 
shows Hemotin is very lowly expressed at larval stages but is clearly detected at pupal 
and adult stages. Rp49 is included as a loading control. C) Summary of modENCODE 
RNA-Sequencing data showing expression of hemotin in various Drosophila 
developmental stages, cell lines and treatments. D) The genomic locus of hemotin and 
the deletion in the A4 deficiency (Df A4) line, which lacks the 5’ ends of fruitless and 
fray and has a complete excision of CG7691. E) Semi-quantitative RT-PCR showing 
that there is no hemotin expression in unfertilised embryos compared to adult flies. 
Rp49 is used as a loading control. F) Pattern of expression of hemotin in stage 11 (A,B) 
and stage 15 (D,E) wild-type Drosophila embryos, as revealed by in situ hybridisation. 
Hemotin is expressed in in the head, amnioserosa, and dispersed along the body in both 
wide-field (A,D) and fluorescently-probed (B,E) images. in situ hybridisation of 
hemocyte-specific Croquemort (Crq) gene (C,F) showed similar distribution of 
Croquemort marker at stages 11 (C) and stage 15 (F) in the head, amnioserosa and along 
the body (arrows). 
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The mRNA levels are normalised RPKM values (Reads per Kilobase/Million) on a 
scale of 1 to >1000. Swiss-smORF transcript is not detected in these experiments during 
embryonic stages. Very low levels of expression can be seen in conditions where the L3 
larvae are treated with Cadmium, Zinc and Ethanol. Swiss-smORF levels increase with 
infection with the Sindbis virus, at the pupal stage (Figure 3.1C). Data from untreated 
flies shows that the expression of Swiss-smORF may be temporally regulated, with a 
peak of expression at the beginning of metamorphosis, 12h after puparium formation 
(WPP stage). This has been verified by RT-PCR, which showed faint expression of 
Swiss-smORF at L1, L2, L3 stages, followed by an increase of expression in the pupal 
and adult stages (Figure 3.1B). Comparably, there is a higher level of Swiss-smORF 
expression in Drosophila cell lines, such as those derived from the imaginal discs of the 
fly, which are the progenitor organs from which the adult structures (i.e. legs, wings, 
halters, eyes, antennae and gonads) are derived. All of these are locales where, over the 
course of Drosophila development, massive cell proliferation and cell death occur. 
Notably, expression is highest in the CNS derived cell line ML-DmBC2-G2, and in 
tumorous blood cells. All of this summarises the information that we knew before I 
began working on the project. 
Drosophila haematopoiesis during development 
In situ hybridisation of Swiss-smORF in Drosophila embryos showed a pattern of 
mRNA expression in the embryo where the signal was localised to the cephalic 
mesoderm in stage 11 (Figure 3.1F). From this result, we could observe that the areas of 
Swiss-smORF mRNA expression are similar to the expression of the Croquemort  (Crq) 
receptor. This receptor recognises apoptotic cells for phagocytosis and is used as a 
marker for labelling haemocytes. Crq expression can be readily detected at late stage 11 
of embryonic development (Franc et al. 1996) and Crq-GAL4 is used as a haemocyte-
specific driver in flies. Swiss-smORF expression is increased and more widespread in 
stage 15 embryos and again follows the expression pattern of GFP expressed using the 
Crq-GAL4 driver. This led us to believe that Swiss-smORF may be expressed in the 
head region, and in haemocytes, which are the functional and cellular homologs of 
mammalian macrophages. At this time, the name of the gene encoding the Swiss-
smORF peptide was changed to Hemotin, and that is how it will be depicted from now. 
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There are two haematopoietic ‘waves’ of blood cell differentiation during Drosophila 
development. The first occurs during embryogenesis and the other arises from the 
transient lymph gland at puparium formation (Holz et al. 2003) (Lanot et al. 2001). The 
main function of both embryonic and lymph gland haemocytes is to perform 
phagocytosis of apoptotic cells and their debris from developmentally programmed cell 
death, and to get rid of foreign pathogens (Tepass et al. 1994; Holz et al. 2003; Tzou 
2002). Embryonic haemocytes are derived from the pro-cephalic mesoderm, in the 
presumptive head region, shortly after gastrulation (stage 10). Most cells in this 
compartment go through several rounds of mitosis to give rise to recognisable pro-
haemocytes (Tepass et al. 1994). During germ-band retraction (stage 12), haemocytes 
begin to migrate from the cephalic region to populate the entire embryo (Tepass et al. 
1994; Cho et al. 2002; Evans et al. 2010). Haemocytes can first be distinguished from 
pro-haemocytes in the head during Central Nervous System (CNS) formation (early 
stage 13), where they are required to clear up the cellular debris around the developing 
nervous system. In haemocyte depleted embryos, the CNS fails to condensate along the 
anteroposterior axis (Defaye et al. 2009). Haemocytes in these areas start to show 
inclusions, or vacuoles, containing the leftovers of apoptotic cells, indicating that the 
haemocytes have become phagocytic. Almost all (~90%) embryonic pro-haemocytes 
change into macrophages by stage 15 of embryogenesis (Tepass et al. 1994). A 
remaining ~5% of pro-haemocytes found near the embryonic head, develop into crystal 
cells (Lanot et al. 2001).  
Vascular endothelial growth factor (VEGF) genes are expressed along the 
developmental migration paths of the haemocytes, and the VEGF receptor (VEGFR) is 
expressed in Drosophila haemocytes. The three isoforms of the VEGFR play a 
redundant, yet essential role in the migration of haemocytes (Cho et al. 2002). The 
ability of haemocytes to migrate at embryonic stages is not dependant on signalling 
from apoptosis but rather, developmental migration of haemocytes is mediated by the 
expression of VEGF, which happens to coincide with areas of embryonic apoptosis 
(Cho et al. 2002). In Drosophila, haemocytes are required for normal embryonic 
development as inducing apoptosis in haemocytes using a haemocyte-specific GAL4 
resulted in 94% lethality of embryos before the first Larval instar stage (Defaye et al. 
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2009). 
Before hatching into larvae, embryos develop a presumptive lymph gland along the 
dorsal vessel, close to the cells that will constitute the heart of the fly. The lymph gland 
is derived from a mesodermal origin during embryogenesis. The lymph glands have two 
pairs of lobes, and the first to appear are the anterior/primary lobes. At early L3 stage, 
the posterior or secondary lobes begin to develop (Crozatier and Meister 2007). The 
second haematopoietic wave occurs at the end of larval stages when the pro-haemocyte 
group of cells found in the posterior lobe of the lymph gland begin to differentiate into 
macrophages. The mature macrophages are released upon pupation, which is followed 
by the disintegration of the lymph gland (Jung et al. 2005). The schematics in Figure 
3.2A depict the process of haematopoiesis in Drosophila. The lymph gland is a source 
of haemocytes primed for the phagocytosis of apoptotic material released during 
metamorphosis, and the later requirement for the adult fly immunity (Lanot et al. 2001). 
However, lineage tracing reveals that both embryonic and lymph gland haemocytes are 
found in the adult haemolymph (Holz et al. 2003). Our initial observation of Hemotin 
mRNA in the presumptive head region during embryogenesis and the increased 
expression of Hemotin during L3 and pupal stages, fits into the timing of important 
haemocyte-related events such as differentiation.  
The haematopoietic role of ecdysone 
In the early 1900’s, it was discovered that insect moulting, the mechanism by which 
insects develop and grow, is a hormone-dependent process. This hormone was 
discovered to be a pentahydroxysteroid (alpha-ecdysone). The conversion of the 
pentahydroxysteroid to a hexahydroxy form in vivo, resulted in the later identification of 
Beta-ecdysone (Garen et al. 1977). Ecdysones have been discovered in many other 
insects that use moulting as a mechanism for growth. Ecdysone is involved in the 
progression of Drosophila developmental stages (Yamanaka et al. 2013), and is required 
for proper embryonic development (Kozlova and Thummel 2003) and the larval to 
pupal stage transition (Figure 3.3B) (Thummel 1996). Waves of ecdysone expression 
coincide with polytene chromosomal puffing, which is a sign of gene transcriptional 
activation. These genes were found to encode the Broad-Complex (BR-C) transcription 
factors E74 and E75, along with the Ecdysone receptor gene (EcR).  
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Figure 3.2: Developmental stages of haematopoiesis and ecdysone activation of 
haemocytes A) Schematic of the differentiation of haemocytes in the Drosophila 
embryo (top) and larval lymph gland (bottom). The haemocytes migrate as they 
differentiate from the anterior to the posterior of both embryo and lymph gland B) Ex 
vivo studies showed a distinct change in cell morphology during the transition from late 
L3 to white pre-pupal stages from ‘normal’ spread at L3 (blue bars) to ‘polarised’ when 
exposed to endogenous ecdysone at WPP stage (red bars). This activation can be 
replicated by Ecdysone treatment of L3 haemocytes (yellow bars) (Sampson CJ, Amin 
UA, Couso JP, 2013, Biology Open). C) I conducted in vivo imaging of GFP-expressing 
Drosophila haemocytes during L3, 1 hour, 2 hours (White Pre-Pupae, WPP) and 24 
hours After Pupal Formation (APF). Haemocytes show a change in morphology from 
rounded (L3, 1hAPF) to activated, polarised shape (2hAPF) as Ecdysone levels increase 
at the WPP stage in vivo. 24hAPF haemoctes are full of phagocytosed material.  
developmental time points, indicating that these cells are
responsive to triggers of developmental timing (reviewed by
Wood and Jacinto, 2007). Broadly speaking, in the overall course
of development, a motile embryonic population changes into a
largely sessile and inactive population at larval stages (forming a
reservoir for release in case of infection), and then back to a
highly motile and phagocytic state at puparium formation (Lanot
et al., 2001; Holz et al., 2003; Crozatier and Meister, 2007; Honti
et al., 2009; Ma´rkus et al., 2009; Wood et al., 2006)
(supplementary material Fig. S1).
By using a novel ex vivo primary cell culture technique, a
study of morphological classes of hemocytes extracted at
different developmental stages revealed the expected ‘switch’
of hemocyte morphology and behaviour between larval (LIII) and
white pre-pupal (WPP) stages. LIII hemocytes are sessile and
quiescent but they are activated towards an exploratory behaviour
at WPP, similar to the behaviour of embryonic hemocytes (Evans
et al., 2010; Sampson and Williams, 2012a; Sampson and
Williams, 2012b). This activation does not take place in mutants
affecting cytoskeletal reorganisation such as Cdc42, Rac1 and
Rac2 (Sampson and Williams, 2012b).
It has been proposed that the change in cell behaviour at the
LIII to WPP transition could be due to the surge of ecdysone at
the onset of metamorphosis (Lanot et al., 2001; Sampson and
Williams, 2012b). This hypothesis remains unproven and,
further, questions arise as to whether the induction of cell
motility would be due to the direct effect of ecdysone on the
hemocytes or an indirect effect caused by ecdysone-dependent
secondary signals from other tissues.
To answer these questions, we have cultured primary Drosophila
post-embryonic hemocytes with ecdysone to recapitulate the
developmentally induced change in cell activity at the onset of
metamorphosis. First, we have analysed morphology, migration
capability and cytoskeletal polarisation of the hemocytes at larval
and pre-pupal stages. Second, we determine the effect of adding
ecdysone to LIII hemocytes and show that there is a shift from
rounded morphology and immotile behaviour to polarised, motile
cell population similar to WPP hemocytes. Reciprocally, we have
also checked the effect of EcR dominant negative forms, and we
have found that they block this hemocyte activity.
Results
The ecdysone hormone changes hemocyte morphology
One of the most striking changes we observed in vivo at
puparium formation was the rapid colonization of the entire body
by hemocytes that were previously sessile and attached to the
larval integument (Fig. 1A). At late LIII stage there were very
few hemocytes circulating in the body (supplementary material
Fig. 1. Ecdysone causes a shift in hemocyte morphology and
distribution. (A) Images of the presumptive thorax/abdominal
region with hemocytes labelled by PxnGAL4-UASGFP;
CrqGAL4-UASGFP. At the Late L3 stage, hemocytes are
attached to the larval integument and are localized to segmental
patches and have rounded morphology (yellow dashed squares in
the low-magnification top rows indicate the region magnified in
the middle panels (26 digital zoom); in these medium-
magnification middle row panels, the red dashed squares indicate
the region magnified (26 digital zoom from middle panels) in
the high-magnification panels in the bottom row). At 1 h APF,
the hemocytes have started to migrate out of these patches and
begin to assume polarized morphology (middle panel, yellow
arrow head). The zoomed image presented in the yellow box,
under 1 h APF, was taken from the last frame of a live time-lapse
and at the most ventral position within the Z-stack. This image
was chosen as the best representative of hemocyte patch dispersal.
At 2 h APF, hemocytes have migrated laterally from the dorsal
patches as well as detached from the integument, as they are no
longer in view at the dorsal plane of focus. Most of the population
has adopted a spindle/polarized shape (bottom panel). At 24 h
APF the hemocytes have colonized most of the thorax and
abdomen and display vacuolation associated with phagocytosis of
larval tissues and secretion of ECM. These in vivo
morphologies are akin to those found in ex vivo culture (see B).
(B) A histogram showing the percentages of cellular
morphologies and behaviours between LIII (2ecdysone) (blue
bars), WPP (red bars), and LIII +ecdysone (yellow bars)
hemocyte populations ex vivo. Black bar with a star
(*) represents significant difference. Sample images of each
morphological class are shown at the bottom.
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The three isoforms of the Ecdysone Receptor (EcRA, EcRB and EcRC) can function as 
receptors for hormonal signalling after they undergo hetero-dimerisation with the 
Drosophila RXR homolog Ultraspiracle (Usp) (Thummel 1996). Tissue-specific 
expression of ecdysone-responsive transcription factors and EcR isoforms occurs to 
regulate the programmed cell death or autophagy pathways in various larval tissues that 
are not needed in the adult fly. These include the salivary glands and segmental muscles, 
which are specific to the feeding and movement requirements of the larvae (Jiang et al. 
1997). Targeted elimination of specific cells in the ommatidia allows the correct 
differentiation of the extremely complex adult Drosophila eye, and in a similar manner, 
specific CNS cells expressing EcRA are removed at the end of the larval stages (Truman 
et al. 1994). As mentioned above, haemocytes are responsible for the removal of 
cellular debris arising from the histolysis of the larval organs.  
It has been shown that haemocytes extracted from mid-third instar, wandering stage and 
late-third instar larvae (L3) are rounded in shape, whilst those extracted from early 
white-pre pupae (WPP) have a flattened appearance when they adhered to a substrate 
(Lanot et al. 2001). The L3 to WPP transition is coincidental with a large peak in 
Ecdysone (Bate 2009). To test whether the change that occurs during this phase is due to 
the action of this hormone, ecdysone was injected into mid-third instar larvae and after 
five hours; the larval haemocytes produced the same morphology as WPP stage 
haemocytes (Lanot et al. 2001). We have further discerned that when L3 haemocytes are 
cultured with ecdysone ex vivo, they do begin to show the characteristics of WPP 
haemocytes (Sampson et al. 2013). Ex vivo cultured wild-type L3 stage haemocytes 
incubated with ecdysone for three hours changed the characteristic morphologies of L3 
haemocytes from sessile to a motile state; with comparable migration velocities and 
cytoskeletal re-arrangements to those of haemocytes extracted from wild-type WPP flies 
(Figure 3.2B) EcR dominant-negative L3 haemocytes do not show the this change when 
cultured with ecdysone ex vivo, as seen in wild-type cells (Sampson et al. 2013). The 
behaviour of haemocytes in ex vivo culture recapitulates what can be observed in vivo 
(Figure 3.2C). I have previously shown that haemocytes found attached to the inside of 
the larval integument at the end of L3 are rounded in shape, and show little movement 
out of the patches and into circulation. One to two hours after puparium formation 
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(APF), the haemocytes that were previously attached to the integument began to show 
characteristics of motility such as protrusion formation, followed by dispersion from the 
dorsal patches, as observed through fluorescent live-imaging of WPP haemocytes. I also 
showed that haemocytes expressing dominant-negative forms of EcR do not migrate out 
of the dorsal patches in vivo. This led us to conclude that larval haemocytes are 
activated into motility upon puparium formation by Ecdysone and this action is 
mediated through the Ecdysone receptors. Twenty-four hours APF, cells found in the 
dorsal region of the thorax and abdomen show large blebs in their cytoplasm. We term 
these ‘vacuoles’ as they resemble large intercellular compartments that are full of 
material, similar to those found in plant cells. The specific temporal expression of 
Hemotin can be correlated to the highest peaks of ecdysone hormone expression level, 
known to trigger apoptosis at L3 to pupal transition, creating requirement for 
phagocytosis by haemocytes in late larval and early pupal stages. 
The role of haemocytes during Drosophila development 
If Hemotin performs a functional role in haemocytes, it becomes necessary to 
understand the role of haemocytes in Drosophila immunity. In the wild, Drosophila 
spend most of their lives inside and around rotting fruit. Eggs are embedded inside, 
providing hatched larvae with an instant food source that remains a reliable, nutrient-
rich habitat for adult flies. It is no wonder then that the fruit fly has evolved a complex 
immune system to prevent infection by the various microorganisms that may be found 
there. Like most insects, Drosophila have a difficult-to-penetrate epidermal cuticle, and 
like most animals, a lower pH in the gut that is inhospitable for microorganism 
proliferation. Drosophila have an open circulatory system and its rudimentary ‘heart’, 
the dorsal vessel, pumps haemolymph around the body. The haemolymph contains the 
cellular arm of the Drosophila immune system, in the form of 3 main cell types: 
lamellocytes, crystal cells and plasmatocytes/haemocytes. Each of these cell types 
perform specific roles in the follow-up to infection (Tzou et al. 2002).  
Wounding the fly triggers a melanisation response by the crystal cells, followed by 
lamellocyte or haemocyte recruitment and the subsequent production of anti-microbial 
peptides (Hoffmann et al. 1999; Ulvila et al. 2011a). Lamellocytes are highly 
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specialised cells that are used in the encapsulation of parasitic wasp eggs or very large 
molecules (Tzou et al. 2002). Therefore, for the purpose of clarity, we maintained focus 
specifically on haemocytes, which are the predominant form of macrophages/
phagocytes of the Drosophila immune system (Lemaitre and Hoffman 2007). 
Drosophila haemocytes are highly motile phagocytic cells that are present at all stages 
of the fly life cycle and represent ~90% of the cellular component of the insect’s 
immune system during post-embryonic life stages (Lanot et al. 2001). 
In mammals, blood cells are derived from stem cells through expression of varying 
combinations of regulators and specific transcription factors. Similarly in Drosophila, 
the mammalian GATA transcription factor homolog Serpent (Srp) is required for the 
development of embryonic pro-haemocytes as well as the embryonic gut. Mature 
haemocytes could not be found in embryos lacking the srp gene, which also showed 
impaired pro-haemocyte differentiation (Rehorn et al. 1996). Another key player in 
mammalian blood cell differentiation is the protein AML1, which is also required for 
haematopoiesis. Lozenge (lz), the Drosophila AML1 homologue, is required for the 
differentiation of crystal cells, and is expressed in a small subset of Srp expressing pro-
haemocytes during stage 11 of embryogenesis, when haemocyte differentiation begins. 
Rather than migrating around the embryo, crystal cells cluster in the head. Lz 
expression is also maintained in a subset of cells in the anterior lobes of the larval 
lymph gland. Srp is required for, and is upstream of Lz expression during 
haematopoeisis. Pro-haemocyte differentiation into macrophages requires the 
transcription factor glial-cells-missing (Gcm) (Lebestky et al. 2000). The mammalian 
Friend-of-GATA (FOG) protein homolog, U-shaped (Ush), is responsible for negative 
regulation of crystal cell production in Drosophila (Fossett et al. 2001) and expressed in 
macrophages.  
The production of anti-microbial peptides (AMP’s) from the fat body is another 
mechanism of the innate immune response that is conserved from Drosophila to 
mammals, with up to 400 peptides identified in insects, plants and humans (Hoffmann 
1999). AMPs are released as a result of a wound or infection. Oral infection of flies 
during the larval stage does not elicit an AMP response in the absence of functional 
haemocytes, though this observation is not repeated in infected adult flies (Charroux 
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and Royet 2009; Defaye et al. 2009). The various parallels between Drosophila and 
vertebrate immunity make it more interesting to investigate whether there is a functional 
role of this SEP in immunity.  
Phagocytosis and intracellular trafficking 
The uptake of material from the cellular environment through phagocytosis is a highly 
conserved mechanism from Drosophila to mammals (Hoffmann et al. 1999). The 
recognition of foreign particles by the haemocyte is the first step of many signalling and 
cytoskeletal re-modelling events that take place in this process (Ulvila et al. 2011a). 
Phagocytosis mediates uptake of particles that are ≥0.5µm in size. One of the receptors 
involved in the recognition of foreign particles is the CD36 scavenger receptor homolog 
Crq, which is expressed in all embryonic haemocytes (Franc et al. 1999).  This is only 
one of the pattern recognition receptors (PRRs) involved in the recognition of 
microbial-associated molecular patterns (MAMPs) which are unique to various micro-
organisms. Binding of these receptors to their respective ligands initiates downstream 
signalling; which induces expression of AMPs in larvae, Actin-associated proteins, 
endocytic machinery and regulators of intracellular vesicle trafficking (Ulvila et al. 
2011a). In a similar manner to pathogens, apoptotic cells release a phylogenetically 
conserved ‘eat me’ signal in the form of a Phosphatidylserine (PS) which is externalised 
by the dying cell (VanDenEijnde et al. 1998; Fullard et al. 2009). In Drosophila, 
recognition of apoptotic cells is conducted by Draper and similar EGF-repeat containing 
proteins Nimrod and Eater; which are also necessary for the recognition of various types 
of bacteria (Fullard et al. 2009). After particle recognition, internalisation of particles is 
mediated by the probing movement of the plasma membrane called membrane ruffling, 
which can be observed in both embryonic and post-embryonic haemocytes. These 
movements facilitate the binding of receptors to their target. Membrane ruffling is 
mediated by the GTP hydrolase enzymes (GTPases) of the Rho family (Cdc42, Rac1 
and Rac2). These GTPases activate the WASP and SCAR/WAVE family of proteins, 
which in turn stimulate Arp2/3. Arp2/3 nucleates actin and promotes filament formation 
to produce the phagocytic cup (Shim et al. 2010). These are the main proteins known to 
be responsible for the formation of membrane protrusions, but there is not that much 
understood about the membrane fusion events that actually mediate the internalisation 
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of particles (Shim et al. 2010; Botelho and Grinstein 2011). The internalised membrane-
bound particles, now called phagosomes, undergo a series of maturation events that 
change the membrane composition as well as the contents. As the phagosome matures 
from an early-endosome to a late-endosome and then a phago-lysosome, the organelle 
becomes more acidic with enzymes, thus leading to the degradation of the phagocytised 
particles. These organelles display different Rab GTPases on the membrane surface 
which act as recruitment factors for various effector proteins which affect the internal 
pH and movement of the organelle through the cell (Stein et al. 2003).  
Avenues of investigation into the function of Hemotin 
There is significant homology between mammalian and Drosophila innate immunity, 
and both insect and vertebrate macrophages function in a similar fashion. Phagocytosis 
is an important cellular function performed by these cells in all organisms in which they 
are found. Our preliminary data on Hemotin required the investigation of several 
potential mechanisms that this smORF peptide could be involved in. We hypothesised 
that Hemotin is expressed in haemocytes during the first wave of haematopoiesis in 
embryos, based on the patterns of mRNA expression in embryos, though we did not 
know the endogenous peptide’s localisation. The peak of hemotin RNA in wild-type and 
Sindbis virus infected pupae, coincides with a the second haematopoietic wave in the 
fly. As Hemotin is a small peptide, it could be involved in immunity as an AMP or 
perhaps act downstream of ecdysone signalling to activate haemocytes into motility and 
phagocytosis. It could even be involved in the mechanism of phagocytosis. The 
possibility that smORF peptides may be involved in these essential cellular functions is 
exciting, as no smORFs have been previously associated with these functions.  
Hemotin is not detected by RT-PCR in unfertilised embryos (Figure 3.1E) indicating 
that it is not a maternally deposited. Therefore, we went on to generate a deficiency line 
over the genomic region of the hemotin gene using two P-element reversions that are 
found between the 5’ ends of the fray and fruitless alleles in the genome. This allowed 
the excision of the entire hemotin gene, as well as CG7691, which is annotated to 
contain a putative Zinc finger domain with predicted functions in metal ion and nucleic 
acid binding. The genomic excision also removes the 5’ ends of the fray and fruitless 
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genes (Figure 3.1D). The hemotin null mutant flies are viable and wild-type looking 
morphologically, but male sterility exists in the deficiency line, possibly due to the 
excision of the 5’ end of the fruitless gene (Demir 2005). We depicted this null mutant 
for hemotin as Df A4 to be used in a reverse genetics approach in the characterisation of 
hemotin. The aim of the experiments described in this chapter were to use various fly 
lines, including the hemotin null mutant Df A4, to elucidate the function of Hemotin 
SEP in a single-smORF study. This reverse genetics approach has been previously used 
by our laboratory to characterise smORF protein function in flies after removal of the 
tarsal-less and sarcolamban genes.  
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Results 
Detecting Hemotin peptide in embryos and post-embryonic haemocytes 
One of the first steps in characterising a putative ORF is to obtain proof of translation. 
The standard technique of antibody staining (immunohistochemistry, IHC) is used to 
detect the translated peptide. Preferential binding of a specific antibody raised against 
the antigen, serves as proof of protein translation of the bait protein. Testing the 
antibody in wild-type flies would technically show where the endogenous peptide is 
being made. A polyclonal antibody was generated against the Hemotin peptide (peptide 
sequence: RISITPGCSMVATTKLTHSRNSVDIY). There were two versions of the 
antibody, a Serum Antibody (SAB), which is the blood serum extracted from the animal 
28-days after the injection of the peptide from the animal (rabbit). Some of the serum is 
subjected to Affinity/Immuno-purification (IP) and checked by ELISA, resulting in a 
concentrated antibody which is specific to the C-terminus sequence of Hemotin 
(Eurogentec).  
Labelling the endogenous expression of Hemotin peptide in fertilised embryos would 
also give a better idea that mRNA expression (as observed previously by in situ 
hybridisation) as to which tissue or cell type where Hemotin is functioning. We had 
previously postulated that Hemotin is expressed in haemocytes from evidence of 
expression at the mRNA level, but we required confirmation that the protein is also 
found in these cells to conduct a functional study, not being exported or transported to 
some other tissue. I used a fly stock carrying SrpGAL4 driving the expression of GFP, 
(w; SrpGAL4>GFP; Df A4/TM3-YFP) to label embryonic haemocytes. Embryos were 
collected 8-16 hours after egg laying, which encompasses stages of development 12-16, 
at which haemocytes have differentiated and migrated around the embryo. The embryos 
contain three genotypes on chromosome III Df A4/TM3-YFP, Df A4/Df A4 and TM3-
YFP/TM3-YFP. All the haemocytes in this fly line express GFP, due to the homozygous 
SrpGAL4>GFP construct on chromosome II. Embryos with the TM3-YFP balancer can 
be seen by the expression of yellow fluorescent protein in the embryos. Dfd-GMR 
drives expression of YFP in the presumptive eye and proboscis of the embryo(Le 2006). 
Df A4/TM3-YFP, and TM3-YFP/TM3-YFP embryos were used as the wild-type sample, 
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Figure 3.3: Testing the anti-Hemotin Serum Antibody in embryos  
Embryos laid from flies with genotype w; srpGAL4>UAS-GFP; DfA4/TM3-YFP 
labeled with anti-GFP (FITC secondary) as seen in A) wild-type DfA4/TM3-YFP or 
TM3-YFP/TM3-YFP embryos and B) hemotin deficient DfA4/DfA4 embryos. These can 
be differentiated by the difference in YFP expression in the presumptive eye and 
proboscis and the hemotin deficient embryos serve as an internal negative control to test 
the antibody Scale bar = 100µm. C) anti-Hemotin Serum-antibody (SAB) (Rhodamine 
secondary) localises in a punctate fashion, found within GFP-labelled hemocytes in 
wild-type embryos. Scale bar = 50µm D) 5x zoom of cells from panel C. Scale bar = 
5µm. E) anti-Hemotin Rhodamine signal can also be seen within haemocytes in hemotin 
deficient (Df A4) mutant embryos  F) 5x zoom of haemocytes from panel E. 
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and would contain the coding sequence for hemotin. The homozygous null (Df A4) 
embryos served as an internal negative control in these samples. The difference between 
wild-type and negative control embryos is shown in Figure 3.3A,B. Using a combined 
pool of wild-type and negative control embryos also ensures that the 
immunohistochemistry protocol is consistent between the two conditions. Using the 
SAB it could be seen that there is strong labelling of puncta within wild-type 
haemocytes, as compared to signal from the mesoderm and non-GFP expressing areas 
(Figure 3.3C,D). However, in Df A4 embryos, there is also punctate signal within 
haemocytes. The signal in the null-mutant embryos is of comparable strength and 
quality as the wild-type condition (Figure 3.3E,F). Firstly, this result made us question 
the specificity of the antibody generated against Hemotin but it was also considered that 
labelling of Hemotin in embryos may have been difficult as there may not be high 
enough levels of expression at embryonic stages (modENCODE data). The main peak 
of Hemotin expression in wild-type flies is seen at L3 to pupal stages, but this requires 
accessing haemocytes at these stages for staining.  
As the SAB showed signal in the Df A4 embryos, we decided to use the 
Immunopurified (IP) version of the antibody for subsequent experiments as it may be 
more specific due to higher purity. When the IP antibody was tested in embryos, it 
showed some signal in wild-type embryonic haemocytes (Figure 3.5A,B). As described 
with the SAB, a lot of fluorescent background can be seen in the mesoderm, and in 
areas where haemocyte-specific GFP is not being expressed. Despite trying different 
staining protocols, signal level is comparable in both GFP-labeled and non-labeled 
regions. This made it hard to tell whether the IP was any better than the SAB. L3 and 
WPP haemocytes were bled from animals to conduct immunohistochemistry directly on 
the haemocytes to reduce background, and in hope that there would be more Hemotin 
expressed at these life stages. Results from IP staining of ex vivo haemocytes revealed 
Punctate red signal in the wild-type, Or-R L3 haemocyte cytoplasm (Figure 3.4A). This 
pattern of signal is reproduced in Or-R and TM3-YFP WPP haemocytes using the IP 
antibody (Figure 3.4B,C) Unfortunately, in haemocytes bled from Df A4 L3 and WPP 
animals (Figure 3.4D,E), the same pattern of signal can be observed in the red channel.  
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Figure 3.4: Ex vivo staining of larval and pre-pupal haemocytes with anti-Hemotin 
IP antibody A) Wild-type (Oregon-R) L3 larval haemocytes stained with immune-
purified (IP) anti-Hemotin antibody (labelled with Rhodamine). The cellular F-actin is 
labelled with Phalloidin-FITC and nuclei are labelled with DAPI (Blue) B) Oregon R  
white pre-pupal (WPP) haemocytes with same treatment as panel A C) Df A4/TM3-YFP 
WPP haemocytes. Anti-Hemotin IP labelling shows a punctate signal in the cytoplasm 
in wild type cells. Df A4 homozygous haemocytes stained with anti-Hemotin IP 
antibody is similar to wild type in Hemotin deficient hemocytes at D) L3 and E) WPP 
stages (Scale Bars = 5µm) 
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In the case of the characterisation of another smORF, detecting the peptide with a 
specific antibody led to similar issues as described above. It was found that Tal could 
only be detected by anti-Tal antibody when expressed as a fusion protein with a 
Glutathione S-transferase (GST) tag (J.I. Pueyo, personal communication), so we 
decided to see whether the same would occur in the case of Hemotin tagged with a 
larger epitope. Using a GFP tagged fusion construct of Hemotin-ORF1, expressed with 
a hemocyte-specific GAL4 (Figure 3.5E), I retested the IP antibody in the hope it will 
detect the larger, GFP-fused Hemotin-ORF1 peptide, hereafter referred to as Hemotin-
GFP. UAS-Hemotin-GFP is a fusion construct in which the GFP sequence (devoid of a 
start codon) has been cloned into the hemotin-Full-Length construct (containing both 
ORFs), downstream and in-frame with hemotin ORF1, which lacks a stop codon (Pueyo 
et al. 2016). In both L3 and WPP haemocytes expressing UAS-Hemotin-GFP, there is 
very little overlap by the signal derived from anti-Hemotin antibody to Hemotin-GFP, in 
fact, they seem to be mutually exclusive of each other (Figure 3.5C,D). This result, 
combined with the fact that there is signal from the IP in Hemotin null mutant 
haemocytes, led me to discontinue use of the Hemotin antibody as it was nonspecific.  
Colocalisation of Hemotin-GFP to organelle markers 
Although I was not able to determine endogenous Hemotin localisation in the embryo 
and specifically in haemocytes, the GAL4-UAS system allowed the targeted expression 
of UAS-Hemotin in specific tissues, including haemocytes, with well-characterised 
haemocyte GAL4s. The detection of GFP-tagged construct of Hemotin provides proof 
of translation of Hemotin, because the GFP is only translated if Hemotin is being 
translated due to the fusion of the GFP sequence. The expression of detectable GFP 
would help to determine the subcellular distribution of the fusion peptide by co-
labelling various organelles or cytoskeleton in haemocytes. This would provide 
information about where Hemotin may be functioning. It has been described that most 
of the organelles share a significant part of their inner membranes. The juxtaposition of 
Endoplasmic reticulum (ER) membranes with mitochondrial outer-membranes are 
called mitochondria-associated membranes (MAM) (Vance et al. 1997). It is also 
common knowledge that peroxisomes and other transport vehicles bud off from the ER 
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Figure 3.5: anti-Hemotin IP antibody staining in embryos and ex vivo Hemotin-
GFP haemocytes A) Staining of Embryos with IP Hemotin Antibody (Rhodamine) 
shows extensive background staining of the mesoderm that does not overlap with 
srpGAL4>UAS-GFP marked hemocytes. Scale Bar=50µm. B) 5x zoom of panel A. 
Scale bar = 5µm. C) UAS-Hemotin-GFP expression driven by haemocyte-specific Hml-
GAL4 in (C) L3 and (D) white pre-pupal haemocytes stained with anti-Hemotin 
Antibody (Rhodamine) and DAPI (Blue). Rhodamine and GFP signal show very little 
overlap. Scale bars = 5µm. E) Schematic of the UAS-Hemotin-GFP construct expressed 
in flies using Hml-GAL4 
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and Golgi (Lodish 2008). Since the expression of GFP was in a network and punctae all 
over the cytoplasm, we decided to look at organelle markers of the inner membrane 
system: the mitochondria/anti-GRP75 (Santa Cruz), anti-KDEL (DSHB) and 
Lysotracker-RED (Molecular Probes). The study was conducted on ex vivo haemocytes 
from L3 and WPP flies, which enabled us to combine the power of fly genetics with 
high high resolution microscopy in the hope of elucidating the cellular function of 
Hemotin peptide.  
Figure 3.6A,B shows staining in L3 and WPP haemocytes with the mitochondrial 
antibody GRP75. There could not be any significant overlap seen between the 
mitochondria and Hemotin-GFP. We then tried to label KDEL which is a protein motif 
that labels the membranes of ER, Golgi and transport vesicles between the two 
organelles, as well as vesicles targeted for the ER from the plasma membrane 
(Stornaiuolo et al. 2003). This staining revealed a high level of overlap between 
Hemotin-GFP and KDEL in L3 haemocytes (Figure 3.6C,D). The amount of overlap 
between Hemotin-GFP and KDEL in WPP haemocytes is lower than what is seen at L3, 
but this result allows us to conclude that Hemotin is found on the ER, Golgi and 
intracellular transport organelles, such as those that bind to lysosomes and phagocytised 
material, thus making it a viable candidate for having a function in intracellular 
trafficking. In order to visualise Hemotin-GFP signal in relation to Lysotracker, which 
labels endo-lysosomal vesicles with a low pH, I had to live-image haemocytes from L3 
and WPP animals. The reason for this was because Lysotracker permeates the 
membranes of live cells, and aldehyde fixation is not feasible subsequent to Lysotracker 
staining. This lack of fixation makes it difficult to amplify fluorescent signals, which in 
turn leads to an overall decrease in the strength of fluorescent signal that can be 
captured, as the microscopy parameters have to be kept at a lesser intensity to avoid 
bleaching the live sample. Despite this limitation, I was able to capture images of 
Hemotin-GFP expressing haemocytes, and the GFP signal in relation to Lysotracker-
Red, which led us to conclude that Hemotin does indeed colocalise quite strongly to 
Lysosomal compartments (Figure 3.6E,F).  
In order to make the result more convincing, I decided to quantify signal overlap 
between the organelle markers and Hemotin-GFP. Colocalisation between pixels can be 
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Figure 3.6: Colocalisation of Hemotin-GFP with Organelle markers  
Hemocytes bled from HmlGAL4>UAS-Hemotin-GFP L3 and WPP animals are co-
stained with (A, B) Mitochondrial marker Grp75 (C, D), ER marker KDEL and (E, F) 
live-imaged using Lysotracker-RED dye to label lysosomes. G) Quantification of 
Hemotin-GFP signal with organelle markers. A 0-1 value calculated using the averaged 
Mander’s coefficients (plotted on the y-axis) shows that Hemotin-GFP has low overlap 
with Mitochondrial marker GRP75 (L3 0.13±0.02, n=18; WPP stage (0.31±0.02, n=14). 
There is high overlap of the Hemotin-GFP SEP with ER marker KDEL, particularly at 
the L3 stage (0.87±0.03, n=16) and lowered at the WPP stage (0.59±0.02, n=15). 
Overlap with Lysotracker is also very high at L3 (0.73±0.02, n=16) and increases at the 
WPP stage (0.85±0.01, n=15). Scale bars = 5µm. 
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quantified using the image analysis software ImageJ, with the Colocalisation Analysis 
plugin package (http://www.uhnresearch.ca/facilities/wcif). Mander’s coefficient is a 
type of Pearson’s correlation coefficient that can be used to define the covariance 
between signals from fluorophores in different channels (i.e. GFP and Rhodamine) 
using a numerical range from 0 (low colocalisation) to 1 (high colocalisation). The 
Mander’s coefficient value for colocalisation between Hemotin-GFP and GRP75 at L3 
(0.13±0.02) is quite low, however this overlap increases at WPP stage (0.31±0.02). 
Though the overall overlap between mitochondria and Hemotin may be low, the 
increase at this stage might indicate that there is a stronger interaction at WPP, possibly 
due to the increase in expression of Hemotin-GFP at pupal stages. Mander’s coefficient 
for Hemotin-GFP and KDEL antibody in L3 haemocytes is very high (0.87±0.03) and is 
lowered in WPP haemocytes (0.59±0.02, n=15). Hemotin-GFP and Lysotracker, which 
labels organelles with low pH, give a Mander’s coefficient value of 0.73±0.02 and the 
overlap is even greater at WPP stage, 0.85±0.01, as summarised in Figure 3.6G. 
Fly viability after wounding and infection 
Due to the mounting evidence of the involvement of the Hemotin peptide in lysosomal 
and endosomal compartments, we decided to test the impact of infection and wounding 
on Hemotin mutant flies. The aims of this experiment was to observe whether the 
overall viability of Hemotin mutant flies was affected by lack of hemotin expression. We 
also wanted to see whether deleting the hemotin gene would be exacerbated by infection 
with various pathogens, thereby implicating a role for Hemotin in immunity via 
intracellular trafficking.  
Drosophila display a differential induction of various AMPs after infection, and there is 
a possibility that Hemotin could be involved in the immune response in this manner, and 
is actuallt being secreted from the cell (via the ER and Golgi as shown by anti-KDEL 
co-localisation). This would become apparent in the flies infected with pathogenic 
bacteria if there is an impairment in the induction of the immune response. If Hemotin 
is mainly involved in the capacity of intracellular trafficking, this could potentially 
become apparent by infecting the flies with a concentrated dose of non-pathogenic E. 
coli (DH5α), similar to an experiment by Akbar et al. (Akbar et al. 2011) which showed 
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a requirement for the endocytic protein called full-of-bacteria (fob) in order to clear 
non-pathogenic bacterial infection. Mutated fob (fob1), flies become ‘hypersensitive’ to 
non-pathogenic bacterial infections and die earlier than wild-type flies, and we used this 
line as a positive control.  
In order to verify the specificity of decreased viability to the Hemotin gene, I used a fly 
line that rescues the deletion of CG7691 in a Df A4 background. Virgin males and 
females, 0-2 days old, were collected and kept at a maximum density of 20 flies per 
vial. For each strain, we kept three classes: untreated, wounded and infected. Infection 
was conducted by pricking the flies in the abdomen, just under the haltere, with a 
tungsten needle dipped into a concentrated culture of the Gram-positive, pathogenic 
bacteria Micrococcus luteus, the Gram-negative pathogenic bacteria Enterobacter 
cloacae, or a concentrated dose of the non-pathogenic DH5α Escherichia coli. As a 
control, flies of each strain were wounded in the abdomen with a tungsten needle dipped 
in sterile PBS. The flies that remained alive were then counted over the next 60 days 
(Figure 3.7A). I investigated the overall life-span viability of Hemotin mutant flies (Df 
A4) as compared to Oregon-R (Or-R), a commonly used wild-type strain, and fob1 flies. 
This was compared to the result of non-pathogenic bacterial infections in these same 
lines.  
The results of this experiment show that the overall lifespan of Df A4 and the Df 
A4;CG7691 rescue fly lines is significantly shorter when compared to both Or-R and 
fob1 flies that undergo the same treatment. These results can also be depicted in a 
fashion similar to LD50, which is defined as the ‘median lethal dose, 50%’ of a given 
toxin or pathogen. As such, the table in Figure 3.7B depicts the average day upon which 
50% of the flies are dead after each respective treatment or infection. Compared to Or-R 
flies (LD50 = 52.8±4.11 days), Df A4 flies have a drastically reduced viability overall, 
without any infection or treatment (LD50 = 32.57±5 days), which is a 38% reduction 
from the LD50 of Or-R flies. Untreated fob1 mutant flies (LD50 = 52.5±4.9 days), have 
comparable viability to Or-R flies. Gram-positive Micrococcus luteus, and Gram-
negative Enterobacter cloacae were grown overnight from concentrated cultures, and 
used to infect the flies with a tungsten needle. Infection with pathogenic gram positive 
M. luteus, drastically decreased the viability of Or-R flies (LD50 = 35± 0 days), which 
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Figure 3.7: Fly viability after wounding and infection  
A) Fly viability assay showing percentage of flies that remain alive (y-axis) over a 
timespan of 60 days. Flies were either untreated, wounded as a control or infected with 
pathogenic or non-pathogenic bacteria in order to investigate the role of Hemotin in 
immunity. Oregon R flies were used as a negative control while fob1 mutant flies were 
used as a positive control for DH5α infection. Overall, the Df A4 line and genomic-
rescue CG7691, Df A4 flies have the lowest viability after all treatments. B) LD50 
averages from all repeats of  fly viability studies showing the number of days at which 
50% of the flies are dead. Df A4 flies have a shorter median life span compared to 
untreated wild-type Oregon-R flies across all treatments.  
control wounded E. coli Dh5a M. luteus E. cloacae
Oregon R 52.75 ± 4.11 48.25 ± 4.86 40.5 ± 3.54 35 ± 0 43.5 ± 2.12
Df A4 32.57 ± 5.0 25.29 ± 7.43 17.33 ± 4.61 28.0 ± 8.49 34 ± 1.41
CG7691; Df A4 
Rescue 
24 ± 2.83 21 ± 9.90 13.5 ± 0.71 - -
fob1 52.5 ± 4.95 47 ± 8.49 36 ± 2.83 - -
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is 34% less than the untreated control. M. luteus infection also has large effect on the 
already less viable Df A4 flies (LD50 = 28± 8.5 days), which is 20% less than M. luteus 
infected Or-R flies, and 15% less than Df A4 overall median longevity.  
Infection with pathogenic gram negative E. cloacae bacteria decreases the viability of E. 
cloacae infected Or-R (LD50 = 43.5±2.1 days) by 18%, compared to untreated Or-R. E. 
cloacae infected Df A4 flies (LD50 = 34±1.4 days) do not show a significant effect by 
Gram negative infection when compared to untreated Df A4 flies, in fact they live for 2 
more days, on average. These results imply that the effect of pathogenic bacteria 
impacts both wild-type and Hemotin mutant flies in the same fashion, by decreasing 
their overall viability. We know from previous RT-PCR (MA Cespedes, personal 
communication) that the Df A4 flies show an increase of Diptericin gene expression 
after infection similar to wild-type flies (not shown). Diptericin is an anti-microbial 
peptide involved in the Gram-negative infection response (Lee et al. 2001). There does 
not seem to be an increased lethality response upon pathogenic infection in Hemotin 
mutant flies.  
The most interesting results come from flies infected with the non-pathogenic E. coli 
DH5α which was performed in order to determine if Hemotin plays a role in 
intracellular trafficking. Wild-type flies have been shown to clear themselves of 
infection with non-pathogenic bacteria and survive, while mutants in the phagocytic 
pathway show an overall lowered viability because they are unable to digest large loads 
of bacteria (Akbar et al. 2011). The phagocytosis defect indirectly affects longevity via 
the phagocytic ability of haemocytes. For this experiment, a much more concentrated 
dose (100x) of non-pathogenic E. coli was used to infect the flies as compared to the 
concentrations of the pathogenic M. luteus and E. cloacae infections. The results from 
this study show a 23% decline in median life span of Or-R flies (LD50 = 40.5±3.5 
days). DH5α infection of Df A4 flies caused a 67% decrease in viability compared to 
untreated Or-R. There is a 47% drop in viability of infected Df A4 flies, compared to 
untreated Df A4. The fob1 mutant allele, which is described to have an endocytic/
phagocytic defect, is only marginally decreased in viability from DH5α infected Or-R, 
by 11%. By comparison, Df A4 flies are 51% less viable than fob1 mutant flies after 
DH5α infection. Infection with pathogenic and non-pathogenic bacteria in Hemotin 
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mutant flies dramatically decreases the viability of these flies. These results indicate that 
Hemotin may initially function in an intracellular capacity, which then later impinges on 
the overall immunity of the fly, as the haemocytes may be unable to clear an infection. 
This is similar to the story of the full-of-bacteria gene, which functions in phagocytosis 
and impinges on the overall health of the fly. Though wild-type animals also show a 
decrease in viability after infection, the viability of Hemotin mutant flies drops 
drastically, even when compared to the fob1 positive control. This result also strongly 
suggested that Hemotin may be involved in intracellular trafficking and phagocytosis. 
In vivo imaging of haemocytes 
If Hemotin is involved in the uptake and processing of material by haemocytes, one way 
to detect a possible phenotype would be to observe the behaviour and morphology of 
haemocytes at stages when their phagocytic functions are required. The availability of 
haemocyte-specific GAL4’s, such as Serpent (Srp) and Peroxidasin (Pxn), which are 
expressed in the cytoplasm of haemocytes, allowed us to express UAS-GFP in these 
cells and visualise them at various stages of the Drosophila life cycle. By crossing flies 
containing these haemocyte-specific GAL4s driving the expression of GFP to our Df 
A4/TM3-YFP line, we were able to obtain Hemotin deficient flies with fluorescent 
haemocytes.  
During Drosophila embryogenesis, haemocytes migrate from the presumptive head 
region, along the ventral midline to populate the entire embryo between stages 10-17 of 
development (Evans et al. 2010a). This method has been used to describe several types 
of embryonic haemocyte behaviours such as motility, wound recruitment and bacterial 
infection. It became apparent through Time-lapse imaging of embryonic haemocytes 
that Df A4 embryonic haemocytes follow the described pattern of dispersion at 
embryonic stages, and hence there does not seem to be a haematopoietic defect at 
embryonic stages (I. R. Evans, personal communication). Using the method described 
by Evans et al. (Evans et al. 2010a) I was able to conduct imaging of haemocytes in live 
embryos during late-embryonic stages. The ability to visualise haemocytes in vivo 
allowed us to determine the effects of the Hemotin mutation at the cellular level.  
 48
Figure 3.8: Measuring vacuolar OAI in embryonic and pupal haemocytes in vivo 
Haemocyte vacuoles were measured in haemocytes labelled with GFP in A) Hemotin 
mutant heterozygote (Df A4/TM3-YFP) embryos containing one copy of the hemotin 
gene. B) Hemotin null mutant (Df A4) embryos. The Occupied Area Index (OAI) was 
calculated by dividing the Vacuole area (solid yellow ROI) by the total cell area (dashed 
red ROI). Scale bar = 10µm C) the OAI is significantly larger in hemotin null 
embryonic haemocytes (P<0.0001). Haemocyte vacuoles measured in D) mutant 
heterozygote (Df A4/TM3-YFP) and E) Hemotin null mutant (Df A4) pupae. Scale bar = 
10µm F) Pupal haemocyte imaging in vivo was achieved by cutting a window into the 
pupal casing and raising the sample by one slide thickness to increase focal depth. G) 
OAI averages of hemotin null Df A4 pupae are significantly different (P<0.0001) to wild 
type and heterozygote pupal haemocytes. 
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In w;srpGAL4>GFP;Df A4 homozygote embryos, haemocyte vacuoles are larger and 
slightly abnormal compared to the heterozygote condition (w;srpGAL4>GFP; Df A4/
TM3-YFP) (Figure 3.8A,B). As previously mentioned, the appearance of large cellular 
inclusion bodies, or vacuoles, are an indicator of pro-haemocytes becoming phagocytic 
at embryonic stages (Lanot et al. 2001). Measurements of the entire area of the 
haemocyte, as well as the vacuolar area within the cell, were obtained by taking Z stack 
images of live homozygous Df A4 and heterozygous TM3-YFP embryos (red and yellow 
dashed lines, Figure 3.8A,B). From these measurements, an Occupied Area Index (OAI) 
was calculated by dividing the sum of total vacuolated area of a cell by the overall area 
of the cell; this ratio gives the total area of a haemocyte that is vacuolated. Df A4 
haemocytes (0.38) at late embryogenesis have significantly (P<0.0001) larger average 
OAI than wild-type embryos (0.29) (Figure 3.8C). 
Fly lines w;SrpGAL4>GFP; CrqGAL4>GFP and w;SrpGAL4>GFP; Df A4 were used 
to conduct live-imaging of pupal haemocytes. Stage P6 pupae (approx. 50h APF) were 
used, as this time point is well after the degradation of larval tissue and subsequent 
phagocytosis by the haemocytes released at pupation. Fly pupae are thick samples that 
present a challenge in laser confocal microscopy, usually restricting imaging to the 
superficial layers only (Nwaneshiudu et al. 2012). In order to get around this, pupae 
were mounted on double-sided tape, and the distance between the lens and the sample 
was increased by adding a 1-slide thick layer to the slide, enabling imaging of several 
cell diameters into the animal (Figure 3.8F). Opening a window in the pupal cuticle, 
over the thorax, allowed clearer imaging of fluorescent GFP-expressing haemocytes 
under the epidermis of the metamorphosing fly. (Figure 3.8D,E). The OAI for pupal 
haemocyte vacuoles in the thorax show that Df A4 pupal haemocytes have larger 
vacuoles, or cellular inclusions, when compared to wild-type flies (Figure 3.8G). At this 
developmentally relevant time point, when haemocyte activity is necessary, Hemotin 
mutant haemocytes appear to contain a larger amount of phagocytised material. This 
supports the hypothesis that Hemotin could be playing a role in the regulation of 
phagocytosis or the breaking down of phagocytised  material in haemocytes. Without 
the Hemotin gene, this process is hampered, giving rise to larger vacuoles in Df A4 
haemocytes, and a quantifiable phenotype of Hemotin peptide function.  
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Labelling haemocyte vacuoles   
So far, the results of my experiments had suggested that Hemotin is involved in the 
processing of intracellular vesicles (or vacuoles), the peptide localises to Lysotracker 
and intracellular trafficking organelles, and is involved in immunity via phagocytosis. 
The main function of haemocytes is phagocytosis of extracellular material. 
Phagocytised material is brought into the cell by encapsulation by the plasma 
membrane. The internalised membrane-bound organelles are fused to organelles 
containing acidifying enzymes, at which point they are called lysosomes, the 
cytoplasmic sites where ingested particles undergo acid-mediated degradation. The 
membrane components of the organelles are then recycled to the plasma membrane 
edge (Velichkova et al. 2010; Jean et al. 2012). If Hemotin is involved in the processing 
of phagocytised material, we would potentially observe enlarged lysosomes, or 
lysosome-precursor organelles, in the cytoplasm of Df A4 fly haemocytes (Luzio et al. 
2000).  
Using Pxn-GAL4 to drive the expression of UAS-GFP reveals cytoplasmic and nuclear 
signal of GFP in haemocytes ex vivo. Peroxidasin (Pxn) is an extracellular matrix 
protein that is specifically expressed in the haemocyte cytoplasm at all stages of 
Drosophila development (Nelson et al. 1994), allowing us to fluorescently visualise the 
haemocytes at any stage. The GFP-expressing haemocytes were extracted from wild-
type and Df A4 larvae from the fly lines w;PxnGAL4>GFP; CrqGAL4>GFP and w; 
PxnGAL4>GFP; A4/TM3-YFP, respectively, and cultured them on collagen-coated 
coverslips in growth media (DHIM). LysoTracker dye freely crosses cell membranes 
and fluoresces upon uptake into compartments with low pH, thus labelling lysosomes. 
After allowing the haemocytes to adhere to the collagen substrate, Lysotracker-Red dye 
was added to the growth media, and the haemocytes were live-imaged to reveal 
lysosomes in a cytoplasmic background labelled with GFP (Figure 3.9A,B). The 
LysoTracker staining in ex vivo primary haemocytes shows that the vacuoles in the 
cytoplasm of the PxnGAL4>UASGFP haemocytes are Lysotracker-positive in both 
wild-type and Df A4 haemocytes. LysoTracker area was determined for each cell and 
frame by separating the Red (C1) and Green (C2) channels and using the ‘Analyse 
particles’ tool in ImageJ to determine the vacuole area (C1) and the entire area of the 
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cells(C2). Thirty-two cells were imaged over three technical repeats, with six larvae per 
repeat. The average OAI of LysoTracker area/Cell Area (C1/C2) is shown in Figure 
3.9C. The average OAI of LysoTracker in Df A4 haemocytes is significantly higher than 
that in wild-type haemocytes. This means that Hemotin mutants contain larger 
lysosomes than their wild-type counterparts, indicating a defect in the growth or 
processing of these intracellular vesicles.  
Lysotracker stained WPP ex vivo haemocytes were also visualised over time, at 5-
minute intervals, for a total of 150 minutes (Figure 3.9D) for a minimum of 15 cells per 
sample, and two technical repeats. This pulse-chase assay in WPP haemocytes was used 
to observe lysosome degradation in the cells over time, providing some insight as to 
whether Df A4 haemocytes have impaired phagocytic and degradation capability 
compared to wild-type haemocytes. Although the overall difference in the OAI is quite 
low, when observed over time, the LysoTracker signal in wild-type haemocytes shows a 
cyclical pattern, with three distinct peaks approximately every 40-45 minutes (circles on 
data plot, Figure 3.9D). Df A4 haemocytes are occupied by a larger lysosomal area from 
the start of the experiment, and there was a small initial peak at 20 minutes and a second 
one at 115 minutes (95 minutes later), which is approximately double the time it takes 
wild-type cells to process their lysosomes (squares on data plot, Figure 3.9D). These 
results showed that not only do Df A4 haemocytes have a larger area occupied by 
lysosomes, but also that the lysosomal mass persisted over time. This could mean that 
Hemotin mutant haemocytes are ingesting more material from their environment, as 
well as having trouble processing the material that they have ingested. This extends the 
‘larger vacuole’ phenotype observed in embryos and pupae to L3 and WPP lysosomes. 
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Figure 3.9: Lysotracker-labelling of ex vivo L3 and WPP haemocyte vacuoles  
A) Haemocytes from w;PxnGAL4>GFP; CrqGAL4>GFP L3 animals show labelling of 
cytoplasmic vacuoles with Lysotracker-Red B) Lysotracker labelling of haemocytes 
from w;PxnGAL4>GFP; Df A4 hemotin null L3 animals. C) This allows us to calculate 
a lysosomal OAI which is significantly larger for Hemotin deficient L3 hemocytes 
(P<0.0001). D) Graph plotting the average OAI of Lysotracker (y axis) in WPP 
haemocytes over a 150 minute period. Data-points are at 5-minute intervals from the 
addition of lysotracker to the cells. Squares represent peaks of lysosomal area in Df A4 
haemocytes and circles depict peaks of lysosomal area in wild type haemocytes. Scale 
bars = 10µm  
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Characterisation of haemocyte morphology ex vivo  
Using the ex vivo primary cell culture technique described by Sampson et al. (Sampson 
2013), a comparison of morphological classes of haemocytes extracted at L3 and WPP 
was conducted. In wild-type flies there is an observable ‘switch’ of haemocyte 
behaviour and morphology between larval and white pre-pupal (WPP) stages, from a 
largely sessile population (minor, normal cell types) to a pre-motile (non-polarised) or 
motile (polarised) population, a switch that we can now attribute to the ‘activation’ of 
haemocytes by ecdysone signalling (Sampson and Williams 2012; Sampson et al. 
2013). Membrane turnover is an important part of the migratory and plasma-membrane 
activity of haemocytes. It has also been documented that haemocytes in embryos 
display a ‘freezing’ phenotype upon phagocytosis of E. coli coated with Mcf1 toxin, 
which they are unable to process and causes a halting of membrane dynamics (Vlisidou 
et al.  2009). Membrane turnover is therefore affected by phagocytosis of bacteria.  
Using this established system of classifying haemocyte morpho-behaviour ex vivo, we 
characterised the membrane characteristics of Df A4 haemocytes. If Hemotin is involved 
in the regulation of the cytoskeleton in haemocytes, this would become evident using 
this technique, and give us another avenue of investigation. A lack of normal morpho-
behavioral characteristics Df A4 haemocytes would also be consistent with the presence 
of enlarged vacuoles and lysosomes in the cytoplasm of the cells.  
The classification system used in Sampson et al. (2012), which employs 6 categories of 
haemocyte spreading types, found in L1, L2, L3 and WPP stages, was simplified to suit 
the cell types found at L3 and WPP. Morphological classes were determined by scoring 
phase-contrast time-lapse videos of the ex vivo haemocytes that were bled from L3 or 
WPP flies of each genotype and then deposited on a collagen-coated coverslip inside a 
culture dish. The ‘normal’ (N) and ‘minor’ (M) haemocyte types, have a relatively 
uniform spread of the plasma membrane around the centroid regions (first and second 
rows, Figure 3.10) where the N haemocytes have a wider spread and M haemocytes 
have a tighter spread of membrane. Both N and M spread represent the quiescent, 
sessile behaviour and morphology of haemocytes before they are activated by ecdysone 
and apoptosis. These cells remain relatively unchanged in regards to their morphology 
and membrane behaviour over the course of a 20 minute time-lapse. The two 
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morphological classes of haemocytes that are predominantly found at WPP stage are 
‘non-polarised’ (NP) and ‘polarised’ (P) types (third and fourth rows, Figure 3.10). Both 
classes represent a fully adhered cell with an active cell membrane that protrudes and 
retracts from the centroid region, resulting in membrane ruffling. The essential 
difference between these two classes is that P cells produce a leading edge (solid 
arrowheads, Figure 3.10), and display directional migration, while NP cells throw out 
protrusions in different directions (white arrowheads, Figure 3.10), without displaying 
directional movement. Anywhere between five and thirty cells can be observed in each 
20-minute time lapse video. In order to make the haemocyte numbers more 
quantitatively viable, the total cell numbers were added together to give a more 
complete profile of the haemocyte population. A minimum of fifty cells per genotype 
were collected over two technical repeats from a sample pool of mixed bleeds from six 
larvae or six WPP (summarised in Figure 3.11).  
For the L3 stage ex vivo characterisation both Or-R and w1118 flies were used as wild-
type controls, and haemocytes from both lines displayed a mixture of M, N, and NP cell 
types, with Or-R L3 haemocytes also containing a small percentage of cells with 
directional motility (P). Hemolectin(Hml) GAL4 (III) flies were crossed with a UAS-
GFP line in order to determine if the ectopic expression of GFP by various haemocyte 
specific GAL4’s has an effect on haemocyte cellular profiles. These profiles were 
compared to the previously described fluorescent haemocyte lines, which served as 
wild-type controls for vacuole measurements, and to see whether there is a deviation 
from non-GFP expressing haemocytes bled from Or-R and w1118 flies. The expression 
of GFP with a haemocyte GAL4 driver shows similar profiles to the wild-type controls. 
At the L3 stage, it is apparent that Hemotin null mutant (Df A4) and the expression of a 
dsRNA designed to deplete the Hemotin mRNA (HmlGAL4>UAS-Hemotin dsRNA) 
decreased the overall percentage of P cells, with the M and N ‘inactivated’ types being 
predominant. Conversely, over-expression of full length Hemotin constructs showed 
wild-type distributions of cell types. With HemeseGAL4, which is a stronger driver than 
HmlGAL4, (observed by strength of GFP expression in haemocytes), several motile P 
cells, were also observed at L3. Notably, expression of full length UAS-Hemotin, UAS-
hemo-ORF1 and full-length UAS-Hemotin-GFP, expressed in a Df A4 background, 
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rescued the effect of the null mutation at L3 by returning the haemocyte population to a 
wild-type state. UAS-Hemotin-ORF1 is a mini-gene consisting of a fragment of mRNA 
truncated after the hemotin-ORF1 stop codon. UAS-Hemotin-ORF2 consists of an 
mRNA fragment carrying the ORF2 sequence and 6nt upstream of its start codon. These 
nucleotides are retained in order to conserve the endogenous Kozak sequence.(Pueyo 
2016). 
At WPP stage, the various control populations of haemocytes from Or-R, w1118, and 
GFP-expressing lines contained largely non-polarised or polarised cell types. Df A4 
heterozygote haemocytes are also similar to wild-type in their cell type profiles. There is 
a lingering presence of some Minor and Normal cells, but this tends to remain around 
5-10% of the overall population. The striking observation in Df A4 haemocytes is that 
they do not display the same proportion of motile P cells at WPP stage, an effect which 
can also be seen in the Hemotin RNAi line. WPP from the cross of HmlGAL4 and UAS-
Hemotin-ORF1 and UAS-Hemotin-ORF2, showed an increase in NP cell types. This 
result is different to the haemocyte profile of HemeseGAL4 driven ORF1 and ORF2 
expression. This could be due to the fact that the peak of Hml expression occurs at 
larval stages, and may be actively repressed after the induction of pupation (Goto 2003). 
HemeseGAL4 driven expression of UAS-Hemotin is closer to the haemocyte profile of 
wild-type WPP than with HmlGAL4.  
HmlGAL4 driven expression of full length UAS-Hemotin and UAS-Hemotin-ORF1 in Df 
A4 background, seems to partially rescue the Df A4 phenotype of lowered number of P 
cells. I was unable to complete the rescues using HemeseGAL4, which may have shown 
an improved effect of the rescue using the Hemotin mini-gene constructs. The full 
length UAS-Hemotin tagged with GFP does not rescue the effects of Df A4 at WPP 
stage. Results gathered by others at the same time showed that when Df A4 L3 
haemocytes were incubated with ecdysone, there was no induction of motility in those 
haemocytes (Christopher Sampson, personal communication). This is similar to the 
result of the dominant-negative mutants of ecdysone receptor at L3 stage (Sampson 
2013). Overall, these results show that lowering or eliminating the expression of 
Hemotin by a specific deficiency, caused deviation from wild-type haemocyte profiles. 
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Figure 3.10: Ex vivo morphological classes of L3 and WPP haemocytes  
Time-lapse imaging of ex vivo hemocytes and classification of cell behaviour through 
morphology over time. Minor (M) and Normal (N) spread classes are shown in the top 
two rows, and it can be seen that over the course of 19 minutes, the shape of these cells 
remain largely unchanged. These cell types are predominantly seen at the L3 stage. 
Polarised (P) and Non Polarised (NP) haemocytes show a dynamic cell edge which 
depict the more active haemocytes that can be predominantly seen in WPP stage 
haemocytes. The difference between these two classes is that NP haemocytes extend 
lamellipodia in different directions (black arrows) whilst P haemocytes display 
directional movement (white arrows).  
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Figure 3.11: Results of ex vivo morphological classification of L3 and WPP 
haemocytes Morphological classification of ex vivo hemocytes isolated from various 
controls expressing GFP in haemocytes, homozygote and heterozygote hemotin 
deficiency mutants, hemotin RNAi knockdown, and over-expression fly lines at Larval 
(Top graph) and WPP stages (Bottom graph). Oregon R and w1118 L3 and WPP were 
used as controls to characterise the wild-type distribution of hemocytes. The profiles 
obtained for haemocytes extracted from transgenic animals at both these stages show 
that Hemotin depletion leads to a change from wild-type distributions, with a fewer 
proportion of activated (P, NP) haemocytes at both L3 and WPP stages in Hemotin 
mutants. Over-expression of Hemotin-ORF1 and Hemotin-full-length constructs results 
in an increase in activated hemocyte types (P, NP) at the L3 stage compared to wild-type 
haemocytes. The Df A4 deficiency phenotype of haemocyte morphologies is partially 
specific to Hemotin as it can be partially rescued by the over-expression of the 
Hemotin-ORF1 and Hemotin-full-length constructs in a hemotin null background at 
both the L3 and WPP stages. 
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A putative vertebrate homolog of Hemotin 
I ran the peptide sequence of Hemotin through the Protein Homology/analogY 
Recognition Engine (Phyre2) program (Kelley et al. 2015) as it had been successfully 
used to find the homolog of Sarcolamban in vertebrates (Magny et al. 2013). It 
appeared that Hemotin (Figure 3.12A) could have a putative homolog in vertebrates 
called Stannin (Snn) (Figure 3.12B). There are a few early papers published on the 
characterisation and function of Snn, with experiments conducted mainly in mammalian 
tissues after the gene was isolated in toxicology studies (Toggas et al. 1992). Snn 
encodes an 88 amino acid peptide expressed in the rat spleen, brain, kidneys and lungs. 
Antibody staining against FLAG, a commonly used protein tag, fused to the Snn 
transcript, expressed in mammalian NIH-3T3 cells showed that Snn-FLAG fusion 
protein is expressed in a punctate pattern all over the cytoplasm of the cells, similar to 
the appearance of Hemotin-GFP expression in haemocytes (Figure 3.12C) (Davidson et 
al. 2004). They also tested whether there is overlap of Snn expression to the 
mitochondria, and they found that Snn-FLAG and GRP75 do colocalise (Figure 3.12D). 
Cell fractionation experiments followed by western blotting showed that Snn-FLAG 
was found to be enriched in peroxisomes and the ER (labeled with anti-GRP78 
antibody) (Davidson et al. 2004; Billingsley et al. 2006). The Snn peptide sequence 
contains a CXC metal-binding motif, which is a conserved chemokine receptor, a 
putative 14-3-3ζ RxSxpSxD binding motif on the cytoplasmic side of the molecule and 
a 25aa transmembrane domain, which can be aligned to the amino acid residues in 
Hemotin (Billingsley et al. 2006) (Figure 3.12E). 14-3-3ζ has been shown to co-
immunoprecipitate with Stannin (Davidson et al. 2005). Knocking down 14-3-3ζ affects 
phagocytosis in Drosophila haemocytes, as depletion of 14-3-3ζ leads to excessive actin 
polymerisation and lack of protrusion formation (Ulvila et al. 2011).  
Colocalisation of Hemotin-GFP and 14-3-3 
The availability of several specific anti-14-3-3 antibodies allowed the verification of the 
functional homology of Snn and Hemotin by colocalisation experiments. (Santa Cruz) 
was checked for colocalisation against Beta-tubulin (DSHB) as a positive control for the 
antibody, as 14-3-3 is known to localise to microtubules (Zhou et al. 2010). The 14-3-3 
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protein has several isoforms, and is a highly conserved master regulator of eukaryotic 
cells. Different isoforms of 14-3-3 are expressed in different cell types, and these 
peptides participate in neuronal function, regulation of cell cycle, apoptosis, exocytosis, 
as well as cytoskeletal dynamics and signalling (Fu et al. 2000). Using extracted 
haemocytes from wild-type Or-R L3 and WPP animals, the colocalisation of 14-3-3 and 
B-tubulin was confirmed (Figure 3.13A,B). I then proceeded to check whether Hemotin 
fused with GFP and 14-3-3 colocalisation could be observed. In a Z-stack projection of 
L3 and WPP haemocytes, there are spatial overlaps between the expression of Hemotin-
GFP and 14-3-3 labelled domains (Figure 3.13C,D). Colocalisation of Hemotin-GFP to 
14-3-3 is higher at L3 stage than at WPP. This shows that there is a moderate amount of 
overlap between Hemotin-GFP and 14-3-3, perhaps enough to mediate an interaction at 
specific foci. The average Mander’s correlation coefficient between Hemotin-GFP and 
14-3-3 (Figure 3.13E) was determined for L3 (0.5643 ± 0.03) and WPP cells (0.4678 ± 
0.03). The Mander’s coefficient for overlap between 14-3-3 and B-tubulin at L3 (0.8516 
± 0.02) is a little higher than at WPP (0.8106 ± 0.02). I have shown that Hemotin co-
localises to similar intracellular membranes in haemocytes as Stannin does in vertebrate 
cells, and that Hemotin mutants have a defect in the processing of endocytosed material. 
The functional characterisation of the actual steps of endosome maturation that Hemotin 
is involved in were researched by other members of the lab, as will be discussed in the 
following section. 
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Figure 3.12: The discovery of Stannin, a putative mammalian homologue of 
Hemotin A) Phyre2 structural homology program predicted structure of Hemotin-ORF1 
and B) The putative vertebrate 88 amino acid homologue of Hemotin-ORF1, called 
Stannin, as shown by the Phyre2 program C) Stannin-FLAG expression in mammalian 
NIH-3T3 cells shows a punctate subcellular distribution (Davidson et al. 2004) D) 
Colocalisation of Snn-FLAG with mitochondrial marker GRP75 shows a high level of 
overlap (Billingsley et al. 2006). E) Domain structure of the Stannin/Hemotin peptide 
(ORF1, 88amino acids) showing the putative transmembrane features and the 14-3-3ζ 
binding domain. F) Clustal Alignment of Hemotin shows the conservation of the 
peptide from (stars) two insect lineages (Diptera and Hymenoptera) and vertebrate 
Stannin (Hagfish and Human). There is a high level of conservation in the 
transmembrane domain motif among these peptides.  
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Figure 3.13: Colocalisation of Hemotin-GFP and anti-14-3-3  
A) Double Antibody staining of ex vivo haemocytes to confirm colocalisation of a pan-
isoform anti-14-3-3 antibody (Santa Cruz) (Rhodamine secondary) with anti-Beta-
Tubulin (FITC secondary) and DAPI staining the nuclei (Blue) in Oregon-R L3 Larvae 
and B) WPP haemocytes. C) HmlGAL4>UAS-Hemotin-GFP haemocyte staining with 
pan isoform anti-14-3-3 antibody in haemocytes from L3 and D) WPP. Scale bars = 
5µm. E) Quantification of colocalisation using Mander’s coefficient. There is very high 
overlap between 14-3-3 antibodies and Beta-tubulin (L3=0.85±0.02, n=24; WPP= 0.47± 
0.03, n=11) Hemotin-GFP and 14-3-3 peptides at L3 show medium level of overlap at 
L3 stage (0.56±0.03, n=25), and this overlap is decreased at the WPP stage (0.47± 0.03, 
n=11). 
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Discussion
Hemotin is a dicistronic smORF gene, which produces two peptides of 88 and 59 amino 
acids from ORF1 and ORF2 respectively. We had previously found that hemotin is 
expressed in regions where haemocytes are derived from in embryos, similar to the 
expression of haemocyte-specific markers. Hemotin mRNA is not maternally deposited 
in the embryo, and the expression of hemotin peaks at the end of larval and beginning of 
pupal stages. The suspicion that hemotin mRNA is expressed in haemocytes at 
embryonic stages led us to investigate whether Hemotin played a role in Drosophila 
immunity, overall longevity of the fly, and the cellular process of intracellular 
trafficking. Haemocytes are excellent cellular models as they are well characterised 
cells. Haemocytes can be bled from the animal at post-embryonic life stages and survive 
for long periods in primary cell culture in ex vivo chambers supplemented with culture 
medium (Sampson and Williams 2012). The affinity of Haemocytes for extra-cellular 
matrix proteins such as collagen, enables live imaging on collagen-coated coverslips 
using organelle dyes and direct labelling of cells by fixing them and bathing the cells 
with antibodies (Sampson and Williams 2012; Sampson et al. 2013).  
Hemotin localises to KDEL and Lysotracker labelled organelles  
As we could not determine the endogenous expression of Hemotin peptide, in order to 
visualise Hemotin localisation with high resolution microscopy at the sub-cellular level, 
we had to express a UAS construct containing Hemotin tagged at the C-terminal with 
GFP, expressed with haemocyte-specific GAL4’s. This method can also be used as 
proof of protein translation, as the GFP coding sequence would only be translated if 
there is translation of the Hemotin coding sequence. I showed that Hemotin-GFP 
colocalises with different membrane markers inside the cell, specifically Lysotracker, 
which labels acidic compartments in the cell; and KDEL which is a peptide motif 
presented on the trans-side of the ER, the cis-side of the Golgi, and any intracellular 
vesicles inside the cell. The presence of a large GFP tag (25KDa) on a small peptide 
could potentially distort the expression and subcellular localisation, but in the cases of 
both Tal and Scl, tagged versions of the smORF rescued lack-of-function phenotypes, 
showing that the fusion proteins were functional. In both previous cases, tagging the 
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smORF with a marker such as GST, GFP and FLAG was only way that smORF 
subcellular expression was detected.(Galindo et al. 2007; Magny et al. 2013). We 
decided to continue using haemocytes as a model as the effects of intracellular 
trafficking would become apparent in these cells. 
Hemotin plays a role in Drosophila immunity via intracellular trafficking 
By performing viability studies on the Hemotin-deficiency mutant (Df A4), it became 
apparent that the lack of Hemotin expression causes a decrease in the life span of flies. 
Although it became clear that Hemotin performs an important function in this way, we 
had yet to actually characterise exactly why the function of Hemotin would impinge 
upon overall life-span, as flies appeared normal until their early deaths. To discern 
whether Hemotin plays a role in immunity, flies were infected with pathogenic and non-
pathogenic bacteria. This showed that Hemotin mutants are more susceptible to 
infection by pathogenic and non-pathogenic bacteria, which decreases their life spans 
significantly when compared to normal flies. Infected mutants of an endosome 
maturation protein called full-of-bacteria (Akbar et al. 2011) live longer than Hemotin 
mutant flies in this experiment. This led us to conclude that Hemotin is definitely 
involved in intracellular trafficking or endocytosis.  
Overall fly viability is a measurable phenotype, but to prove the Hemotin functional 
hypothesis, required taking a closer look at haemocyte function. Embryonic and pupal 
stages are important times for haemocytic function, and imaging haemocytes in vivo at 
both stages showed that Hemotin mutant haemocytes have larger vacuoles than wild-
type haemocytes, indicating a problem with phagocytosis or processing of ingested 
material. In addition, a LysoTracker pulse chase assay revealed larger lysosomal 
compartments in Hemotin mutant haemocytes  ex vivo, after the start of metamorphosis. 
Hemotin mutant haemocytes also displayed a delay of lysosomal processing when 
comparing the measurements of cyclical increasing/decreasing lysosomal area to wild-
type haemocytes. This further indicates that there is a defect in endosome maturation, as 
lysosomal contents are supposed to be degraded and through subsequent fusion events, 
the membrane that is brought inside the cell through phagocytosis is recycled to the cell 
edge (Lindmo and Stenmark 2006; Huotari and Helenius 2011; Akbar et al. 2011).  
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If the removal of Hemotin results in a defect in the endosome maturation pathway, this 
would potentially be reflected in the overall cytoskeletal morphology and the motile 
characteristics of Hemotin mutant haemocytes. By culturing the primary haemocytes 
using the ex-vivo system, I attempted to show that there are reduced characteristics of 
motile behaviour in hemotin mutant haemocytes at both L3 and WPP stage. As 
previously described, it is through the action of the Rho-family GTP-ases Cdc42, Rac1 
and Rac2 causes the ruffling of plasma membrane, which allows haemocytes to probe 
their environment in order to recognise apoptotic debris and bacterial pathogens. This 
induces a receptor-ligand mediated signalling cascade which acts upon the actin scaffold 
of the cytoskeleton, allowing phagocytosis to occur. The switch in membrane behaviour 
from a largely sessile population to a motile, ‘pathogen-seeking’ haemocyte population 
does not take place in haemocytes derived from loss-of-function mutants of the Rho-
family GTP-ases (Sampson and Williams 2012). I found that hemotin mutant 
haemocytes show a different set of cell morphological classes than wild-type cells, at 
both L3 and WPP stages. This phenotype could be a result of a phagocytic block inside 
the cytoplasm of cells, which hampers membrane turnover and leads to a block in the 
membrane ruffling and directional motility of haemocytes. These phenotypes were 
either completely (L3) or partially (WPP) rescued by expressing a full length construct 
of Hemotin in the haemocytes, returning the profile of the extracted haemocytes to more 
wild-type proportions.  
This result, though not a direct read-out of Hemotin function, supports the idea that 
Hemotin is affecting membrane turnover, and was consistent with our hypothesis, 
considering that Hemotin mutants seem unable to process intracellular vesicles 
efficiently. Though, as it later turned out, the inhibition of motile characteristics can also 
be attributed to the deletion of CG7691 in the Df A4 line (C.J. Sampson, personal 
communication). This discovery helped explain some of the confusion around the ex 
vivo characterisation of hemotin mutant haemocytes, and also why rescues with the 
UAS-hemotin constructs only partially rescued the non-motile phenotypes. Direct 
comparison of the cell morphology profiles to that of actin cytoskeleton mutants, or 
phagocytosis mutants, would have made this analysis more reliable. The fact that 
ecdysone fails to stimulate Df A4 haemocytes into activation also remains to be further 
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investigated.  
Recently, we were able to confirm that Hemotin is indeed a novel regulator of the 
endosome maturation pathway. Other members in the lab have found that Hemotin 
localises to specific endosomal compartments which are labeled by markers of the 
early-to-mid transition of endosome maturation. The vacuoles I was previously 
measuring in hemotin mutants can be labeled with markers specific to late endosome 
maturation (Rab7, FYVE) and show a significant increase in size compared to wild 
type. This phenotype of enlarged late-endosomal compartments is fully rescued by the 
expression of hemotin in a null-mutant background. The knock-down of Stannin in a 
mammalian macrophage-like cell line also showed enlarged LysoTracker vacuoles, 
indicating a functional homology of Hemotin in vertebrates (Pueyo et al. 2016).  
The polyclonal antibody that was generated against Hemotin did not exhibit specificity 
despite best efforts and different immunohistochemistry techniques employed. It would 
have been helpful as a tool to detect, visualise, and quantify endogenous Hemotin 
protein levels. As there was always strong, comparable levels of background signal 
present in Df A4 mutant embryos and haemocytes, I was unable to show that the 
antibody specifically binds to Hemotin,. It has previously been verified by genomic and 
RT-PCR by others in our group that Df A4 mutants completely lack hemotin at the 
genomic and RNA level, therefore it could not be possible that the antibody is specific 
to Hemotin. The non-specific antibody hampered our ability to look at a bigger picture 
of endogenous Hemotin expression, as there may be other tissues where Hemotin could 
be playing an important role such as the CNS, which is supported by the expression of 
hemotin in a CNS-derived cell line from modENCODE RNA expression data. 
Regardless of these shortcomings, finding a role for Hemotin in a context of 
phagocytosis and intracellular trafficking is very exciting.  
By combining the knowledge of the localisation of Hemotin and using the deficiency 
mutant to functionally characterise a phenotype involved with the localisation of the 
peptide, I was able to find the first breadcrumbs on the trail to the functional 
characterisation of this novel SEP. This information helped others to study the role of 
Stannin in the context of endosome maturation, which had not previously been 
described. The information presented here may enlighten our understanding of 
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phagocytosis in higher animals as well as in Drosophila. The use of tagging and 
subcellular characterisation also drove us toward the broader eukaryotic concept of 
intracellular trafficking. Although the overall effect of stalling endosome maturation 
would not cause lethality in early life stages, the life span and quality of life of the flies 
are affected in hemotin deficiency mutants, especially at adult stages, which can be seen 
from the viability and infection studies.  
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Chapter IV - Cellular characterisation of translated Drosophila 
smORFs
Introduction
Characterising the smORF gene family on an individual basis is a time consuming 
process, requiring years of work from the discovery of a smORF gene, to the 
completion of functional characterisation at a molecular or cellular level. Previously, the 
characterisation of tarsal-less, sarcolamban and hemotin have taken up to 5 years each. 
The process of smORF characterisation on an experimental basis can only begin after 
the verification of a translated peptide product. Bioinformatic studies of sequenced 
genomes have revealed that hundreds and potentially thousands of smORF sequences 
exist in bacteria, yeast, plants and more complex organisms such as fruit flies, mice and 
humans (Ladoukakis et al. 2011). However, from these smORF sequences, the 
proportional rate of smORF peptide detection using traditional biochemical and 
proteomic techniques is very low. The question still remained as to how many smORF 
sequences are translated into functional proteins. Considering the presence of thousands 
of putative smORF genes (Flybase, Ensembl databases), the characterisation of three 
smORFs (tal, Scl, Hemotin) is unrepresentative of the entire pool that may exist overall. 
What is needed is the characterisation of a more representative sample of this new gene 
family. In order to conduct the functional characterisation of smORFs on a larger scale 
than before, we needed a comprehensive list of translated smORFs in which we have 
high confidence. This process is made difficult by the discovery of abundantly present 
non-coding RNA in the genomes of several organisms. These sequences are transcribed 
with RNA polymerase II and undergo post-transcriptional processing such as 
polyadenylation and splicing, just like normal protein coding transcripts, and many 
could contain putative smORFs, but there was previously no good method to make this 
differentiation.  
N.B. Portions of this chapter have been published in Aspden et al., (2014) eLife.  
For these experiments, J.L. Aspden designed the plasmids for tagged smORFs and 
cloning of plasmids was conducted by R.J. Phillips. 
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Therefore, it is difficult to differentiate real ncRNA from peptide-encoding smORFs due 
to these shared characteristics, as the only thing that truly differentiates them is whether 
they are translated into protein. There are several evolutionary conserved genes that 
have been found to encode RNA rather than peptides. These non-coding RNAs are 
abundant in number and may be involved in a variety of cellular processes such as the 
processing of other RNA, transcriptional and translational regulation of genes and 
protein trafficking. An example of important mRNA-like ncRNAs includes Pgc RNA, 
which maintains germ cell fate in Drosophila by regulating transcriptional repression 
during early embryonic stages. Drosophila mutants of bereft ncRNA, usually expressed 
in the peripheral nervous system, exhibit malformed extrasensory organs and bristles 
found in the eye (Inagaki et al. 2005).  
The results from Ribosome profiling experiments have recently led to the expansion of 
the putative proteomes of several organisms and the discovery of several novel aspects 
of ORF translation. The new technique of ribosome profiling has been conducted in 
yeast (Ingolia et al. 2009; Duncan and Mata 2014; Smith et al. 2014), Drosophila (Dunn 
et al. 2013), Mice (Ingolia et al. 2011) and zebrafish (Chew et al. 2013; Bazzini et al. 
2014). In the case of identifying novel coding regions, ribosome profiling results 
indicate the presence of translated ORFs in previously unproductive genomic regions, 
including uORFs in the 5’ UTR, as well as within ‘non-coding RNAs’ (ncr_ORFs) 
(reviewed by Ingolia 2014), as well as the discovery of alternative ORF translation 
(AltORFs) (Vanderperre et al. 2013). This method was employed by our lab to 
distinguish true coding smORFs from non-coding varieties of genes. 
Ribosome Profiling methods to determine translation 
The ribosome profiling method entails the Next Generation Sequencing of mRNAs 
protected by ribosomes. These are called ‘ribosome bound fragments’ (RBFs). RBFs are 
generated by nuclease digestion of mRNAs being transcribed in real time, thus allowing 
the identification of mRNA regions that are being actively translated by a ribosome. 
These short mRNA fragments (28-34nt) are then purified, sequenced and mapped to the 
transcriptome. This reveals the ribosome occupation along the mRNA, and shows 
actively translated regions of the transcripts, or where ribosomes may pile up and be 
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hindered from translating in some way. Sequenced mRNA fragments can then be 
quantified to also reveal the abundance of specific mRNAs that are undergoing 
translation (Ingolia et al. 2009). 
The most recent releases of the Drosophila S2 cell genome (R5.50) upon writing of this 
thesis, showed the putative presence of 829 smORF peptide encoding genes, (~4% of 
total annotated protein-coding genes), which is double the predicted amounts in other 
metazoans. However, only 54 of these smORFs (6% of total pool) appear as candidates 
that we would consider for further study in the fly through some previous evidence of 
translation. These 54 smORFs each have 1) proteomics evidence, 2) a molecular GO 
term predicting a protein function from sequence homology and 3) coding sequence 
conservation in higher animals. These smORFs are often allocated a gene name based 
on protein homology of specific domains, but lack any specific functional data or in-
depth study. A remaining 110 ‘partially corroborated smORFs’ have two out of the three 
aforementioned hallmarks of translation. The remaining 665 annotated smORFs in 
Drosophila melanogaster have insufficient evidence of translation and most of these are 
identified by numerical cognate identifiers (CG numbers) rather than a gene name 
(Aspden et al. 2014). This amounts to a proportion of less than 20% (164/829) of 
‘Flybase-annotated’ (FB) smORF genes with anything resembling solid evidence of 
translation in the fruit fly.  
Given this lack of information, it is not surprising that Drosophila smORFs are 
considered untranslated, or potential lncRNAs at best. Better techniques were needed in 
order to assess smORF translation on a large scale. This endeavour led to the recently 
published work conducted by our lab, where a genome-wide assessment of smORF 
translation was performed, using an ‘improvement’ of the ribosome profiling method, 
which we call Poly-Ribo-Seq (Aspden et al. 2014). We addressed the question of non-
productive ribosomal association by modifying the experimental protocol to add a 
Polysomal fractionation step prior to ribosome foot-printing (Arava et al. 2003). 
Polysomal fractionation allows separation of mRNA by the number of bound 
ribosomes, prior to nuclease digestion of the mRNA into RBFs which are subsequently 
purified and sequenced. By sequencing only the mRNAs bound to more than one 
ribosome, we hoped to improve the chances of detecting smORF mRNAs that 
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undergoing ‘active translation’ and in this case, active translation is inferred from the 
idea that more than one ribosome would not typically bind an mRNA in the absence of 
translation. Studies on yeast have shown that each translating ribosome spans a length 
of ~80nt (Arava 2003). It was therefore estimated that longer smORF mRNAs coding 
up to one hundred amino acids (303nt) can contain anywhere between 2-6 ribosomes. A 
potential caveat of sequencing mRNAs with two or more ribosomes is that it may instil 
a bias against dwarf smORFs such as tarsal-less (33nt) or sarcolamban (81nt), which 
would only need one ribosome to span the transcript. However, due to the observation 
that short smORF mRNAs seem to be enriched in smaller polysomes (<6 ribosomes), it 
could also be the case that ribosomes may be more densely packed in Drosophila 
(Aspden et al. 2014).  
For an mRNA to be classified as translated in our Poly-Ribo-Seq experiments, stringent 
cut-offs were used. These were based on the subtraction of background signal from 
3’UTRs of canonical protein-coding mRNAs (above the 90% percentile). The criteria 
for translation was 1) a minimum abundance of 11.8 RPKM (Reads Per Kilobase Per 
Million) to show that there is comparable abundance to canonical transcripts and 2) 0.57 
Coverage (proportion of Poly-Ribo-Seq footprints covering the RNA transcript) because 
the higher the coverage, the more chances there are that the ORF is translated due to the 
binding of ribosomes across a longer stretch of the transcript (Aspden et al. 2014). Of 
the 274 smORFs transcribed in our S2 cells (from in-house RNA-seq of total S2 cell 
mRNA), 228 smORFs in total were found to be translated across two Poly-Ribo-Seq 
sequencing experiments.  
The number of smORFs found to be translated by Poly-Ribo-Seq almost doubles the 
previous number of smORFs (164) with evidence of translation in Drosophila 
(proteomics evidence, a molecular GO term, coding sequence conservation) and gives a 
grand total of 285 smORFs with strong evidence of translation. There were also 2708 
uORFs found to be translated in S2 cells, as well as 313 smORFs found in potential 
ncRNA transcripts. High confidence translated smORFs in ncRNA and 5’UTR regions 
(uORFs) would be interesting to follow up, as that would help to highlight whether 
there are any functional trends or differences between the smORFs found within these 
different transcripts. 
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A requirement to corroborate translation of Poly-Ribo-Seq results 
Before ribosome profiling can become evidence of translation in lieu of a peptide 
product, previous ribosome profiling papers argue that there still exists a need to 
directly detect the peptide from novel protein-coding mRNAs found by ribosome 
profiling methods. The presence of non-AUG start codons, internal ribosome entry sites 
(IRES) and nonsense read through may hamper the correct prediction of peptide 
sequences (Ingolia et al. 2009). mRNA is subject to extensive post-transcriptional 
regulation, such as capping, splicing, polyadenylation and editing, which may or may 
not result in formation of a viable peptide product (Colgan and Manley 1997; Day and 
Tuite 1998; Li  and Kiledgian 2010). mRNA can also be of varying stability, with a long 
or short half-life (Schoenberg and Maquat 2012). To prove that the high-confidence 
Poly-Ribo-Seq smORFs produce a peptide product, we had to independently 
demonstrate proof of translation. Independent monitoring of peptide translation would 
also show us whether our cut-offs for translation are meaningful. The Poly-Ribo-Seq 
experiment eliminates the question of active translation, but in order to provide 
evidence that this technique is indeed better than previous attempts, we decided to 
independently corroborate a representative pool of the 228 translated smORFs (at least 
10%). 
Plasmid transfection and cellular imaging as a tool for smORF characterisation  
Engineered gene expression in Drosophila is a technique has been used previously by 
our lab to characterise smORF peptide function in vivo (GAL4-UAS system) and in cell 
lines using plasmid transfection (Galindo et al. 2007; Magny et al. 2013). The material 
used for Poly-Ribo-Seq by our laboratory was derived from Drosophila embryonic 
tissue culture (S2 cells) which are ideal for conducting sensitive RNA-based 
experiments as they are grown using aseptic methods. Using cells which can grow 
exponentially in a few days also provides abundant material for experiments of this type 
as there are several purification steps in the protocol, which leads to loss of some 
material as samples are carried over. Although there are almost 100 cell lines derived 
from Drosophila melanogaster, S2 cells are one of the most widely used cell lines for 
gene expression studies (Cherbas et al. 1994). 
 73
The Actin5C gene encodes cytoskeletal actin, which is present in all cell types. The 
proximal actin 5C promoter enables high levels of constitutive expression of 
downstream coding sequences (Chung et al. 1990). Plasmid transfection is a very 
powerful tool to introduce ectopic gene expression in Drosophila and other animal cell 
lines. The plasmid is combined with a lipid transfection agent to form membrane-bound 
liposomes, which are internalised by the cells. After internalisation, the plasmid is 
transcribed and translated by the host-cell machinery. (Lee et al. 2000; Wilder 2000). 
This technique allows us to ectopically express smORF peptides in S2 cells by 
transfecting the cells with a promoter and smORF-cDNA fusion plasmid, creating large 
amounts of expression of the target smORF. The main limitation of this approach is that 
the over-expression of some genes may lead to cell lethality, in which case we would 
fail to observe many cells expressing the construct (Wilder 2000).  
This chapter entails the findings of the tagging-transfection assay designed to detect and 
corroborate Poly-Ribo-Seq smORF translation in S2 cells. This assay, coupled with the 
power of imaging, revealed specific patterns of smORF peptide subcellular distribution, 
which led us to assess the subcellular distributions and localisation of a larger sample of 
smORFs than have ever been tested before. These discoveries help us to shed some light 
on the potential functional roles of smORFs being expressed in Drosophila embryonic 
cells. This assay was conducted of smORFs across a range of different translation 
metrics, and amounted to 20% of the total smORFs deemed translated by Poly-Ribo-
Seq. 
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Results
The tagging-transfection Assay 
Verification of smORF translation in vivo requires contextual and developmental 
knowledge of when and where the mRNA expressed. Generating specific antibodies to 
each smORF would be a time-consuming and expensive endeavour that has not proven 
to be very successful in the past. In order to bypass this requirement, we decided to use 
inducible gene expression using plasmid transfection in S2 cells. By constructing a 
fusion plasmid containing a constitutively active promoter and smORF cDNA fused to a 
tag which can be labelled with a specific, efficient antibody, we can specifically label 
smORF peptides and image them at a cellular level.  
Total S2 cell cDNA was used to clone individual smORF sequences from primers 
specific to each smORFs 5’UTR and coding sequence (CDS), minus the stop codon of 
the transcript. The full 5’UTR of the smORF was included to retain the Kozak sequence 
as well as any upstream translational regulation sequences. The cloned smORFs were 
inserted into a modified plasmid containing the actin 5C promoter, and a C-terminal tag 
(Figure 4.1A). The 3’ end of the smORF lacking a ‘stop’ codon, is fused to the 5’ of the 
tag so any expression of the peptide tag would be the result of translation of the smORF. 
This method can be repeated for a large number of smORFs, and can be used to provide 
corroboration of smORF translation in S2 cells. 
Experimental controls  
We initially tested two different tags for the detection of smORF-fusion peptides. It was 
decided that we try the FLAG-tag, which is a small tag (amino acid sequence: 
DYKDDDDK) that can be readily detected by a very efficient commercially available 
antibody. The other tag we tested was Venus, which is a highly fluorescent tag that can 
be directly detected in cells without any subsequent labelling with antibodies. The use 
of a fluorescent tag could be useful in live-imaging, as we could potentially use it to 
observe translation or protein degradation in real time using live cells. Four constructs 
were initially designed as positive and negative controls for the experiment. Using site-
directed mutagenesis, the ATG (methionine) at the start of the FLAG or Venus coding 
sequences was mutated to a GCG (alanine). These plasmids were called GCG-FLAG 
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(1) and GCG-Venus (2). These constructs served as the negative controls for the 
experiment, and should not be technically translated on their own as there is no start of 
translation included in these plasmids.  
The positive controls for the experiment used the plasmids designed above, with the 
5’UTR and first few codons of a translated smORF, CG42371 (Peptide Atlas Database) 
inserted upstream to introduce a non-plasmid AUG upstream of the GCG-FLAG and 
GCG-Venus sequences. These constructs were named AUG-mod-FLAG (3) and AUG-
mod-Venus (4). If we observe translation of the tag from these constructs, it should be 
because of the non-plasmid start codon, such as those inserted from smORFs.  
The AUG-mod-FLAG and AUG-mod-Venus constructs show FLAG and Venus signal 
in the cells, and this showed that the presence of a non-plasmid AUG leads to the 
translation of the tag, as expected. The GCG-FLAG plasmid showed no signal in the 
cells, however the GCG-Venus plasmid shows signal that is comparable to that present 
in the AUG-mod-Venus transfection, despite not containing a canonical start codon. As 
can be seen Figure 4.1B, the problem with the Venus fluorescent tag became apparent 
when these constructs were tested. We decided to clone the putative ORF within a 
known long non-coding RNA called Uhg2, into the GCG-tag constructs as an additional 
negative control, as Uhg2 is a snoRNA-host gene, which are a family of genes that have 
been shown to not be protein coding (Tycowski and Steitz 2001). Uhg2-mod-Venus 
showed signal in the cells, whilst Uhg2-mod-FLAG failed to produce a peptide that 
could be detected. Thus the reliability of the results from the Venus tagged constructs 
came further into question, as Venus was being translated in both of the negative 
controls.  
As each of the constructs had been sequenced to verify insertions and mutations, I 
looked into the GCG-Venus sequence and found that there are several downstream 
alternative start codons within the coding sequence of the Venus tag (GTG,Valine and 
CTG, Leucine). Western blots used to detect Venus and FLAG signal from these 
constructs showed the presence of multiple Venus protein bands corresponding to the 
size of the Venus tag alone, thus we concluded that there was translation of Venus from 
these alternative start codons (personal communication with MAS Mumtaz and JL 
Aspden). We therefore discontinued using the Venus tag in the tagging-transfection 
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assay as it would potentially result in the quantification of false-positives. The 
remainder of the study was conducted using the FLAG tag as it was not translated on its 
own by any alternative start codons and also, using the mod-FLAG construct did not 
show translation of Uhg2, a known ncRNA. Transfections with a frameshift version of a 
translated smORF (CG14482) cds cloned into the GCG-FLAG plasmid did not result in 
any peptide being detected using antibody staining. This indicates that translation of the 
GCG-FLAG tag also does not occur when the coding sequence contains a nonsense 
mutation. 
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Figure 4.1: Experimental controls for the tagging-transfection assay   
A) Modification of Murphy Lab Gateway Cloning expression vectors used in the 
transfection-tagging assay. Plasmid transcription is under control of the Actin5C 
promoter and the vector contains a C-terminal 3xFLAG/Venus tag sequence followed 
by an SV40 polyA signal. In order to eliminate expression of the tag only, the AUG start 
codon of the tag was changed to a GCG codon. These are termed GCG-FLAG and GCG 
Venus, and serve as a negative control in the experiment as there should not be 
translation of the tag in these constructs. The positive control AUG-FLAG/Venus 
construct was made by adding the 5’UTR plus the start codon of the translated smORF 
gene CG42371. These are termed AUG-mod-FLAG and AUG-mod-Venus.  
B) S2 cells transfected with both negative and positive control constructs. In the case of 
FLAG constructs, cells were immune-stained to label FLAG (FITC secondary), 
followed by labelling of all samples with F-actin (Rhodamine-Phalloidin). Translation 
from both the positive control AUG-mod-FLAG/Venus constructs can be seen. No 
FLAG tag signal was observed for the negative control GCG-FLAG construct but 
GCG-Venus shows comparable levels of signal as the positive control. Testing the 
translation of a putative ORF in a known ncRNA, Uhg2 (Tycowski and Steitz 2001) 
reveals signal with the Venus tag, but not with the FLAG tag. Examining the first few in 
frame codons of the Venus tag reveals putative alternative start codons (orange) 
downstream of the original start codon (blue) and in the modified start codon (red). The 
presence of signal from the Venus tag in these negative controls rendered the Venus 
plasmids unusable to assess smORF translation in our assay. The bottom panel shows a 
frameshift construct of the translated smORF CG14482 to show that FLAG signal is 
specific to having an in-frame ORF. Scale bars = 5µm. 
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smORF controls  
In order to assess the strength of the peptide tagging-transfection assay, we examined a 
smORF that is not normally translated, which is the last ORF of tarsal-less (tal). The tal 
transcript contains 5 ORFs (Galindo et al. 2007) and our lab have previously shown that 
ORFs 1A, 2A, 3A and AA are translated, whilst ORF-B is not translated, in a similar 
tagging-transfection experiment conducted in S2R+ cells (Figure 4.2A). A tal-ORFB 
mini-gene construct also does not rescue the tarsal-less mutant phenotype, indicating 
that this ORF is both nonfunctional and untranslated (Galindo et al. 2007) in the 
endogenous context of the gene. A new construct was designed for tal-ORFB for my 
study, and this plasmid contains the full-length tal transcript (ORF1A, 2A, 3A, AA and 
ORFB minus stop codon) inserted into the GCG-FLAG plasmid as described above. 
This construct did not appear to be translated, similar to the published observations of 
our lab and this result was verified several times (Figure 4.2B). Another tal construct 
was made, which essentially contained only ORFB, and lacks any of the upstream 
ORFs. This construct contains the inter-ORF sequence between the second-last and last 
ORFs of tal (ORFAA and ORFB), which serves as a 5’UTR for tal-ORFB. The 
sequence was then inserted in-frame with the GCG-FLAG tag. When tested, this tal-
ORFB construct showed FLAG signal in the tagging-transfection assay (Figure 4.2C). 
The tal-ORFB transcript in the absence of upstream ORFs has not previously been 
tagged and tested in this manner. This result could mean that the presence of the 
upstream ORFs in dicistronic transcripts may ‘soak up’ the translation of downstream 
ORFs. In vitro translation has already shown that the amount of protein translated from 
each ORF decreases along the transcript according to the ORF position, with the 5’-
most ORF1A showing the highest levels of protein (Galindo et al. 2007). The 
implications of this result for the corroboration of Poly-Ribo-Seq smORFs is that 
downstream dicistronic smORF ORFs should always be cloned into the GCG-FLAG 
plasmid in the context of their upstream ORFs to correctly determine whether they are 
translated.  
As a negative control for the Poly-Ribo-Seq experiment, I tested the translation of four 
smORFs that had Poly-Ribo-Seq metrics below the cut-off for translated smORFs. 
CG33494, CecB (CG1878), CG13315 and CG34330 showed some ribosomal foot-
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printing reads in one of the two Poly-Ribo-Seq experiments, but in the final analysis 
they fell below the high-confidence cut-offs for translation (Figure 4.2D). In the 
tagging-transfection assay, these smORFs showed FLAG signal comparable to that of 
smORFs that pass the translation filters. This result is also corroborated by Western 
Blotting, as protein could be detected from these transfections, but the signal was 
generally lower (MAS Mumtaz, personal communication). This result shows that 
smORFs below the cut-off for translation in the Poly-Ribo-Seq can be translated. This 
may mean that the filters for Poly-Ribo-Seq are too stringent or that these could be 
examples of false-positives in the tagging-transfection assay, resulting from the massive 
amount of induced expression with the Actin5C promoter, but it is clear that this 
promoter cannot ‘force’ the expression of something that lacks coding potential in the 
context of its endogenous gene model. It is more likely that the Poly-Ribo-Seq 
translation filters are the limiting factor, as other negative controls for translation, 
(frame-shift, ncRNA, tal-ORFB), do not show any signal in the cells. This makes the 
tagging-transfection a powerful tool as on a wider scale this result shows that if a 
translatable sequence is present, the tagging-transfection assay will detect the peptide 
with success. 
Testing the Poly-Ribo-Seq smORFs 
In the tagging-transfection assay, I tested several canonical smORF genes, dicistronic 
smORF genes, a number of long non-coding RNA ORFs as well as some uORFs that 
were deemed as translated in the Poly-Ribo-Seq experiments. At first, low-resolution 
light microscopy was used to assess whether FLAG signal, labelled by mouse anti-
FLAG M2 antibody (SIGMA) followed by anti-mouse FITC secondary, could be 
observed in transfected cells (Outline of final method in Figure 4.3A). I was able to 
detect signal for all of the 19 FlyBase smORFs, 4 dicistronic smORF transcripts (8 
smORF constructs), as well as the smORFs found in 6 lncRNA transcripts (12 
constructs) and 6 smORFs found in 5’UTRs (uORFs) that were tested in the tagging-
translation assay. The results of this experiment are summarised in Figure 4.3B. This 
provides proof of translation for the Poly-Ribo-Seq smORFs tested in this assay.  
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The result from tal-ORFB using a full length transcript versus just the ORFB sequence, 
showed us that true translation of downstream ORFs in dicistronic smORFs can only be 
reliably observed in the context of the upstream ORFs. Therefore, the ORF1 construct 
of the polycistronic smORFs contained just the 5’UTR but all downstream ORFs were 
tagged in a similar fashion to the full length tal-ORFB construct. Hence, two constructs 
were made for each of the dicistronic smORFs, i.e CG15386 is ORF1 to CG42371 and 
so on. Both ORFs in Hemotin (CG43210/CG43194) were found to be translated by our 
Poly-Ribo-Seq experiments, and are also corroborated by this assay. Interestingly, the 
polycistronic lncRNAs that were tested (pncr009:3L ORFs1-4, CR30055 ORFs 2,4-5), 
showed a similar result to that observed from the in vitro translation experiments of tal 
in Galindo et al. (2007); where decreasing levels of signal were observed for each 
subsequent downstream ORF (also see next section). uORFs (CG11284, CrebA, Sec22, 
FBtr0072084, FBtr0072210, FBtr0081720) and monocistronic lncRNA smORFs 
(CR32582, CR43144, CR43250) showed signal levels comparable to that of FlyBase 
smORFs. These results corroborate the translation of a significant proportion of high-
confidence results of our Poly-Ribo-Seq experiments. 
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Figure 4.2: Negative controls for the tagging-transfection assay  
A) The GFP tagging-transfection assay previously published by our lab. This 
experiment was conducted to determine tarsal-less ORF translation in Drosophila S2R+ 
cells. The results showed GFP signal from tagging of all ORFs except tal-ORFB, which 
is why it was chosen as a negative control for the new tagging-transfection assay. tal-
ORFB has also been shown to not be functional (Galindo et al. 2007). B) FLAG-tagged 
expression of the full-length tal construct, tagging ORFB in S2 cells. tal-ORFB is not 
translated in the presence of upstream ORFs. C) When tal is cloned without the 
upstream ORFs, FLAG signal can be observed from the translation of the tal-ORFB 
sequence. D) Proof of translation of smORFs CG33494, CecB (CG1878), CG13315 and 
CG34330 in the S2 cell tagging-transfection assay, showing the sensitivity of this assay 
as it can detect the translation of smORFs that fall below the stringent translation cut-
offs used in the Poly-Ribo-Seq data. Scale bars = 5µm. 
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misplaced, and tracheal fusion is incomplete (Figure 4 and
unpublished data). The loss of denticles in the epidermis does
not seem based on alterations of the segmental patterning
cascade, but on cell morphology defects that do not involve
defects in apico-basal cell polarity or epidermal integrity
(Figure 4 and unpublished data). Altogether, these results
suggest that tal is required for the control of cell movements
during tissue morphogenesis. Further research beyond the
scope of this initial study should identify the cellular and
molecular targets of this function.
An 11-aa Peptide Defines a New Polycistronic Gene Family
Our results provide experimental evidence for function
and translation of the type-A ORFs. These include the in vitro
and in vivo translation assays, functional rescues, and
sequence analysis. Our results therefore imply that tal is
polycistronic, because several ORFs can be translated from a
single RNA molecule. The question arises of how this can be
accomplished in an eukaryotic gene, but the literature
provides a possible mechanism. Polycistronic genes are
known in eukaryotes including Drosophila [38–40], and so in
principle, all tal ORFs could be potentially translated
simultaneously. Experimental evidence supports three mod-
els for translation of polycistronic messengers in eukaryotes,
namely ‘‘internal ribosomal entry sites (IRES),’’ ‘‘leaky
scanning,’’ and ‘‘reinitiation’’ [41]. There are clear rules
backed by experimental data concerning the DNA sequences
and transcript structure involved in each of these models.
The tal RNA sequence seems to exclude both the IRES and
the leaky scanning possibilities. There is not enough space for
IRES between the tal ORFs, and the initiation consensi are
stronger in the 59 ORFs than in the 39 ones, the opposite of
conditions favourable for leaky scanning. However, polycis-
tronic translation of type-A ORFs in the tal transcript is
possible under the reinitiation model because their spacing is
between 40 and 200 bp, and the short type-A ORFs (1A to 3A)
are much shorter than 35 aa. In all cases studied, the presence
of 59 ORFs has a dramatic impact on the rate of translation of
Figure 6. Directed Mutagenesis and Translation of tal
(A) In these constructs, the coloured boxes indicate ORFs, and deletions are represented as empty segments. Engineered new ORFs are represented by
bridged boxes. The UAS-tal construct contains the full cDNA and produces the complete rescue of the tal phenotypes and ectopic effects shown in
Figures 1 and 4. Construct AB comprises one type-A ORF and one ORF-B, and produces the same functional effects. Construct delA has no type-A ORF
and produces no effects. ATG-B forces translation of ORF-B, but still shows no effects. NoB has a mutation of the putative start codon of the ORF-B
(empty box), thus preventing its translation, and produces the same functional effects as UAS-tal. delB has ORF-B deleted and is also fully functional. The
1A construct, which consists of the AB construct plus the deletion delB, contains only one type-A ORF and mimics the tal functional effects. In the
construct 1A-FS, a single G was introduced after the start codon, causing a frameshift, which would result in the translation of a spurious 13-codon ORF
(purple box). This construct is not functional. The Bm-wds construct contains one of the Bombyx tal full-length cDNAs and mimics the Drosophila UAS-tal
results.
(B) UAS-tal-GFP constructs tagging different ORFs, showing the in-frame insertion of the GFP coding sequence (green)
(C) Peptides of expected size produced in vitro by Luciferase (61 kDa, control), 1A-GFP, 2A-GFP (28.4 kDa), and AA-GFP (33.1 kDa), but none by B-GFP
(expected size, 31.6 kDa) The amount of protein produced seems to decay from 59 to 39 according to the ORF position, ORF 1A being the highest, and
ORF AA the lowest.
(D) UAS-tal-GFP constructs transfected into S2Rþ cells. 1A-GFP, 2A-GFP, 3A-GFP, and AA-GFP (green) are detected, but not B-GFP. DAPI labels nuclei
(blue), and nuclear DsRed transfected cells (red).
doi:10.1371/journal.pbio.0050106.g006
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and produces no effects. ATG-B forces translation of ORF-B, but still shows no effects. NoB has a mutation of the putative start codon of the ORF-B
(empty box), thus preventing its translation, and produces the same functional effects as UAS-tal. delB has ORF-B deleted and is also fully functional. The
1A construct, which consists of the AB construct plus the deletion delB, contains only one type-A ORF and mimics the tal functional effects. In the
construct 1A-FS, a single G was introduced aft r the start codon, using a frameshift, which w uld result in the translation of a spurious 13-codon ORF
(purple box). This construct is not functional. The Bm-wds construct contains one of the Bombyx tal full-length cDNAs and mimics the Drosophila UAS-tal
results.
(B) UAS-tal-GFP constructs tagging different ORFs, showi g the in-frame insertion of the GFP coding sequence (green)
(C) Peptides of expected size produced in vitro by Luciferase (61 kDa, control), 1A-GFP, 2A-GFP (28.4 kDa), and AA-GFP (33.1 kDa), but none by B-GFP
(expected size, 31.6 kDa) The amount of protein produced seems to decay from 59 to 39 according to the ORF position, ORF 1A being the highest, and
ORF AA the lowest.
(D) UAS-tal-GFP constructs transfected into S2Rþ cells. 1A-GFP, 2A-GFP, 3A-GFP, and AA-GFP (green) are detected, but not B-GFP. DAPI labels nuclei
(blue), and nuclear DsRed transfected cells (red).
doi:10.1371/journal.pbio.0050106.g006
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Figure 4.3:  Tagging-transfection assay results  
A) Overview of the tagging-transfection assay protocol: the 5’UTR plus the ORF 
sequence of the candidate smORF are cloned in-frame with the C-terminal tag in the 
GCG-FLAG plasmid and these are transfected in to S2 cells. These cells are harvested 
48-hours post-transfection, fixed and an antibody stain using the FLAG M2 antibody, 
followed by anti-mouse FITC secondary, is performed before imaging. B) Summary of 
the tagging-transfection assay results. Tick marks indicate that signal was observed 
from FLAG-staining and Cross marks indicate that no signal was detected. This chart 
shows all 19 monocistronic smORFs, 4 pairs of dicistronic smORFs, 6 lncRNA 
smORFs (2 polycistronic and 1 monocistronic) and 6 upstream-ORFs tested are 
translated using this assay. The negative controls mod-FLAG, Uhg2-FLAG and full-
length tal-B FLAG showed an absence of signal.  
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Subcellular distribution of FLAG tagged smORFs 
The main advantage of using imaging to investigate smORF translation is that it 
presents a unique opportunity to observe other characteristics of the peptides besides 
translation. As I have previously demonstrated in flies using a GFP-tagged construct of 
Hemotin expressed in Drosophila haemocytes, this approach can allow us to assess 
potential function using the subcellular localisation of the tagged peptide. To observe 
the subcellular distribution of the FLAG-tagged smORF peptides in finer detail, 
transfected S2 cells were imaged using Laser Scanning Microscopy, which allows 
greater resolution and magnification of the samples. Using this imaging method, it 
became apparent that each smORF exhibited a specific arrangement within the cells. 
The smORFs were categorised into four classes of subcellular distribution based upon 
the pattern of tagged-peptide expression within the cells. Figures 4.4 to 4.9 show the 
labelling of smORF-FLAG (FITC, green channel) and F-actin (Rhodamine-Phalloidin, 
red channel) for the different smORFs that were tested in this experiment.  
The most abundant class of tagged SEPs were the ‘Reticular’ SEPs (Figure 4.4), which 
are are distributed in a pattern of strings and puncta all over the cytoplasm, reminiscent 
of mitochondria. ‘Limited’ SEPs, such as those in Figure 4.5, are restricted to small and 
large punctae, sometimes surrounded by F-actin in the cytoplasm. ‘Other Cytoplasmic’ 
SEPs (Figure 4.6) appear as a diffuse signal all over the cytoplasm of the cells. FLAG-
label showing some overlap with Rhodamine-Phalloidin were labeled as ‘Cortical’ SEPs 
(Figure 4.7).  
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Figure 4.4: FLAG-tagged SEPs with a ‘Reticular’ sub-cellular distribution 
The FLAG tagged peptide is labelled with FITC (green) while F-actin is highlighted by 
Rhodamine-Phalloidin dye. This most abundant class represents a mostly filamentous, 
reticulate distribution of peptides in a pattern similar to mitochondria. Scale bars = 5µm. 
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Figure 4.5: FLAG-tagged SEPs with a ‘Limited’ sub-cellular distribution 
The FLAG tagged peptide is labelled with FITC (green) while F-actin is highlighted by 
Phalloidin dye conjugated to Rhodamine (red). This class represents SEPs with a a sub-
cellular distribution that is limited to a small area of the cell and sometimes found in 
actin-enclosed spaces (CG34200, uORF FBtr0081720). Scale bars = 5µm. 
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Figure 4.6: FLAG-tagged SEPs with ‘Other Cytoplasmic’ sub-cellular distribution 
The FLAG tagged peptide is labelled with FITC (green) while F-actin is highlighted by 
Phalloidin dye conjugated to Rhodamine (red). This class represents SEPs with an even, 
non-specific distribution through the cytoplasm. Scale bars = 5µm. 
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Perhaps the Cortical SEPs, which include both of the Hemotin peptides, are involved in 
other aspects of endocytosis or intracellular trafficking. Overall, of the 45 smORF 
constructs tested, 19 are Reticular, 11 are Limited, 8 are ‘Other Cytoplasmic’ and 7 are 
Cortical. It was curious that the distribution of Hemotin ORFs were quite different with 
the FLAG-tag when compared to the expression found using the Hemotin-GFP 
construct in flies. 
The high number of Reticular SEPs, as well as the distinct and varying patterns of the 
remaining classes, shows that the peptides have specific roles within the cell and are not 
just being translated due to a byproduct of the nature of the plasmid construct, which 
may have restricted expression of all of the SEPs in a similar manner. If smORF 
peptides are localising to specific organelles or other intracellular structures, this 
indicates that they may be functional, from a localisation point of view. The varying 
SEP localisation between the tested smORFs means the intracellular sorting of these 
peptides cannot be solely attributed to information found in the plasmid or the FLAG 
tag. Rather, SEP sequences contain their own information that help transport the peptide 
to their respective location in the cytoplasm (also see TargetP section below).  
Cortical and Reticular SEPs are easy to distinguish, but the distributions of Limited and 
Other Cytoplasmic SEPs is harder to discern. It could be that the Limited SEPs are 
localised to an inclusion body or are being degraded in a degradation vesicle, which 
could be further verified by testing whether they are Lysosomal markers such as 
LysoTracker or the LAMP1 antibody, which labels the lysosomal membranes 
(Humphries et al. 2012). But the patterns of CG34200, CG33155, Sec22 and 
FBtr0081720 (uORFs) and pncr009 ORFs 2-4 (lncRNA) could also be associated with 
the nucleus since the peptides are found close to the centre of the cell. Due to the 
inability to conduct laser confocal imaging of the DAPI nuclear stain, I was unable to 
determine whether this is true. However, I believe that this experiment should be 
conducted in the future if resources and time permit. 
Overlap of SEP-FLAG with F-actin 
In order to see whether any of the SEPs tested show overlap with F-actin, Mander’s 
colocalisation coefficient was used to quantify the overlap between SEP-FLAG 
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expression in transfected S2 cells, and the Rhodamine-Phalloidin labelled F-actin 
(Figure 4.7). Colocalisation analysis was performed for all smORFs having a minimum 
of 15 cells imaged in each transfection, with over three replicates. Overall, the co-
localisation coefficients were quite low for overlap between SEPs and F-actin. 
However, the Cortical smORFs (CG12384, CG15456, CG6770, CG14036, CG43194, 
CG43210 and the uORF CG11284) have higher Mander’s coefficients for overlap 
between FLAG peptide and Rhodamine-Phalloidin compared to the other subcellular 
distribution classes, but clearly the overlap does not account for all of the Cortical SEP 
that can be observed in the cells.  
Two of the Cortical smORFs with considerable overlap to F-actin are the Hemotin 
peptides. As described earlier, Hemotin plays a role in phagocytosis, which depends on 
the F-actin cytoskeleton to conduct protrusion formation and endocytosis of material 
from the cellular environment. The colocalisation of Hemotin peptides to F-actin was 
previously not investigated in haemocytes, and it could be very likely that some of the 
peptide localises near actin, as per its proposed role in endosome maturation. As we did 
not have a positive control SEP to use as a positive control for localisation to F-actin, it 
is difficult to establish a cut-off in this case. However, if we take the lowest Mander’s 
score of the Cortical smORFs as a cut-off (0.362), then all the other classes of 
distribution fall below any significant observable overlap to Phalloidin-Rhodamine. 
This shows that the visual observation of Cortical SEPs being localised to the cell 
periphery can be correlated to a numerical range of overlap of the smORF protein to a 
major cytoskeletal component. 
Overlap of SEP-FLAG with Mitochondria 
The most abundant class of Reticular SEPs exhibit a distribution pattern similar to 
mitochondria, therefore I decided to test whether these SEPs localise specifically to S2 
cell mitochondria. This experiment required transfecting S2 cells with the smORF-
FLAG constructs and labelling the mitochondria, which we chose to do with 
MitoTracker-RED dye (Life technologies). Cells were imaged using LSM at a 
magnification of 63x and Z-stacks obtained at an interval of 0.15-0.2um, which is the 
size range of of mitochondria (0.5-1um). Mander’s colocalisation coefficient plugin was 
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Figure 4.7: FLAG-tagged SEPs with ‘Cortical’ sub-cellular distribution  
The FLAG tagged peptide is labelled with FITC (green) while F-actin is highlighted by 
Phalloidin dye conjugated to Rhodamine (red). Cortical SEPs tend to be localised to the 
periphery of the cytoplasm and thus have the highest amount of overlap with F-Actin, as 
can be seen from the graph. The y axis represents the 0-1 numerical value of overlap 
obtained by calculating averaged Mander’s coefficients for 15 cells over three replicate 
transfections for each SEP. Scale bars = 5µm. 
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used to quantify the overlap between the SEP-FLAG expressed in the S2 cells, and the 
mitochondrial dye Mitotracker-RED (Figure 4.8). Colocalisation for Reticular SEPs, 
and some SEPs from other distribution categories for comparison, was quantified with a 
minimum of 15 cells imaged per transfection, in triplicate.  
In order to establish a positive control for what amount of overlap can be considered to 
truly localise to MitoTracker-Red and thus mitochondria, I used haemocytes from larvae 
(L3) and white-prepupae (WPP) of a cross between flies containing HemeseGAL4 and 
UAS-mito-GFP (w[1118]; UAS-mito-HA-GFP.AP)2/CyO). This construct expresses a 
peptide with a mitochondrial-import signal fused to GFP. The haemocytes were fixed 
and stained using a similar protocol to that used with S2 cells and the samples were 
imaged as described above. The Mander’s coefficients for mito-GFP and MitoTracker-
Red signal in haemocytes at L3 (0.62±0.18) and WPP (0.74±.08) showed that mito-GFP 
and MitoTracker-Red did not colocalise completely, but still in quite high proportions. 
This control was chosen due to the availability of this construct in flies, and limited 
resources which prevented further cloning of plasmids. Otherwise, the ideal condition 
for the positive control would have been to transfect the mito-GFP construct as a 
plasmid in S2 cells under the control of the Actin5C promoter to ensure consistency 
between transfection conditions.  
In order to establish a lower cut-off for mitochondrial colocalisation, as a negative 
control, we used the characterised SEP Sarcolamban (Scl) by tagging Scl-ORFA in the 
same GCG-FLAG plasmid as the tested smORFs. Scl-ORFA shows an ‘other 
cytoplasmic’ subcellular distribution, and had a medium (0.52±0.04) level of overlap to 
MitoTracker-Red. Scl peptide has been shown to be bound to and interacting with the 
Ca2+ ATPase pump SERCA in the sarcoplasmic reticulum (ER of cardiac muscles), as 
well as in the ER of Drosophila S2R+ cell line (Magny et al. 2013). The SERCA pump 
has also been shown to be present in the mitochondria of rat brown adipose tissue cells 
(De Meis et al. 2010), but we have never verified if this is the case in Drosophila.  This 
made us consider that a partial overlap of Scl to MitoTracker-RED was not surprising as 
Scl would be found wherever the SERCA pump is required.  
Alternatively, the amount of overlap between an ER protein and the mitochondria could 
be an artefact of imaging as standard laser confocal microscopy does not have the 
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resolving power to differentiate between structures closer than 0.1um. Hence, the 
relatively high score of Scl-ORFA to MitoTracker-Red may depict how closely tied the 
ER and Mitochondrial membranes are in S2 cells. Therefore, our cut-off for meaningful 
and total mitochondrial localisation of smORFs was chosen to be a minimum Mander’s 
score of 0.52. Two Reticular uORFs (FBtr0072084 and CrebA) were not tested in this 
experiment, and there is one Reticular SEP (CG33170) that falls just below the 0.52 cut-
off for Mitochondrial localisation. CG33170 could be partially associated with other 
inner-membrane networks that associate with the Mitochondria, such as the 
Mitochondrial Associated Membrane (MAM) of the Endoplasmic Reticulum (ER), or 
the ER itself. The Cortical and Limited SEPs that were tested had the lowest levels of 
colocalisation to MitoTracker-Red. This shows that by determining the subcellular 
distribution in these categories, I decreased the need for further testing of these SEP’s 
for colocalisation to mitochondria.  
Analysis of Different Subcellular Distributions of SEPs 
It should be noted that 64% of the Limited SEPs are encoded by smORFs present in 
long non-coding RNA transcripts. These include the downstream ORFs in pncr009:3L 
and CR30055. The SEPs encoded by the most 5’ ORFs had a more widespread 
distribution of Other Cytoplasmic and Reticular, respectively, while the downstream 
ORFs of both of these lncRNA smORFs are classified as ‘Limited’. The SEPs encoded 
by both ORFs of Rox2 are also Limited in their distribution. Generally, 50% of the 
SEPs tested in this analysis show a ‘Reticular’ sub cellular distribution (Figure 4.9A).  
In order to test any correlation between SEP length and its sub cellular distribution, I 
compared the average peptide lengths of the different categories (Figure 4.9B). It is 
evident that Cortical and Reticular SEP’s are larger in size, with median values of 
73.71aa (± 29.14) and 66.79aa (±22.19) respectively, whilst Limited SEP’s are shorter 
at35.38aa (± 18.84),and Other Cytoplasmic SEP’s exhibit a wide range of sizes 
(53.00±27.39). Though these values may not be significantly different, this analysis 
suggests that the larger peptides tend to be Reticular or Cortical in distribution. 
17 of the 18 Reticular SEPs tested show a high level of colocalisation to Mitotracker-
Red, with average Mander’s coefficients over 0.70, which means that these peptides 
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localise almost entirely to the Mitochondria. Determining subcellular distribution of 
SEPs using high resolution microscopy predicts their Mitochondrial localisation with 
high accuracy. However, there are three ‘Other Cytoplasmic’ SEPs (CG9878, CG32267 
and CG14104) that localise quite highly to MitoTracker-Red, as well as one Cortical 
SEP (CG14036). These represent marginal cases like the previously mentioned 
CG33170, which could potentially fall either side of the cut-off. In total, this gives us 20 
SEPs that show overlap to Mitotracker above the cut-off (Figure 4.9C). Altogether, 
categorising a SEP’s subcellular distribution as Reticular confers a mitochondrial 
identity in most cases (Figure 4.9D), but the analysis is definitely improved and made 
more stringent when followed up by a localisation study and consistent imaging 
practice. 
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Figure 4.8: MitoTracker-Red staining of S2 cells transfected with FLAG-tagged 
smORFs Haemocytes from transgenic L3 and WPP animals expressing mitochondria 
localisation signal (UAS-mito-GFP) with haemocyte specific HemeseGAL4 driver is 
used as a positive control for overlap with MitoTracker. In order to establish a cut-off 
value, S2 cells were transfected with Scl-ORFA, which has been been shown to interact 
with SERCA, a calcium pump that is present in ER (Mander’s score 0.52). Using this 
method, the graph shows that out of the 28 SEPs tested, 20 have high overlap to 
MitoTracker-Red. Scale bars = 5µm. 
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The Poly-Ribo-Seq smORFs were also assessed for the presence of a transmembrane-
alpha-helix (YC Eyre-Walker, unpublished data). Out of all the smORFs tagged and 
tested, 12 were predicted to contain a Hidden-Markov Model for a transmembrane 
alpha-helix (TMHMM) in the peptide sequence. Seven of the predicted TMHMM SEPs 
were found to localise to the mitochondria, showing an over-representation of 
mitochondrial SEPs in the overall TMHMM smORF sample. Conversely, 7 of 19 
mitochondrial SEPs (37%) have predicted alpha helices (Figure 4.9E), meaning that 
these peptides may be embedded in the mitochondrial membrane. To confirm this, we 
would require higher resolution fluorescence microscopy, or more definitively, the much 
higher resolution technique of electron microscopy, to prove that the alpha-helical 
mitochondrial SEPs are actually spanning the mitochondrial membrane. 
TargetP analysis of subcellular localisation 
Translated peptides are sorted to various compartments depending on their N-terminal 
amino acid sequences, and correct subcellular localisation is essential for protein 
function (Schatz 1996). Signal peptides (SPs) motifs target proteins to the ER for 
processing through the secretory pathway, and have charged amino-acid residues close 
to a signal peptidase cleavage site in the amino acid sequence. Mitochondrial targeting 
peptides (mTPs) have a large proportion of Arginine, Alanine and Serine and usually 
lack negatively charged amino acid residues at the N-terminus (Schatz and Dobberstein 
1996; Emanuelsson et al. 2000). TargetP is a program that was designed to predict 
whether a peptide sequence contains a SP or mTP motif and scores these at various 
confidence levels (Emanuelsson et al. 2000; Emanuelsson et al. 2007).  
The TargetP localisation tool was used to analyse the peptide sequences of different 
smORF data sets in order to predict the localisation of the peptide from smORF N-
terminal sequences (Figure 4.10). 805 of the 829 ‘annotated’ FlyBase smORFs were run 
through the TargetP program and only 79 (9.8%) of these are predicted to localise to 
Mitochondria. However, 351(43.5%) Flybase smORFs are predicted to contain a Signal 
peptide (SP) motif, which is quite a large proportion of all Drosophila smORFs. Of the 
228 smORFs peptides found to be translated by Poly-Ribo-Seq in S2 cells, 39 (17.5%) 
are predicted to be Mitochondrial, and 43 (19.3%) are predicted to be Signal peptides. 
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TargetP analysis of the subset of Poly-Ribo-Seq smORFs that were tested in the tagging 
assay shows that 22% contain mTP motifs and 15.6% contain SP motifs. A shortcoming 
of TargetP is erroneous high-confidence prediction, as can be seen from our tagged pool. 
Of the 20 mitochondrial SEPs, only half were predicted to have mTPs by TargetP, of the 
remaining SEPs, 3 were predicted to have SP motifs, which is incorrect. This shows that 
bioinformatics predictions alone are not a reliable method to asses the subcellular 
localisation of SEPs. However based on my own experimental data showing overlap 
between Reticular smORFs and MitoTracker-Red; I have shown that the proportion of 
mitochondrial smORFs is actually closer to 44% of the entire smORF sample tested. If 
we extrapolate the data from the tested smORFs to all Poly-Ribo-Seq smORFs, it could 
mean that up to half of the Poly-Ribo-Seq smORFs are mitochondrial, which would be 
very surprising, but it was also very surprising that such a high proportion of our tested 
sample are mitochondrially localised. Considering that S2 cells are an immortalised cell 
line, it would not be a far flung assumption to conclude that homeostatic and cellular 
function related smORFs are the more abundant ones, but in order to conclude if this is 
a representative pool of the entire sample, we would need to tag even more of the 
translated S2 cell Poly-Ribo-Seq smORFs. The complete results of all the smORFs 
tested in the tagging-transfection assay are summarised in Figure 4.11. 
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Figure 4.9: Summary of tagged-SEP subcellular distributions 
A) Distribution of the subcellular localisation of each category of smORFs. Overall, 
Reticular SEPs are the most abundant class of smORFs (42%) followed by Limited 
SEPs (24%) B) Box plots showing the median peptide length for each sub-cellular 
distribution class of smORFs. The Cortical (median-88 aa) and Reticular (median-71 aa) 
SEPs tend to have a longer peptide length, while the Limited class has the shortest 
median length (34 aa), possibly due to the abundance of shorter ncr_ORF ‘dwarf 
smORFs’localisation in this class. C) List of smORF genes whose SEP’s show 
mitochondrial localisation; the majority (89%) of these exhibits a Reticular distribution 
D) Overlap between the mitochondrial SEP’s and those SEP’s predicted to contain an 
alpha helix by the prediction program TMHMM, there is no significant correlation and 
only 37% of the mitochondrial SEP’s are predicted to contain a transmembrane alpha-
helix. 
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Figure 4.10: TargetP predictions for all translated smORF categories 
smORF peptide sequences were run through the TargetP program to predict for the 
presence of a putative signal peptide (SP) or mitochondrial localisation (mTP) motifs in 
the complete pool of annotated smORFs (FB smORFs), the Poly-Ribo-Seq candidate 
smORFs and the pool of tagged smORFs. The MitoTracker colocalisation results show 
the localisation of an additional 7 SEP’s that are not predicted to have either a SP or 
mTP motif. 
FB smORF Poly Ribo Seq smORF Tagged smORF
mTP 79 (9.8%) 39 (17.5%) 10 (22.2%)
SP 351 (43.5%) 43 (19.3%) 7 (15.6%)
Not 
determined 376 (46.7%) 141 (63.2%) 28 (62.2%)
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Figure 4.11: Summary table of all the tagged smORFs  
This table shows the data previously known about these smORFs, such as SEP length 
(aa), TMHMM prediction, Poly-Ribo-Seq translation and prior peptidomic evidence. 
There is now additional data provided by the tagging-transfection assay, such as 
translation in the transfection-tagging assay, subcellular distribution class and results 
from the co-localisation analysis with Phalloidin-Rhodamine (F-Actin) and MitoTracker 
Red along with the TargetP predictions of SP and mTP motifs.  
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smORF Length (aa)
Tm alpha 
helix
Poly Ribo 
Seq Tranlated
Peptidomic 
Evidence
FLAG-tag 
translation TargetP Distribution
Phalloidin-
Rhodamine MitoTracker-Red
CG32230 83 1 Yes Pep. Atlas Yes -  Reticular Low High
CG44242 70 0 Yes Couso Lab Yes Mito Reticular Low High
CG33170 71 0 Yes No Yes Signal Reticular Low Medium
CG32267 49 1 Yes Pep. Atlas Yes Mito Other Cytoplasmic Low Not tested
CG12384 96 0 Yes Pep. Atlas Yes - Cortical Medium Low
CG15456 95 0 Yes Pep. Atlas Yes - Cortical Medium Medium
CG7630 90 1 Yes Pep. Atlas Yes Mito Reticular Low High
CG33199 79 0 Yes Pep. Atlas Yes Mito Reticular Low High
CG33155 60 1 Yes Pep. Atlas Yes - Limited Low Low
CG33774 40 1 Yes Pep. Atlas Yes Signal Other Cytoplasmic Low Medium
CG14482 57 0 Yes Pep. Atlas Yes Mito Reticular Low High
CG34200 52 0 Yes Pep. Atlas Yes - Limited Low Medium
CG6770 69 0 Yes Pep. Atlas Yes - Cortical Medium Not tested
CG34242 58 1 Yes No Yes Signal Reticular Low High
CG33714 90 0 Yes Pep. Atlas Yes Mito Reticular Low High
CG32276 64 1 Yes No Yes Mito Other Cytoplasmic Low High
CG14104 68 0 Yes No Yes - Other Cytoplasmic Low High
CG14036 93 0 Yes Pep. Atlas Yes - Cortical Medium High
CG17278 80 0 Yes No Yes - Reticular Low High
CR43144 91 0 Yes No Yes - Reticular Low High
CR32582 52 0 Yes No Yes Mito Reticular Low High
CR43250 73 0 Yes No Yes - Reticular Low High
pncr009:3L 1-21, 2-20 3 - 33 0 Yes No Yes - Other Cytoplasmic + Limited Low Not tested
Rox2
1 - 38, 
2-17 0 Yes No Yes - Limited - Not tested
CR30055
2-53, 
4-17, 5-56 0 Yes No Yes - Reticular + Limited Low (ORF1) High (ORF1)
CG11284 16 NA Yes No Yes - Cortical Medium Not tested
CrebA 16 NA Yes No Yes - Reticular - Not tested
FBtr0072084 14 NA Yes No Yes - Reticular Low Not tested
FBtr0072210 13 NA Yes No Yes - Other Cytoplasmic Low Not tested
FBtr0081720 11 NA Yes No Yes - Limited Low Not tested
CG15386 77 0 Yes No Yes Signal Other Cytoplasmic Low Not tested
CG42371 87 0 Yes No Yes Mito Reticular Low High
CG42497 65 0 Yes No Yes - Reticular Low High
CG9878 92 1 Yes No Yes Signal Other Cytoplasmic Low High
CG32736 79 1 Yes No Yes Mito Reticular Low High
CG42308 61 1 Yes No Yes Signal Reticular Low High
CG43194 88 1 Yes Pep. Atlas Yes Signal Cortical Medium Low
CG43210 59 1 Yes Pep. Atlas Yes Mito Cortical Medium Medium
tal-B 49 Yes No Yes - Other Cytoplasmic Low Not tested
tal-B full length 49 No No No - N/A not tested Not tested
Scl-A 28 No Yes Yes - Other Cytoplasmic not tested Medium
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Discussion
Polysomal Ribosome profiling is a new method being used to describe smORF 
translation,  therefore we decided to independently corroborate translation of Poly-Ribo-
Seq smORFs using heterologous gene expression in S2 cells. This would require the 
detection of the peptide product that is being encoded by a smORF. It is difficult to 
make a good specific antibody against a smORF peptide, as we have found in the case 
of Tarsal-less, Sarcolamban and Hemotin. This presents a challenge in detecting the 
endogenous gene product in wild type animals, therefore we chose to circumvent the 
problem by conducting a tagging-transfection assay in S2 cells. Thus we employed the 
use of a cleverly designed smORF-tag-fusion plasmid to help independently corroborate 
that smORF genes are able to produce a peptide product.  
Independent corroboration of translated smORFs 
Two different tags were used to help label the SEPs, these are: Venus, a bright, modified 
YFP tag, and FLAG which is a synthetic peptide readily detected by an efficient 
antibody (Einhauer and Jungbauer 2001). Testing negative controls with both tags 
revealed that Venus signal is detected in cells which in theory, should not translate the 
tag due to the mutation of the start codon from ATG to GCG. It was postulated that the 
abundance of the transfected plasmid, due to the Actin promoter, leads to the translation 
of the Venus peptide from alternative start codons. This has has been shown in the case 
of NAT1 which uses GUG as a translation initiation codon in Drosophila (Takahashi et 
al. 2005). Rather than also mutating all further downstream start codons in the modified 
Venus plasmid, the Tagging-transfection Assay was continued with the constructs 
containing modified-FLAG tag, which contains no putative downstream start-codons in 
its sequence. The strengths of the tagging-transfection assay were highlighted by the 
results from the testing of tal-ORFB using different cloning conditions. As tal-ORFB 
did not rescue tal mutant phenotypes, and is not as conserved as the other tal ORFs, it 
was previously deemed to be untranslated and nonfunctional (Galindo et al. 2007). My 
results corroborate these findings, as when tal-ORFB is cloned in its in vivo context, 
with all the upstream ORFs present in the transcript. I did not observe translation of this 
ORF, despite the massive over-expression of the mRNA that would occur due to the 
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actin 5c promoter. When the upstream ORFs are removed in the plasmid, FLAG signal 
can be seen from the translation of tal-ORFB. This shows that in the tagging translation 
assay, when entire smORF transcripts are cloned in the context of their endogenous 
5’UTR and upstream coding regions, they will only be translated if they have 
translational potential.  
For all smORFs that appear to be translated using Poly-Ribo-Seq, as well as some that 
fall below the translation cut-off, we could visualise the FLAG-tagged SEP using 
fluorescent antibody staining of S2 cells. The fact that smORFs below the translation 
cut-offs also appear translated does not necessarily mean that they are false-positives 
since closer inspection of the Poly-Ribo-Seq data reveals that these smORFs were found 
to be translated in one repeat of the Poly-Ribo-Seq experiments, but their RPKM fell 
below the cut-off when averaged over all the repeats. Although the smORFs are 
probably being massively over-expressed by the Actin5C promoter, the tagged smORF 
constructs are derived from the cDNA and gene models from the same Drosophila cell 
line used for the Poly-Ribo-Seq experiment. The detection of a peptide product from 
these smORF sequences, and evidence of their translation from Poly-Ribo-Seq, shows 
that this sub-population of smORFs are definitely translated by two independent 
methods. The real lncRNA Uhg2 is not expressed under these same conditions, despite 
the constitutively active nature of the Actin5C promoter and being under the context of 
its own 5’UTR. Additionally, Western Blotting of S2 cells transfected with the negative 
control smORF constructs failed to detect peptide products by that method (MAS 
Mumtaz, personal communication; Aspden et al. 2014).  
The process of detection through imaging has emerged as more sensitive in the 
detection of SEPs as it allows the researcher to search by eye for the cells that contain 
fluorescent signal, as opposed to using western blotting, which would need a large 
proportion of cells expressing the construct to counteract any possible effects of low 
transfection efficiency as well as loss of material over the several steps involved in the 
immunoblotting protocol. By extrapolation, the 228 high-stringency Poly-Ribo-Seq 
smORF hits can therefore be believed to be translated, due to the work presented here, 
where I have corroborated the translation of a representative selection of almost 12% of 
the entire translated pool.  
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Most of these high-stringency smORFs have no previous proof of function or 
translation and are therefore ideal novel candidates to screen for further characterisation. 
These results are significant in our claim that smORFs are a special class of small 
peptide-encoding genes and that there exists huge potential for several thousand  other 
smORF sequences in the genome to also be translated. The fact that smORFs which fall 
just under the translation metric cut-offs are also translated, shows that our metrics for 
assessing translation for Poly-Ribo-Seq are probably too stringent. However, some 
smORFs may just be transcribed at lower levels in normal, wild type S2 cells. It may be 
that we have not have sampled the required cellular context or experimental condition 
allowing for the translation of the many more smORF transcripts that exist in the 
genome. The Poly-Ribo-Seq experiment should therefore be repeated under different 
cellular growth conditions, similar to the modENCODE RNA-Seq data, to include 
conditions like infection, toxification, as well as nutrient stress or starvation. This would 
reveal smORFs which may be involved in the cellular stress response, as opposed to 
those involved in normal cellular homeostasis which may be the case for these high 
stringency smORFs translated in wild type S2 cells. 
Functional assessment of SEPs by Subcellular Distribution and Colocalisation  
Imaging of FLAG-tagged SEPs not only allowed more sensitive detection of these 
peptides than immunoblotting but also enabled us to assess characteristics of  their 
potential cellular function. The transfected smORFs showed distinct subcellular 
distributions in the cytoplasm of the S2 cells, indicating that they may be performing 
specific functions. Though using a plasmid with a strong constitutive promoter may 
have exaggerated levels of transcription of these smORFs, the display of four distinct 
types of subcellular distributions of the translated SEPs indicates that the higher levels 
of transcription did not affect the expression of smORFs in such an aberrant manner. as 
even if the cell is overwhelmed by the smORF transcript, it seems to maintain the 
homeostasis which allowed the peptides to be shuttled to various subcellular 
compartments, and the peptide can be found in enough cells to be seen and imaged. The 
presence of the FLAG tag also does not seem to make the SEP behave in any one 
particular fashion, and despite the presence of this additional peptide, the cellular 
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machinery is able to conduct the post-translational modifications needed to sort the 
individual peptides to their distinct locations. If the question arises of whether 
translation of these peptides resulted in cell stress or abnormality, this can be negated by 
the fact that the peptides were readily detected in the transfected samples over several 
repeats, showing that smORF encoded peptides are stable and non-toxic in the cells. 
This encouraging result led us to classify the SEPs into subcategories of localisation and 
distribution in order to postulate their potential functions. Some FLAG tagged SEPs 
showed overlap with Rhodamine-Phalloidin marker which was used to label the cell 
periphery, these were labelled as ‘Cortical’ SEPs. There are similar numbers of ‘Other 
Cytoplasmic’ SEPs, which show a hazy network of peptide distribution all over the cell 
body. The ‘Limited’ SEPs were highly represented by ncRNA smORF types, and their 
restricted localisation may lend an explanation as to why they are detected at lower 
levels in Poly-Ribo-Seq experiments. It was revealed by imaging that they tend to be 
localised in a single or just a few small punctae, bound by F-actin in some cases, and 
found close to the centre of the cell. It is generally accepted that mRNA transcripts are 
shuttled close to regions in the cell where they are required (Brar et al. 2015). It may be 
that smORFs located in putative ncRNAs are generally lowly translated, or perhaps they 
are sampled at lower levels because they are associated to the nuclear region (which is 
excluded from RNA-profiling by crude fractionation) (Aspden 2014).. In either case, 
this hypothesis should be tested as it would provide some insight as to whether the 
spatial domain of a smORF transcript may result in variations in detection and also 
confirm whether Limited SEPs are localised to the nucleus. This could be done by 
checkcing overlap of the peptide with nuclear stain such as Hoechst.  
By labelling the cellular F-actin with Rhodamine-Phalloidin dye, SEP overlap to this 
major cytoskeletal component could be quantified using Colocalisation analysis 
(Mander’s overlap coefficient). This revealed very low levels of overlap values of 
Rhodamine-Phalloidin with most SEPs, but for all the SEPs that were in the ‘Cortical’ 
category, the coefficient is above 0.3. This indicates that not all of the ‘Cortical’ SEP 
localises to F-actin, but a partial spatial overlap can definitely be observed specifically 
for these peptides in relation to the colocalisation coefficients of the‘Reticular’, ‘Other 
Cytoplasmic’ and ‘Limited’ SEPs. Hemotin was also tested in the tagging-transfection 
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assay, and as expected, both of the ORFs produced a tagged peptide product. 
Interestingly, the 88aa ORF1 was found mainly at the cell edge, and the 59aa ORF2 
localised to the cell edge as well as in puncta around the cytoplasm. Therefore, it would 
be interesting to see whether the other ‘Cortical’ smORFs are also involved in 
endocytosis or immunity, based on their similar localisation to Hemotin.  
Discovery of novel mitochondrial SEPs 
The most abundant category of smORFs were the ‘Reticular’ smORFs, which displayed 
a pattern reminiscent to mitochondria. The punctate and stringy distribution of the 
Reticular smORFs led to the hypothesis that the Reticular smORFs are localising to 
mitochondrial structures in the cell. This hypothesis was tested by transfecting S2 cells 
with the smORF-FLAG constructs and labelling mitochondria with MitoTracker-Red 
dye. The signal overlap between smORF-FLAG and MitoTracker-Red was quantified, 
and the colocalisation coefficients for almost all of the Reticular smORFs to 
Mitochondria was revealed to be very high, showing that these are indeed localised to 
mitochondrial structures. Since the smORFs tested in this assay were chosen at random 
from the Poly-Ribo-Seq experiment, it is a significant result that almost half (42.22%) 
of the tested smORFs are mitochondrial. Several of the mitochondrial proteins required 
for basic processes in the mitochondria are encoded by mitochondrial DNA (mtDNA) 
found within the organelle itself. The potential role for nuclear genomic smORFs in the 
mitochondria may be separate from these primary roles of energy production or perhaps 
supplement them in some way.  
Experimental validation of subcellular localisation was compared to bioinformatics 
predictions using the TargetP program (Emanuelsson et al. 2000; Emanuelsson et al. 
2007). For all ~800 FlyBase smORFs, only 9.8% are predicted by TargetP to have mTP 
domains. 17.5% of all the smORFs we found to be translated in S2 cells have mTP 
motifs, showing that the predicted proportion of mitochondrial SEPs is higher in our 
target pool. TargetP correctly predicted the subcellular localisation of almost half of the 
SEPs that I observed to localise to mitochondria. However three SEPs (CG32230, 
CR30055, CG42497) which have high colocalisation levels to MitoTracker-Red, were 
given no high-confidence prediction for localisation by TargetP. Additionally, two SEPs 
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(CG34242 and CG42308) were incorrectly predicted to have a SP motif, but instead 
localise to the mitochondria. Since TargetP predictions fall short of actual experimental 
validation, we can assume that the proportion of mitochondria localised SEPs is actually 
higher in the FlyBase smORFs as well. However even if this number is potentially 
higher, the overall difference between the FlyBase and Poly-Ribo-Seq smORF pools 
may be due to the fact that the FlyBase smORFs contain developmentally related 
smORFs and are therefore more diverse, whilst S2 cells may be preferentially 
expressing smORFs required for cellular homeostasis. Considering that such a large 
proportion of S2 cell smORFs are predicted and experimentally verified to associate 
with the mitochondria, further investigation was conducted into whether they are 
essential or required for correct mitochondrial function. The role of mitochondria in 
cells, and the potential cellular function of mitochondrial smORFs, are discussed further 
in the next chapter.  
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Chapter V - Testing smORF function in Drosophila S2 cells
Introduction
This chapter of my thesis describes a series of RNA-interference (RNAi) experiments 
aimed at exploring the functional characterisation of smORF encoded peptides (SEPs) 
in Drosophila S2 cells. These experiments were conducted to assess whether knocking 
down smORF gene transcripts can lead to observable cellular phenotypes. If true, this 
would provide support to our hypothesis that smORFs are indeed important genomic 
elements. From the experiments discussed in the previous chapter, we obtained 
corroboration of the translation of a subset of smORFs deemed to be translated by 
Ribosome Profiling in S2 cells. Those results support the notion that the larger group of 
hundreds of Poly-Ribo-Seq smORFs are translated into peptides as well. Evidence of 
smORF translation allowed us to approach the subject of characterising smORF 
function by using RNA interference (RNAi), with confidence that this method of 
silencing transcripts would reduce the levels of the SEPs in the cells. RNAi in 
Drosophila elicits a post-transcriptional gene silencing (PTGS) event, specifically of the 
gene that is chosen to be depleted. In the previous decade, RNAi has been widely used 
to assess loss-of-function phenotypes of genes within known pathways. RNAi screening 
is also used to find novel genes that may be involved in particular developmental or 
cellular processes. Applying RNAi to knockdown smORF transcripts in S2 cells would 
be the definitive next step in the larger scale characterisation of smORF function at the 
cellular level. 
Mechanism of Post-transcriptional Gene Silencing 
The PTGS method was first described in transgenic tobacco plants, which were 
genetically modified to express portions of viral genomic DNA. The expression of this 
DNA rendered the plant resistant to that virus by RNAi of viral mRNA (Lindbo et al. 
1993). Later, studies conducted on C. elegans identified that the gene silencing response 
was initiated by the production of double-stranded RNA (dsRNA) molecules that are 
homologous to the target gene (Fire 1999; Tabara et al. 1999). The mechanism was 
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further unravelled to show that there are two main steps to RNAi, which are initiation, 
and execution.  
dsRNA acts as a template to identify and degrade potential ‘non-self RNAs’ in order to 
limit the expression of harmful foreign RNAs, such as those from viruses which hijack 
the cellular transcriptional machinery to replicate (Vaucheret et al. 1998; Fire 1999). 
dsRNA molecules can be made naturally, being derived from short hairpin RNA’s in the 
genome, called micro-RNAs (miRNA). miRNA help to regulate gene expression and 
are found within the genome, therefore they are considered a type of endogenous RNAi. 
RNAi can also be induced by a viral pathogen, or created experimentally and injected 
into animals, or even added to the growth media of cells in culture. To conduct 
exogenous RNAi in Drosophila, long dsRNAs are made against large stretches of target 
mRNA, and sequences are processed into smaller dsRNA fragments by Dicer, which is 
a member of the ATP-dependent RNAse III gene family (Blaszczyk et al. 2001). Dicer 
is a highly conserved RNAse III gene, and homologues have been found in organisms 
ranging from yeast to humans (Bernstein et al. 2001). The resulting small-interfering 
RNA molecules (siRNA) are between 19-23 nucleotides in length (Blaszczyk et al. 
2001; Nykänen et al. 2001) and have a 2-3 nucleotide overhang at the 3’ hydroxyl 
end.These features of the ‘bait’ sequence enable the RNAi machinery to detect a 
bonafide siRNA (Nykänen et al. 2001; Kao and Megraw 2004). Mature miRNA and 
siRNA are very similar in structure, and a pre-miRNA is processed by Dicer in a similar 
way to dsRNAs.  
The execution phase of RNAi begins by the incorporation of the siRNA or miRNA 
fragments into the 360kDa multiprotein complex called the RNA-induced silencing 
complex (RISC) (Nykänen et al. 2001; Hammond et al. 2001). The siRNA is unwound 
in an ATP-dependent manner, and the single-stranded siRNA acts as a guide for the 
RISC to target complementary sequences of mRNA in the cell. An endonuclease present 
in the RISC, called Argonaute, degrades the mRNA, leading to its overall decrease (Liu 
et al. 2003; Hammond et al. 2001). The degraded target mRNA can be further recycled 
into new siRNA and the RNAi process is amplified (Lipardi et al. 2001). The schematic 
presented in Figure 5.1 outlines the RNAi process. 
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Figure 5.1: Overview of the mechanism of RNAi in cells using dsRNA 
Exogenous RNA interference is conducted using double-stranded RNA-mediated 
knockdown. The ~300 bp long duplex is added to the cells, and this is taken up by the 
cells where in the cytoplasm they are cleaved by the ribonuclease Dicer into ~21nt short 
interfering RNA’s (siRNA’s) with 2-3nt overhang at both ends. The 3’ of the siRNAs 
contain a hydroxyl group and the 5’ overhang has a phosphate group. The siRNA 
fragments are incorporated into the RNA-Induced Silencing Complex (RISC). The 
siRNA is then able to conduct knock-down of complementary target mRNAs by base-
pairing via the argonaute endonuclease proteins. This produces an direct decrease in 
target gene product and indirectly upon the peptide produced from the transcript. 
Long dsRNA
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ATP
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RISC
RISC
ATP
target mRNA 
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Figure 5.1
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RNAi Screening in Drosophila cells 
RNAi in Drosophila cells has now become a mainstream technique used to identify 
novel genetic hits for further investigation. Traditional RNAi screens are carried out 
with a specific goal, which typically entails a directed screen for a missing component 
in a well-characterised pathway, resulting in a catalog of genes involved in a particular 
process (Boutros and Ahringer 2008). The first RNAi screen in Drosophila S2 cells 
catalogued genes involved in the insulin signal-transduction pathway (Clemens et al. 
2000). This study showed reliable loss-of-function of target genes simply by adding 
dsRNA to the media of S2 cells, which are shown to uptake synthetically-made long 
dsRNAs, and thus show a decrease in target mRNA over time, which can be assessed 
(by quantifying the peptide product) (Kao and Megraw 2004; Zambon et al. 2006). 
Genome-wide, high-throughput screening has been used to identify candidate genes 
involved in cell morphology (Kiger et al. 2003), cell growth and viability (Boutros et al. 
2004), protein kinases involved in cell-cycle progression (BettencourtDias et al. 2004), 
and genes associated with cytokinesis (Eggert et al. 2004).  
The development of a reliable and robust RNAi screen is often a painstaking process. 
The screen must contain an assay that is specific to the function being investigated. 
Identifying a hit is aided by some knowledge of the possible phenotypes, or read-outs, 
that could be expected. These may include up-regulation of certain proteins or reporters, 
the occurrence of cell death, or the inhibition of the cell cycle. However, the easier it is 
to screen for a broad and overt phenotype, such as cell lethality, the harder it is to obtain 
specific functional information of the hits (Boutros and Ahringer 2008). The overall 
pool of genes being tested will contain a lower proportion of peptides involved in cell 
death for example, as this is a highly regulated process. There will be proportionally 
more hits retained when searching for a more subtle phenotype i.e. changes in cell 
morphology and shape as there could be many potential factors that regulate this 
process. However, the more specific, technical, and time-consuming an assay is, the 
more unfeasible it sometimes becomes to conduct on a larger scale.  
The use of fluorometric/colorimetric assays, and visual interpretation of results by 
imaging, have allowed the phenotyping process to become easier. In order to conduct a 
high-throughput screen of smORF function, we needed to decide upon an observable 
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cellular or physiological process that smORFs could be involved in, and how best to 
quantify it. For this purpose, we first attempted the RNAi screen using a cell viability 
assay with the Alamar Blue reagent, which measures viability of a given cell sample by 
providing a fluorescent read-out of respiration. In addition to this, using information 
gained from the previous chapter that described the colocalisation of several S2 cell 
translated SEPs to the mitochondria, a mitochondrial morphology assay was designed. 
By using bioinformatic prediction tools such as TargetP, or by extrapolating the results 
of my colocalisation experiments,  we can estimate that anywhere between 9.8% 
(FlyBase smORFs) and17.5% (Poly-Ribo-Seq smORFs) to 44% (Experimental Data) of 
SEPs in S2 cells may be localising to the Mitochondria. Localisation of a protein to a 
specific organelle indicates that there is high likelihood that it performs a function 
related to that organelle. This encouraged us to search for smORF loss-of-function 
phenotypes related to the mitochondria. 
Mitochondrial function 
Mitochondria are hypothesised to arise from an α-proteobacterium, which may have 
been engulfed by progenitors of eukaryotic cells (Lane and Martin 2010). The structure 
of mitochondria remains similar to that of their Gram-negative bacterial ancestor, with 
an outer membrane to separate from the cytoplasm, and an inner membrane, which 
envelops the mitochondrial matrix. The schematic of a mitochondrion shown in Figure 
5.2, highlights some of the many processes that are conducted inside mitochondria. 
Mitochondria are known as the ‘powerhouse of the cell’ as they are the cell’s main site 
of energy production. The matrix contains the mtDNA and the various enzymes that 
perform oxidative metabolism. The reason for this is to enable the mitochondrion to 
retain control over the gene expression of these specific respiratory chain proteins, as it 
allows each mitochondrion to quickly respond to changes in the membrane potential. 
There is a direct link between the amount of mtDNA within the mitochondria and 
cellular respiration rates, and the depletion of mitochondrial genes causes mitochondrial 
disease (Lane and Martin 2010). The imaging conducted for the previous chapter 
showed that our S2 cells contain a tightly connected reticular network of mitochondria 
all over the cell cytoplasm. 
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Mitochondria perform respiration by using the energy stored in ingested food, primarily 
through the metabolism of glucose. Glucose is converted into pyruvate in the cytoplasm 
and transported into the mitochondria. Metabolism occurs in the mitochondrial matrix 
from the oxidation of glucose and fatty acids into acetyl-CoA. Processing of acetyl-CoA 
by the Krebs cycle utilises reduction of NAD+ and FAD to yield CO2, the final product 
of oxidative metabolism. Oxidative phosphorylation takes place on the inner 
mitochondrial membrane (James et al. 2012). Transport of electrons from NADH and 
FADH2 carrier molecules is converted into energy as a membrane potential. The energy 
stored in the proton gradient drives the synthesis of ATP (Lodish 2008). Disruptions of 
the metabolic process in mitochondria can be measured using assays which target key 
steps in oxidative phosphorylation, and the production of ATP (Mcbride et al. 2006; 
James et al. 2012).  
It is thought that all of the proteins involved in oxidative phosphorylation are localised 
to the inner mitochondrial membrane (Ernster and Schatz 1981). The inner membrane is 
only permeable to pyruvate and fatty acids while excluding large molecules. The outer 
membrane of mitochondria contains porin channels which allow the diffusion of 
cytosolic contents smaller than 6 KDa (peptides of about 50 amino acids) into the inter-
membrane space (Lodish 2008; Park et al. 2010). It is quite interesting that this size 
range corresponds to that of smORF peptides, and could be a clue as to why such a large 
proportion of smORFs localise to the mitochondria.   
Programmed cell death (PCD), another very important cellular process, is mediated by 
the mitochondria. Drosophila-inhibitor of apoptosis protein (DIAP1) acts as a ‘brake’ on 
apoptosis. Apoptosis is promoted by the protein Reaper, which is a 68 aa smORF 
peptide (White et al. 1994). Reaper is part of the well characterised RHG (Reaper, Hid, 
Grim) protein family, which encode peptides that localise to the outer mitochondrial 
membrane (Thomenius et al. 2011). Expression of Reaper disrupts DIAP1 function by 
directly binding DIAP1 and translocating it to the mitochondria, where DIAP1 is 
ubiquinated and destroyed (Freel et al. 2008; Steller 2008). Reaper and Hid expression 
has been shown to induce ‘swelling’ of mitochondria in S2 cells (Abdelwahid et al. 
2007). 
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Figure 5.2: The structure and function of mitochondria in eukaryotic cells The 
mitochondria has a matrix within the inner mitochondrial membrane (IMM) and these 
structures are enveloped within the outer mitochondrial membrane (OMM). The matrix 
contains the mtDNA, which encodes for some essential peptides of the electron 
transport chain. Glucose and fatty acids transported across the OMM, are metabolised 
on the IMM via the Krebs cycle, which generates a membrane potential, allowing the 
electron transport chain to generate ATP. During oxidative stress, hydrogen peroxide is 
released from the mitochondria to the nucleus and other organelles. The mitochondrial-
associated membranes (MAM) shared with the ER allow influx of Calcium, which is 
involved in the conversion of Acetyl CoA. Drp1, OPA1 and Mitofusin regulate the 
fission and fusion of mitochondria to increase mtDNA quality, or respond to cellular 
energy requirements.  
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Mitochondrial morphology has been shown to be affected when cells are treated with 
various stimuli. Developmental cell death of larval tissues during pupation also induces 
mitochondrial remodelling, causing mitochondria to change from reticular distribution 
to ‘condensed bodies’ in vivo (Goyal et al. 2007). A key phenotype exhibited by cells 
under stress is the perinuclear aggregation of mitochondria. The cytokine Tumour 
Necrosis Factor (TNF) is a known promotor of cell death. TNF treatment of the murine 
fibrosarcoma L929 cell line showed a distinct translocation of mitochondria from a 
dispersed network into a peri-nuclear cluster (DeVos et al. 1998). This spatial change in 
mitochondrial distribution preceded cell death by several hours. The morphological 
effect on mitochondria by TNF, was due to the disruption of kinesin motor function, 
which prevented the mitochondria from traveling along microtubules.  
Perinuclear clustering of mitochondria has been observed during programmed cell death 
in Drosophila Nurse cells during mid-oogenesis (Tanner et al. 2011). In Drosophila S2 
cells, perinuclear clustering of mitochondria has been shown after prolonged exposure 
to paraquat, which is a herbicide linked to Parkinson’s Disease, and after genetic over-
expression of the Parkin protein (Okatsu et al. 2010; Ivatt et al. 2014). Knockdown of 
mitochondrial fission and fusion proteins such as Drp1, also results in perinuclear 
mitochondrial remodelling in mammalian and Drosophila cells (GandreBabbe and van 
der Bliek 2008; Tanner et al. 2011).  
The aggregation response of mitochondria has been thought to occur in order to increase 
the concentration of apoptogenic factors near the nucleus, which seems feasible and 
logical as it is this signalling event that commits the cell to apoptosis (Pucci 2008). It 
has also been shown that mitochondria fuse together in cells as a response to starvation 
(Rambold et al. 2015). Autophagy and nutrient stress in mammalian cells forces an 
increase in the transfer of fatty-acids from lipid-droplet stores to the mitochondria. The 
boost in oxidation of fatty-acids enables starved cells to continue oxidation and escape 
cell death. The hyper-fusion and aggregation of mitochondria allows rapid distribution 
of fatty-acids, and the cells maintain almost equal levels of mitochondrial respiration 
levels as wild-type cells until committing to cell death (Rambold et al. 2015). The 
hyper-fusion of mitochondria occurs prior to the induction of apoptosis under continued 
stress (Tondera et al. 2009). Together, this information strongly indicates that cellular 
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stress in the form of autophagy, apoptosis, lack of nutrients or nutrient transport, and the 
inhibition of mitochondrial transport, causes mitochondria to translocate. The clumping, 
or hyper-fusion of mitochondria occurs as a cell survival mechanism (Tondera et al. 
2009). 
RNAi screening for smORF function 
I conducted two different assays on cells after conducting RNAi of target smORF genes. 
As these assays were conducted in chronological fashion, the best way to understand the 
information presented here is to compare the assay conducted ‘before and after’ more 
information was obtained regarding the localisation of S2 cell smORFs by the tagging-
transfection assay described in the previous chapter. Initially, we tried an assay that 
could be conducted in 96-well plate format, potentially allowing for many samples to be 
analysed at the same time. The Alamar Blue (AB) reagent can be used to monitor 
metabolic function and cellular health by reading fluorescence in wells using a plate 
reader (Rampersad et al. 2012). AB, which is a compound called Resazurin, measures 
the ‘reducing environment’ of viable cells by acting as an intermediate electron 
acceptor.  As the cells metabolise and grow, AB accepts electrons and changes from a 
non-fluorescent blue compound into its highly-fluorescent pink/red form, Resorufin. 
The oxidation-reduction potential of AB allows it to be reduced by NADPH, FADH, 
FMNH, NADH and the cytochromes of the electron transport chain (Figure 5.3A). The 
Alamar Blue screen was selected by the lab to be a type of RNAi viability screen, where 
the result would hopefully reveal which smORFs, are essential to maintain cell viability 
in the form of normal respiration, as measured by the % of reduction of the Alamar Blue 
reagent.  
The second study presented in this chapter involves imaging of S2 cell mitochondria 
after RNAi treatment. These experiments were conducted after complete interpretation 
of the assessment of the candidate smORFs’ translation by Poly-Ribo-Seq as well as the 
tagging-transfection assay, which also revealed that a large proportion of the smORFs 
tested actually localise to the mitochondria. I had also previously found that we could 
observe the mitochondrial stress response of perinuclear aggregation after the induction 
of cellular stress by various stimuli. The schematic in Figure 5.3B outlines this 
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mitochondrial stress response and shows examples of a mitochondrial clump/
aggregation phenotype in our S2 cells. By quantifying the proportion of cells that 
display this mitochondrial stress response in dsRNA treated S2 cells, we would be able 
to discern which smORFs are inducing stress directly upon the mitochondria, prior to 
any decrease in respiratory activity or commitment to cell death. Generally, this 
approach should confer a favourable selection bias on the screen, as we are fishing for 
phenotypes in mitochondria, where a potentially large proportion of S2 cell smORFs are 
localised and may be functioning. 
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Figure 5.3: The assays used to test smORF function using RNAi 
A) Overview of the Alamar Blue assay which is used to assess cellular health by acting 
as a read-out of cellular metabolism. AB consists of Resazurin reagent, which acts as an 
intermediate electron acceptor from all the major electron carriers of the mitochondria. 
If metabolism is taking place, AB is reduced from a weakly fluorescent blue compound 
(Resazurin) to a highly fluorescent pink compound (Resorufin). The fluorescent signal 
can then be detected by a Fluorescent plate reader. This assay would allow the rapid 
screening of several samples at the same time. B) The mitochondria imaging RNAi 
screen, which uses the detection of clumped-mitochondrial morphology as a read-out to 
detect mitochondrial stress. The schematic shows the proposed model for the induction 
of mitochondrial stress by modulators of programmed cell death DIAP1 and reaper. In 
S2 cells, wild type mitochondria appear as strings and small punctae distributed through 
the cytoplasm in a filamentous network. The induction of cellular stress by Heat-shock, 
prolonged serum-starvation and incubating cells with the translation inhibitor 
cyclohexamide leads to perinuclear aggregation and clumping of mitochondria. Scale 
bars = 5µm. 
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Results
Section I - Alamar Blue RNAi screen  
Alamar Blue reagent is non-toxic and permeable through cell membranes. Fluorescence 
and absorbance of AB is observed at 560nm excitation and 590nm emission 
wavelengths. AB reagent is water-soluble and stable in culture medium, though the 
presence of Foetal Bovine Serum, which is used to supplement Schneider’s media for 
S2 cells, can quench signal. There have not been many studies conducted with AB in 
Drosophila cell lines. The novelty of this approach, and the fact that we had the 
necessary tools available to conduct the assay, made AB a feasible choice. Cells that are 
inhibited in growth and metabolism by the presence of a drug or treatment do not 
effectively reduce the reagent, and show a smaller percentage of AB reduction 
compared to healthy cells. 
Temperature Testing of Alamar Blue Assay 
The optimum incubation temperature for AB is 37°C, and thus far this assay has mainly 
been used for mammalian and bacterial cells, for which 37°C is the optimal growth 
temperature (HamalainenLaanaya and Orloff 2012). The first step to see whether we can 
use AB to conduct our screen on smORF function would require testing whether we can 
use it at lower temperatures, as Drosophila physiological temperature is 25-29°C, and 
cells and flies are known to exhibit a heat-shock response at 37°C (Lindquist et al. 
1984). A previous study on Drosophila S2 cells shows that Pseudomonas exotoxin 
causes apoptosis, and this was determined by incubation of Drosophila cells with AB at 
37°C after treatment with toxin (Sharma and Fitzgerald 2010). In order to clarify 
whether the results of this study are due to the Pseudomonas exotoxin or heat shock, I 
decided to perform a temperature test on the cells.  
S2 cells produce large amounts of Heat-Shock Proteins when kept at a temperature 37 
°C for longer than 5 hours (Cevallos and Sarnow 2010). Therefore, I assessed whether 
we obtain similar AB response curves from cells plated at lower temperatures, such as 
S2 cells, which require culturing and incubations at 25°C. S2 Cells were grown in flasks 
resuspended in Serum free media, counted, and diluted to concentrations of 2.0x105, 
2.5x105, 5.0x105, 1.0x106 and 2.5x106 cells per mL, of which 100µl was plated in 10 
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wells each. 10 wells of media-only were also plated in order to obtaining a reading of 
background signal. Three identical plates were prepared for each temperature that was 
to be tested. In order to keep conditions consistent with dsRNA treatment, cells were 
supplemented with 100µl of 10%FBS media after 1h, and then allowed to grow for 48 
hours at 25°C. After the 2-day growth period, the media of the cells was aspirated and 
200µl of 10% AB (v/v) Serum Free media was added to the cells in order to obtain a 
reduction curve. Each plate was kept at different incubation temperatures, (25°C, 29°C 
and 37°C) after the addition of AB, and readings were obtained at 1-hour intervals for 4 
hours followed by a final reading at 24 hours. After this time, all the plates were 
autoclaved at 155°C, and an endpoint reading of AB reduction was obtained and 
averaged. The assay endpoint is required in order to determine the % of AB reduction, 
and is constant for all experiments conducted from this point (115322 fluorescent units). 
The % reduction calculation is conducted by manufacturer’s instructions, described 
below. The results of this experiment are presented in Figure 5.4A.  
To conduct an assay under consistent experimental conditions, especially when plating a 
large number of samples at the same time for comparison, requires optimisation of the 
technique so that it can be reliably reproduced at a larger scale. Due to this, we had to 
determine the starting cell density at which to plate the S2 cells, as well as the technique 
of adding and removing media and reagents from the sample. S2 cells double after 
every 24 hours, and the amount of dsRNA added to the cells is determined by the cell 
density at the beginning of the experiment. The following tests were conducted to select 
the lowest number of cells that we can use for plating, while remaining within the 
recommended experimental range for conducting the AB assay (under 250,000 cells/
well). The general formula for dsRNA to cell ratio is 1.0µg per 250,000 cells 
(Drosophila RNAi protocol DRSC), and I aimed to be far below this starting point due 
to limited amounts of dsRNA as well as the fact that AB reduction is hampered at cells 
grown above this density. A series of dilutions were plated in triplicate wells using a 
range from 1.0x104 cells/ml (1,000 cells/well) to 5.0x105 cells/ml (50,000 cells/well). 
Cells were plated using the method described above, this time using a multichannel 
pipette to aid the scaling up process of the assay, and the plates were incubated at 25°C. 
Previously, reagents were being pipetted into the wells carefully using a single channel  
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Figure 5.4: Optimisation of the Alamar Blue assay  
A) A range of 20,000 to 250,000 S2 cells were plated in wells of a 96-well plate and 
incubated with AB reagent at 25°, 29° and 37°C for 4 hours. Fluorescent readings were 
obtained every hour and the average percent reduction of AB by the cells was 
calculated.  These tests showed that incubating cells at different temperatures does not 
change the response curve of AB B) Different methods used to add AB reagent to the 
cells. The method of removing growth media followed by the addition of 10% AB 
reagent in Serum free media gave the most consistent readings. C) Test of plating very 
low cell density in order to conserve dsRNA. 
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pipette. Though this approach was thought to lead to error, the results from the 
temperature test showed that there was not too much variation between the different 
dilutions of cells. As 
this was not feasible when dealing with hundreds of samples, different approaches were 
considered regarding the adding of AB reagent to the cells after the 2 day phase of 
growth and incubation with dsRNA. The table in Figure 5.4B summarises various 
techniques that were used to add Alamar Blue into the media of the cells. Fluorescent 
readings were obtained at 1-hour intervals up to 6-hours after adding AB reagent. The 
first trial was conducted by adding 20µl of AB into the existing growth media of the 
cells. The readings obtained for each cell density range were highly variable. The 
second trial involved the aspiration of the 2-day old growth media, and cells were 
resuspended in  fresh 10% AB serum-free media and incubated for 4 hours. The results 
from resuspending the cells were even more variable than adding AB into the growth 
media. The act of resuspending cells by pipetting up and down in the wells may have 
caused removal of some media and cells.  
The third and fourth trials were conducted under identical conditions, by removal of 
growth media and gentle addition of 10% AB serum free media into the wells. The 
results of these two experiments were averaged and are presented in Figure 5.4C. From 
this, I saw that plating between 5000-50,000 cells/well is achievable, and still shows a 
dynamic range of AB reduction over time. The overall percentage of AB reduction is 
lower than in the results of similar cell density in the temperature-testing experiments. 
This is most likely due to the transfer of cells into Multichannel Pipette Reservoirs, 
which may cause some loss of cells as they get stuck to the reservoir plastic, or sink to 
the bottom before being pipetted. Therefore I decided to plate 25,000 cells/well for the 
RNAi experiment as it provided a small enough number of cells to require only 0.1µg of 
dsRNA per well. The incubation time with AB was selected at 4h after addition of 10% 
AB Serum Free media, as this provided enough time for the reagent to show a large 
change in fluorescence for cells plated at lower densities.   
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Pilot RNAi screen  
The experimental protocol that was followed for the first RNAi AB Pilot has been 
shown in Figure 5.5A along with the names of the various candidate smORF and control 
dsRNAs that were tested using the AB assay in the Pilot screens. The smORFs that were 
to be tested with the AB assay RNAi screen were selected from the Peptide Atlas 
database of smORFs (Desiere et al. 2006), as the data from the Poly-Ribo-Seq 
experiments had not yet been analysed. These SEPs have evidence of translation 
through mass spectrometry studies in the fly. We aimed to identify genes that encode 
peptides which, when removed, impinge on the levels of mitochondrial metabolism as 
compared to wild type and positive controls. This can be calculated by by comparing 
percentage AB reduction of cells by applying the formula provided by the 
manufacturers. (AB signal reduced by sample - AB signal from media only ÷ 115322 
fluorescent units - AB signal from media only). 
As previously mentioned, an important role of mitochondria is the regulation of 
programmed cell death, or apoptosis (Liu et al. 1996; Susin et al. 1996; Desagher and 
Martinou 2000). Apoptosis can be initiated externally by cell surface receptors leading 
to caspase activation, or internally regulated by the mitochondria (Suen et al. 2008). 
Drosophila Inhibitor of Apoptosis Protein-1 (DIAP1) is a key player in the ‘gas and 
brake’ model of apoptosis in flies (Steller 2008). DIAP1 is essential for cell survival, 
and this is the reason that this gene was chosen as a positive control for cell death. 
Elimination of DIAP1 results in early embryonic cell death in Drosophila (Wang et al. 
1999). Treatment of Drosophila SL2 cells with DIAP1 dsRNA showed caspase 
activation and cell death after a decrease of DIAP1 mRNA expression (Zimmermann et 
al. 2002). In Drosophila, caspases have been found to be constitutively active, and 
require the constant presence of DIAP1 binding in order to inhibit the apoptotic 
response (Zimmermann et al. 2002; Freel et al. 2008). Another control for cell growth 
was used, in the form of Cyclin-dependent kinase-1 which is encoded by the cdc2/Cdk1 
gene (Edgar et al. 1994) and will be referred to as cdc2 in this thesis. Cdk1/Cdc2 
dsRNA has been shown to cause cell death and the formation of giant cells, in a 
previous study conducted on S2 cells (Björklund et al. 2006). It was hoped that either of 
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these controls would show us the effect on cellular respiration when cell survival 
proteins are knocked down. 
A total of 31 samples were plated in triplicate, including a no-dsRNA/wild-type cell 
control in a 96-well plate. The Pilot screen was run in triplicate, using the initial cell 
density of 25,000 cells/well incubated with 0.1µg of dsRNA. The remaining 3 wells of 
each plate were dedicated to media-only, to provide a background reading, which is 
subtracted from the fluorescence readings obtained from the test samples. dsRNA-
Untreated cells and dsBlueScript-treated cells were used as wild-type controls for these 
experiments. The dsRNA-untreated control acted as a baseline of S2 cell mitochondrial 
metabolism, in order to measure any variation imposed by the experimental protocol. 
dsBlueScript is designed against a bacterial plasmid that is not found in S2 cells and is 
used as a control to show if there is any variation imposed simply by the addition of a 
non-specific dsRNA to the cells, which may elicit an RNAi response from the cellular 
machinery without targeting a specific mRNA. The results of the first round of 
experiments are shown in Figure 5.5B.  
The expected result from the knockdown of DIAP1 would be a lower percentage of AB 
reduction than that in wild-type (dsRNA untreated) and BlueScript dsRNA treated S2 
cells. Though percent reduction of DIAP1 RNAi is significantly different to untreated 
cells (p<0.0001), it is actually higher than % AB reduction in wild type cells, which is 
the opposite to what was expected. The difference between percent AB reduction of 
DIAP1 RNAi cells is non-significant compared to dsBluescript treated cells (p=0.4368). 
Percent AB reduction of cells treated with cdc2 dsRNA did not differ significantly when 
compared to dsBluescript treated cells either (p=0.0938). This result rendered the base-
line of the experiment flawed, as there was no difference between the positive and 
negative controls, therefore the difference between DIAP1 and wild type cells cannot be 
attributed to a specific knockdown of DIAP1 and may just be arising due to the 
induction of an RNAi response. Without a significant difference between these 
conditions, we would be unable to interpret results from smORF RNAi samples as cells 
with decreased viability should show a percentage reduction of AB significantly lower 
than the negative controls and around the range of positive-control treated cell values. 
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Figure 5.5: The Alamar Blue Assay to detect smORF function  
A) Overview of final AB assay protocol: 25,000 S2 cells were plated in each well of a 
black 96-well plate. 0.1µg of dsRNA were added to cells in triplicate wells. Plates were 
sealed and left to grow for 2 days. The growing media of the cells was then replaced by 
10% (v/v) AB media and fluorescent readings were obtained after 4 hours at 25 °C. The 
dsRNAs tested in the AB assay are listed in the table. Tarsal-less, Renilla-Luciferase, 
and Bluescript dsRNAs are used as negative controls, while DIAP1 and Cdc2 are used 
as positive controls. smORFs tested in both screens are in bold B) Results of the first 
pilot screen. No significant difference is observed in average %AB reduction between 
the untreated cells and the controls. C) Repeat of the AB assay with just the control 
duplexes and double the amount of dsRNA, again no significant difference is observed. 
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This led us to question whether the knock-down is taking place at all, especially for the 
positive controls. Therefore, I decided to increase the amount of dsRNA in an attempt to 
verify the affects of the positive controls. Figure 5.5C shows the results of a duplicate 
experiment where I retested the positive and negative controls. Cells were plated as 
described above, but this time using double the amount of dsRNA. The percentage 
reduction of AB in DIAP1 and Bluescript dsRNA treated cells was still nonsignificant 
(p=0.8792). dsRNA treatment targeting cdc2, a cell cycle protein, had a higher level of 
AB reduction than all the other controls. However, compared to Bluescript treated cells, 
this result was still nonsignificant (p=0.1156). Therefore, the need arose for verifying 
the knockdown of the positive controls. 
Validation of positive controls of cell death and cell growth 
Upon analysing the results from the first pilot screen, I decided to experimentally verify 
knock-down of the DIAP1 and cdc2 transcripts using semi-quantitative RT-PCR on 
dsRNA treated cells. Primers for RT-PCR were designed for targeted amplification of 
the endogenous cdc2 and DIAP1 transcripts. This was achieved by excluding regions of 
the transcripts complementary to the dsRNA sequence from the amplicon, thus 
preventing any signal from dsRNA amplification from distorting the measurements. 
Samples were prepared using 1mL of cells in serum-free media, plated at a 
concentration of 2x106 cells/mL. 8µg of each dsRNA (Bluescript, cdc2 and DIAP1) was 
added to the cells, and after a 1h incubation, the cells were supplemented with 1mL of 
10% FBS supplemented media and allowed to grow for 4 days. Cells were harvested 
and pelleted for RNA extraction using Trizol Reagent. The results of the RT-PCR are 
shown in Figure 5.6A. The RT-PCRs showed that there is knockdown of cdc2 and 
DIAP1 transcripts in cells treated with each dsRNA when compared to levels of 
expression of these genes in Bluescript dsRNA-treated cells. This shows that our 
dsRNAs are indeed working in reducing the expression of their positive control targets.  
I decided to conduct a cell count of cells treated with the control dsRNAs. The results of 
this experiment are presented in Figure 5.6B. From each of the 2 repeats of the RT-PCR 
experiment, I sampled 100µl of cells and plated them on acid-treated coverslips. The 
cells were allowed to adhere for 1h, and fixed with 4% paraformaldehyde, followed by a  
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 Figure 5.6: Validating the knock-down of positive controls  
A) Semiquantitative RT-PCR to asses level of knockdown of control genes in S2 cells 
using the dsRNA-soaking method. The gel image shows significant knockdown of both 
DIAP1 and cdc2 as compared to the expression of these in cells treated with the dsRNA 
negative control Bluescript. Rp49 is used as a loading control. B) A small sample of 
cells were stained with DAPI and the nuclei were counted to assess cell number. 
Though there is no significant difference between the test and control samples  DIAP1 
nuclei numbers are slightly lower than negative control cells. Scale bar = 10µm. 
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DAPI staining to label nuclei. The coverslips were then mounted on glass slides with a 
drop of Vectashield and imaged on a wide-field fluorescent microscope (Leica). pictures 
were taken of each slide, and the nuclei were counted using automated particle 
recognition in the ImageJ program and the total number of cells counted in each 
replicate was averaged. Neither cdc2 nor DIAP1 RNAi’s showed significantly higher or 
lower cell numbers than samples treated with Bluescript dsRNA, however the DIAP1 
RNAi cell counts were slightly lower. The fact that knockdown of controls can be seen 
by RT PCR, and cell counts are slightly lowered in DIAP1 dsRNA samples was 
encouraging enough to try the assay again with a larger amount of dsRNA. 
Optimisation of Alamar Blue RNAi screen 
The Pilot RNAi was repeated again, at the same starting cell density as before, but in 
the hope of seeing an improved effect of dsRNA treatment, I added twice the amount of 
dsRNA (0.2µg) in both these attempts and Pilot 2 cells were incubated for 2-days and 
Pilot 3 cells were allowed to grow for 4-days, to help improve knock-down and see a 
more pronounced effect of RNAi on the signal derived from AB. The results of these 
rounds of experiments are shown in Figure 5.7A,B. The overall percentage of AB 
reduction has increased in these experiments compared to the first pilot. This increased 
signal is probably due to the longer 4-day growth phase and therefore the presence of a 
higher number of cells .  
Unfortunately, the results from these two experiments showed a wild-type  (Bluescript-
dsRNA treated) level of percentage AB reduction in positive-control DIAP1 and cdc2 
dsRNA treated cells. This indicated that knockdown of these genes over the course  of 
both of 2 and 4 days does not impose a decrease in AB signal as  expected; as neither 
DIAP1 or cdc2 RNAi show a decreased level of AB reduction. We have previously 
verified the effectiveness of these control dsRNAs, so this means that the effect of 
knocking down DIAP1 and cdc2 does not decrease the levels of respiration in the cells. 
We have previously verified the effectiveness of these control dsRNAs, so this means 
that the effect of knocking down DIAP1 and cdc2 does not decrease the levels of 
respiration in the cells. Although the experimental conditions were identical in both of 
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Figure 5.7: Alamar Blue Assay results after optimisation of RNAi 
A) Results of the second pilot screen, which was conducted with double the amount of 
dsRNA as the first pilot. There are no significant effects on AB reduction observed from 
positive controls B) Results of the third pilot screen, conducted with double the dsRNA 
and 4-days of incubation of dsRNA and cells before the AB assay with similar lack of 
effect from positive controls as Pilots 1 and 2. C) ANOVA summary of all three pilot 
screens, each pilot screen results are statistically significant (p<0.0001). 
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these Pilot runs, the percentage AB reduction between the two experiments for specific 
dsRNAs was variable and inconsistent. One-way ANOVA (Figure 5.7C) of all three 
screens shows that we can reject the null hypothesis, that there is no effect of RNAi, as 
the F ratio of each Pilot run is much higher than 1. Each experiment also has a highly 
significant P-value, therefore we can conclude that the groups are not all the same. 
Without significantly higher or lower percentage AB reduction of positive controls, 
there is not much hope of extracting meaningful data by comparing each smORF RNAi 
with wild type conditions. "Dunnett's multiple comparisons test" was used to compile 
the multiple t-tests of each smORF and control RNAi treatments against Bluescript-
dsRNA treated cells.  
The table in Figure 5.8 shows the statistical significance of percentage AB reduction for 
each dsRNA in each experiment compared to that of Bluescript-dsRNA treated cells. 
The chart depicts the number of times a particular hit or control was significantly 
different to the negative control. The graph at the bottom of Figure 5.8 summarises the 
hits that were highly significant (either P ≤ 0.001 or P ≤ 0.0001). The reason for only 
considering samples at high confidence levels was that untreated cells show a 
significant (P ≤ 0.05) difference to Bluescript-dsRNA treated cells in some of the tests. 
There are four samples which stand out in these screens, one of them being DIAP1 (2 
experiments) and another is RenLuc, which is a negative control targeting the Renilla-
Luciferase transcript, which is not endogenously expressed in S2 cells.  
Two smORF RNAi samples stand out, and these are CG11985 and CG17059. CG11985 
has been described to be a component of the Splicing factor 3B (SF3B) complex by 
sequence similarity. The SF3B complex associates with the splicing factor SF3A 
complex and a 12S RNA unit to form the U2 small nuclear ribo-nucleoproteins complex 
and may be involved in mitotic spindle assembly (Flybase). The SEP from CG11985 
has not been studied individually or in depth and could be a good candidate for further 
characterisation as lowering the expression of CG11985 resulted in decreased viability 
of S2 cells in 2 experiments. The peptide derived from CG17059 has been described to 
be a homolog of Myeloma-overexpressed 2-like (MYEOV2-like) protein (FlyBase). 
Myeov2 is a 57aa peptide, but is annotated as 252aa in mammals. Myeov2 encodes a 
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Figure 5.8: Summary of the three Alamar Blue pilot screens 
‘Dunnett's multiple comparisons t-test for each dsRNA tested in the AB assay. Each 
column shows whether the %AB reduction is significantly different to the Bluescript 
dsRNA control for each Pilot each experiment (****P<0.0001,***P<0.001,**P<0.01, 
*P<0.05, Non-significant, ns P>0.05). The graph at the bottom shows the number of 
times each dsRNA shows up as statistically significant compared to Bluescript in each 
pilot. There are two smORFs (CG11985 and CG17059) that stand out from this 
analysis.  
  Pilot 1 Pilot 2 Pilot 3 
Untreated Cells * * *
DIAP1 ns **** ****
Reaper ns ns ****
CDC2 ns ns ****
tarsal-less ns ns ****
RenLuc * **** ****
CG34250 * ns ****
CG14701 ** ns ****
CG32267 * **** **
CG40439 * ** ****
CG17343 ns ns ****
CG32069 ns **** ***
CG13018 ** ns ns
CG33627 ns ns ns
CG2021 * ns ns
CG11985 **** **** ****
CG18624 ns ns ****
CG9065 ns ns ****
CG17059 **** ns ****
CG14818 ns ns ****
CG3321 ns ns ****
CG9603 ns ns ****
CG33714 *** ns ****
CG17931 ns ns ****
CG13551 ns ns ****
CG8860 ns ns ****
CG32368 ns ns ****
CG7630 ns ns ****
CG5174 ns * *
CG14235 ns * ***
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peptide which has been implicated to play a role in regulation of the cell cycle (Ebina et 
al. 2013). Since the positive controls of cell cycle and cell death did not seem to show a 
significant effect in this screen, it is difficult to say whether these two smORFs are 
actually producing an effect because if they are, it is stronger than the metabolic 
response of cells in which DIAP1 and cdc2 knock-down is occurring. 
Section II - smORF RNAi screen in S2 cell Mitochondria 
Although the Alamar Blue screen was not as successful as we had hoped, there were 
several observations made through those experiments that enabled us to move forward 
with the RNAi screening technique. The validation of RNAi knockdown of the positive 
controls for cell viability (DIAP1 and cdc2) by RT-PCR showed that the dsRNA soaking 
technique is effective at inducing knock-down by this mechanism. The Poly-Ribo-Seq 
experiments also revealed which smORFs are being translated at high levels our lab’s 
S2 cell line, which is important because every S2 cell population is unique due to the 
rapid accumulation of mutations based on the growth and cell culture conditions used to 
maintain the cells.  
It had been previously validated that MitoTracker-Red dye specifically labelled 
mitochondria in live cells (Chapter IV). S2 cell mitochondria were observed to be a 
mixture of puncta and strings, displaying a snapshot of the dynamic nature of 
mitochondria in healthy cells. The stringy and punctate mitochondria are distributed 
symmetrically around the cell cytoplasm in a filamentous network. When S2 cells were 
heat-shocked, serum starved for prolonged periods, or treated with cyclohexamide, the 
mitochondria became aggregated into large punctae, and localised asymmetrically in the 
cell (Figure 5.3B). As described in the introduction of this chapter, mitochondria have 
been shown to remodel in response to stress. Since we had preliminary evidence of this 
phenotype existing in our S2 cell population, I decided to conduct an imaging screen of 
mitochondrial morphology after RNAi treatment in order to identify smORFs with 
mitochondrial function. This mitochondrial stress response has been described in the 
literature by many, but it has never specifically been used as a direct indicator of cellular 
stress after inducing gene loss-of-function. 
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smORF RNAi and imaging S2 cell mitochondria  
Cultured S2 cells were resuspended in serum-free media and counted using a 
haemocytometer before dilution to 250,000 cells/mL. Cells were plated at a density of 
250,000 cells per well, which is a standard number for imaging. 6-well culture plates 
were prepared to contain an acid-treated coverslip upon which 2µg of dsRNA (or in 
untreated cells, 2µl of milliQ H2O) was added. 1mL of cells were added to the coverslip 
and allowed to mix with the dsRNA by gentle swirling of the plate. After a 45 minute 
incubation, the cells + dsRNA were supplemented with an equal volume of Schneider’s 
media containing 20% FBS and allowed to grow for 2 days (48 hours) on the coverslip. 
After this time, MitoTracker-Red, diluted to 500nM in 10% FBS Schneider’s media, 
was added to the wells and incubated for 1h. After which the media was removed and 
the cells were fixed with 4% paraformaldehyde, stained with DAPI for 10 minutes to 
label the nuclei. The coverslip was mounted on glass slides containing a drop of 
Vectashield before Imaging.  
In order to remove sampling bias depending on the dsRNA being used, the samples 
were randomised during the coverslip mounting process. Slides were labeled with a 
random letter and coordinate of the well in which they were plated. This information 
was recorded by another member of the lab who kept it hidden from me until after I had 
completed the imaging and analysis. This enabled me to score the mitochondrial 
morphology phenotypes using a blind method, in which there was no distinction made 
between the slides for wild-type controls, positive controls and test smORFs. After 
scoring the imaged cells for aggregated mitochondria, the proportion of aggregated cells 
was calculated from the total cells imaged. If a significant proportion of cells in a 
smORF RNAi sample displayed perinuclear aggregation of mitochondria when 
compared to wild-type and negative control samples, it would indicate that knocking 
down of the smORF gene product causes mitochondrial stress. Figure 5.9A summarises 
the process of plating and randomisation of the samples for analysis.  
There were two possibilities for conducting the imaging of S2 cell mitochondria in this 
experiment; the first would be to image the S2 cells using basic wide-field fluorescence, 
which is faster and less expensive than the second option of Laser Scanning 
Microscopy. LSM confocal microscopy is most often used for more detailed imaging of 
 138
samples, and if the phenotype could be reliably discerned from wide-field fluorescence 
microscopy, this would be the preferred method as it would enable us to apply this study 
to a larger number of samples. As shown in Figure 5.9B-C, samples imaged using wide-
field microscopy resulted in signal from mitochondria lying above and below the plane 
of focus, which lowers the resolution of the image. Blind scoring of mitochondria using 
these low resolution images was inconsistent when repeated for the same sample, as it 
was often difficult to differentiated true ‘clump’ morphology (Figure 5.9C) from 
ubiquitously distributed mitochondria (Figure 5.9B) even though they were discernible 
by eye. 
LSM imaging proved to be a more successful approach for this assay as Z-stack images 
were obtained of each plane of focus through the cells at intervals of 0.2µm. The Z-
stack projections of these images showed the mitochondria in higher detail, and distinct 
differences between normal (Figure 5.9D) and clumped or aggregated (Figure 5.9E’) 
mitochondrial morphologies could be observed. In order to make imaging of the 
samples more efficient, single-channel (Red) imaging was conducted to speed up the 
collection of between 50-100 cells per repeat of each dsRNA. Z-stack imaging not only 
provides clearer mitochondrial morphologies, but images can be projected into a 3D 
reconstruction and rotated around the Y axis using the 3D projection tool in the ImageJ 
program. Figure 5.9F shows 3D projections of S2 cells at 0°, 45° and 90° rotation of the 
the axis. By scoring the cells using 3D rotation of the images, it was even easier to 
differentiate between the normal (Ubiquitous) and abnormal (Clumped) mitochondrial 
classes. Aggregation of mitochondria can occur along the Z-plane, which cannot be seen 
without imaging the entire cell from the coverslip to the slide. ‘Ubiquitous’ 
mitochondria were described as a reticular distribution of mitochondrial structures 
evenly in the cell, along each plane. Clumped mitochondria have large gaps  in the cell, 
and most of the mitochondria are polarised towards one side of the cell, along any 
plane. For robustness, only the severely clumped mitochondria, where all the 
mitochondria of the cell are contained in only one half of the cell, were quantified as 
abnormal. 
For the Mitochondrial morphology screen, dsRNAs were designed to target all 
transcripts of the smORF gene, therefore for 8 SEP’s found in dicistronic transcripts, 
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there are four dsRNAs targeting their transcripts for knockdown. For this reason, uORFs 
were excluded from this screen as the dsRNA would also knock-down the canonical 
downstream ORF, and the effect observed would not be specific to the smORF being 
tested. The pilot list of this screen included all the smORFs that we tested in the 
tagging-transfection assay. Figure 5.10 summarises the list of smORFs and controls that 
were tested in this screen including 27 smORFs, 4 dicistronic smORFs and 6 lncRNA 
smORFs, of which 3 are monocistronic and 4 are polycistronic.  
Results from mitochondrial morphology RNAi screen  
Cells were prepared for imaging as described for the controls. The samples contained 
250,000 cells at the time of plating, which is the standard protocol for the plating of 
cells on a coverslip. Due to the semi-adherent nature of S2 cells, some of these would 
be inevitably lost through staining and fixing, but this is still a very high number of cells 
to image at high magnification using the Laser Scanning technique. Therefore, the 
number of cells imaged was limited to a realistic range which could be imaged for 
hundreds of samples. A minimum of 50 cells and up to a maximum of 100 cells were 
imaged per replicate of each smORF. The images obtained were named according to the 
randomised coordinate of the sample, and blind-scored from 3D reconstructions. After 
scoring the cells, the proportion of imaged cells with abnormal mitochondria was 
determined for each repeat of every sample. For each round of repeats, wild-type and 
positive controls were also present amongst the sample wells and hence repeated several 
times. Each smORF RNAi sample was tested at a minimum in triplicate. The results of 
the mitochondrial morphology RNAi Screen are shown in Figure 5.10A, as well as the 
complete list of different smORFs and controls that were targeted for RNAi (Figure 
5.10B). The One-way ANOVA of the results (Figure 5.10C) showed that the differences 
between the average percentages of cells with abnormal mitochondria between each 
sample in the overall experiment were statistically significant (P< 0.0001). The results 
from this experiment are depicted in ‘% abnormal mitochondria’, after averaging the 
proportions of abnormal mitochondria cells in the imaged samples. dsRNA-Untreated 
cells and dsBlueScript-treated cells were used as wild-type controls for these 
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Figure 5.9: smORF RNAi and imaging S2 cell mitochondria  
A) Overview of the mitochondrial morphology assay using RNAi against DIAP1, 
reaper, Drp1 and 14-3-3 as positive controls. Bluescript-RNAi and untreated cells are 
used as negative controls. 250,000 S2 cells are plated onto a coverslip in the presence of 
2 µg of dsRNA and allowed to grow for 2 days; the cells are then labelled with 
MitoTracker Red and fixed before imaging and blind scoring of phenotypes. B) Imaging 
normal mitochondria using wide-field microscopy. C) Imaging clumped mitochondria 
after RNAi using wide-field microscopy. This was conducted at the highest 
magnification of this microscope (100x, Oil Immersion Lens), however the low 
resolution of the microscope means that it is difficult to resolve the filamentous network 
of mitochondria in B from the clumped mitochondria in C. D) Normal cells imaged 
using LSM confocal microscopy increases resolution, allowing visualisation of stringy 
and punctate mitochondria E) LSM imaging of clumped mitochondrial morphology can 
be seen as different to the normal mitochondria in D. F) 3-D reconstructions of Z-stacks 
taken using LSM, the three columns of images show the mitochondrial morphology at 
different angles (0, 45 and 90 degrees on y-axis) while severity of mitochondrial 
clumping increase from top to bottom. Scale bars = 5µm. 
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experiments. dsRNA-untreated cells had 16.76% (±4.2, 5 repeats) and dsBluescript 
treated cells 21.18% (±8.2, 7 repeats) of cells with aggregated mitochondria. I also 
designed a dsRNA against tarsal-less, which is not expressed in S2 cells. dsRNA-tal 
would act as a negative control for whether RNAi against an untranscribed smORF 
causes any changes to mitochondrial morphology. dsRNA-tal cells contained an average 
of 29.68% (±7.72, 3 repeats, P>0.05, ns) of cells showing aggregated mitochondria, 
which is similar to the wild type and dsBlueScript-treated results.  
I also used several positive control dsRNAs based on their effects in published studies, 
in which they are shown to be implicated in cellular stress, death, or mitochondrial re-
arrangements. DIAP1 was once again used as a positive control for cell death, as in the 
AB screen. In the mitochondrial morphology screen, DIAP1 dsRNA treated cells had an 
average of 41.67% (±7.46, 6 repeats, P≤0.0001) cells with abnormal mitochondria. 
Dynamic-Related protein 1 (Drp1) regulates mitochondrial fission by directly 
interacting with fission and fusion molecules found on the outer mitochondrial 
membrane. It has been well characterised that knocking down Drp1 causes perinuclear 
aggregation of mitochondria in many cell types (GandreBabbe and van der Bliek 2008). 
In our screen, RNAi against Drp1 showed 62.61% (±11.90, 5 repeats, P≤0.0001) of cells 
with aggregated mitochondria, which is one of the most severe phenotypes characterised 
in this assay.  
This screen also tested whether the effect of knocking down other known genes would 
have an effect on mitochondrial morphology. PI3K68D is an enzyme which regulates 
endosome and phagosome maturation, as well as intracellular trafficking of lysosomes 
(Rusten et al. 2004; Velichkova et al. 2010). Cells treated with dsRNA against PI3K68D 
showed 34.93% (±12.11, 3 repeats, P>0.05, ns) of the cells with abnormal mitochondria, 
which was a nonsignificant result compared to wild type cells. Reaper is a well 
characterised inducer of cell death (Freel et al. 2008; Thomenius et al. 2011), but it was 
previously unknown what effect RNAi against Reaper has on mitochondrial 
morphology. Cells treated with Reaper dsRNA showed 40.94% (± 8.82, 4 repeats, 
P≤0.01) of abnormal mitochondria, which is almost as severe as the phenotype of 
DIAP1. RNAi against the master cellular regulator 14-3-3z at 59.88% (±6.1, 3 repeats 
P≤0.0001) resulted in almost as many abnormal cells per sample as Drp1. 14-3-3zeta is 
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involved in many vital cellular functions, including correct chromosomal separation 
during mitosis (Su et al. 2001). The knockdown of this protein has been shown to 
induce apoptosis in hepatic cancer cells (Lee et al. 2014).  
RNAi mediated knockdown of these known important cellular components helps 
determine a potential range of abnormal mitochondrial populations that can be expected 
in the cell populations. As opposed to the results from the Alamar Blue screen, the 
negative control Bluescript-dsRNA treated sample is not significantly different to the 
wild-type dsRNA-untreated cells. Additionally, the negative control for smORFs, tarsal-
less, was also non-significant to both of the wild-type controls. DIAP1, Reaper and 
Drp1 positive control samples show a significantly higher proportion of abnormal 
mitochondria than wild-type cells, as does the 14-3-3z dsRNA. Knocking down the 
known lncRNA Uhg2 (Tycowski and Steitz 2001) causes significant mitochondrial 
stress (42.71±2.35% cells with abnormal mitochondria, 3 repeats, P≤0.01). Uhg2 (U-
snoRNA host gene) ORFs themselves are not translated (Tycowski and Steitz 2001), the 
knocking down of snoRNA transcripts can have a deleterious effect on cells because it 
would target the translational machinery of the cell.  
In all, the smORF RNAi screen showed that 41% (15/37) of the total smORFs knocked 
down using RNAi, have an effect on mitochondrial morphology. 80% (12/15) of the 
smORFs showing a RNAi phenotype have either experimental data or TargetP 
prediction of localisation to the mitochondria, thus showing that this screen is a direct 
assessment of the function of mitochondria associated SEPs. The complete results have 
been summarised in a table (Figure 5.11) showing for each individual smORF the 
average percentage of abnormal mitochondria, standard deviation, number of repeats 
and statistical significance against dsRNA-BlueScript treated cells. The smORFs were 
scored by a lettering system according to known information about localisation, either 
through experimental validation or by a TargetP mTP prediction (Figure 5.11B). The 
results discussed below are smORFs which have a phenotype in this screen, as well as 
an indication of mitochondrial localisation. These smORFs, which have been given a 
score of A*, A, or B and are classed as real hits in the mitochondrial morphology RNAi 
screen, will be referred to as Functional mito-SEPs.   
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Figure 5.10: Complete results from mitochondrial morphology RNAi screen  
A) This graph shows the results from the mitochondrial imaging RNAi screen. The 
proportion of cells containing abnormal, clumped mitochondria were averaged over all 
the repeats for each dsRNA and are shown on the y-axis. Positive controls in this screen 
showed a significant difference to wild type and negative controls. Statistical analysis of 
these results is presented in Figure 5.11 B) Table showing the list of duplexes tested in 
the mitochondrial morphology RNAi screen. The columns show the controls, 
monocistronic, dicistronic and long non-coding RNA encoded smORFs tested in this 
screen. CG7630 and CG32230 are present in both AB and mitochondrial morphology 
screens C) ANOVA summary of the RNAi screen data showing the high statistical 
significance of the results within the screen. 
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All four dicistronic smORF genes tested in this experiment also elicit a mitochondrial 
stress response, three of these(CG42497/CG9878, CG42371/CG15386, CG32736/ 
CG42308) have mitochondrial localisation, and the results from the screen show that 
knocking down these smORFs has a highly significant effect. Of these, CG42497/
CG9878 has now been annotated as Tim10 on the basis of sequence homology 
(Flybase). The Tim9-Tim10 chaperone complex is responsible for the transfer of 
hydrophobic precursor proteins through the mitochondrial inter-membrane space, where 
it is localised (Schmidt et al. 2010). Interestingly, RNAi against Hemotin (CG43194/
CG43210) also causes mitochondrial abnormality (46.46±8.75%, 4 repeats, P≤0.0001), 
even though Hemotin peptides do not localise to mitochondria in my colocalisation 
experiments (Chapter IV). TargetP predicts the Hemotin-ORF2 peptide to contain a 
mTP sequence with high confidence. Additionally, Stannin, the vertebrate homolog of 
Hemotin has been shown to co-localise to mitochondrial markers, so a possibility does 
exist that there is some role for Hemotin in the regulation of mitochondrial dynamics 
(Davidson et al. 2004).  
The monocistronic mitochondrial smORFs CG7630, CG32230, CG33199, CG14036, 
CG14014, and CG33714 are all positive hits in the screen. CG7630 has a mild 
phenotype of abnormal mitochondria (36.42±6.15%, 4 repeats, P≤0.05) and I have 
found it to be co-localised to MitoTracker-Red. CG7630 has also been detected in the 
proteome of lipid droplets (Cermelli et al. 2006). Mitochondria utilise oxidation to 
enzymatically reduce Fatty-acids into metabolic intermediates that drive respiration 
(Rambold et al. 2015). Fatty acids are contained within lipid droplets, which are 
transported into the mitochondria from the Mitochondria Associate Membranes of the 
ER (Vance et al. 1997). The mitochondrial morphology screen shows that removing the 
Lipid droplet CG7630 by RNAi has an effect on mitochondria which is similar to when 
cells are put under starvation conditions (Rambold et al. 2015). CG32230 has a similar 
effect on mitochondrial morphology as CG7630, (38.24±5.52%, 3 repeats, P≤0.05). 
CG32230 is described as a NADH dehydrogenase subunit (complex 1) and this is 
inferred from sequence or structural similarity of CG32230 to this peptide in human 
cells. NADH is one of the main electron carrier molecules responsible for the 
conversion of energy in the mitochondria, and is localised to the inner mitochondrial 
 146
Figure 5.11:Summary of mitochondrial morphology screen results 
A) Summary table of the mitochondrial morphology screen showing the average 
percentage abnormal mitochondria, standard deviation, number of repeats and statistical 
significance of each test dsRNA result against dsRNA-BlueScript treated cells 
(Dunnett’s multiple comparison t-test). (****P<0.0001,***P<0.001,**P<0.01, *P<0.05, 
Non-significant, ns P>0.05). The results of the screen are scored by a lettering system 
according as shown in the table in panel B. B) Table describing the various score classes 
of hits in the screen by known information about localisation either by experimental 
validation or a TargetP mTP prediction and phenotype in the screen C) Cortical 
distribution of CG14036 in the sub-cellular distribution study, where some signal can 
also be observed in cytoplasmic puncta. Scale bars = 5µm.  
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Table 5.5
dsRNA % abnormal ± # of Cells # of 
Repeats significant Phenotype Score
    Bluescript 21.18 8.18 380 7
    untreated 16.76 4.18 196 5 ns
    DIAP1 41.67 7.46 436 6 **** Yes
    Reaper 40.94 8.82 222 4 ** Yes
    Drp1 62.61 11.90 289 5 **** Yes
    Pi3K 34.93 12.11 168 3 ns no
    tal 29.68 7.72 221 3 ns no
    14-3-3z 59.88 6.10 156 3 **** Yes
    Uhg2 42.71 2.35 204 3 ** Yes
    pncr009 31.25 7.52 186 3 ns no
    CR30055 34.18 9.41 218 3 ns no F
    Rox2 30.75 6.81 243 4 ns no
    CR43144 41.88 4.65 153 3 ** Yes A
    CR32582 35.14 6.99 223 4 ns no D
    CR43250 38.36 9.99 141 3 * Yes A
CG43194
CG43210 46.46 8.75 259 4 **** Yes B
CG42497
CG9878 44.07 6.02 194 3 *** Yes A*
CG42371 
CG15386 40.38 4.40 157 3 ** Yes A*
CG32736 
CG42308 47.54 10.07 213 3 **** Yes
A
    CG33170 24.18 6.06 225 4 ns no
    CG12384 47.18 12.00 213 4 **** Yes C
    CG18622 26.00 2.27 355 3 ns no
    CG17680(s) 22.45 4.40 201 3 ns no D
    cg17680(j) 35.35 3.06 167 3 ns no
    CG7630 36.42 6.15 196 4 * Yes A*
    CG14014 42.92 8.34 221 3 ** Yes A
    CG32276 24.86 4.23 175 4 ns no D
    CG32230 38.24 5.52 159 3 * Yes A
    CG14482 30.25 1.83 240 4 ns no D
    CG34200 35.64 2.76 214 4 * Yes C
    CG4101 32.05 3.40 232 3 ns no
    CG33774 32.50 3.84 175 3 ns no
    CG44242 29.06 6.38 206 3 ns no D
    CG33155 36.45 10.01 208 3 ns no
    CG33199 55.34 11.24 156 3 **** Yes A*
    CG18343 24.71 8.09 278 4 ns no
    CG13784 34.78 3.41 205 3 ns no
    CG31360 23.98 2.55 232 3 ns no
    CG9669 26.76 1.77 215 3 ns no
    CG32248 27.30 5.05 261 3 ns no
    CG11686 64.69 7.70 286 3 **** Yes C
    CG14036 54.26 13.22 167 3 **** Yes A
    CG32267 24.86 4.23 151 3 ns no
    CG33714 54.21 6.03 213 3 **** Yes A*
    CG34242 31.03 5.47 166 3 ns no F
    CG6770 29.01 3.67 172 3 ns no
    CG17278 22.71 6.30 188 3 ns no F
Mitochondrial 
Phenotype
MitoTracker 
Colocalisation mTP Score
x x x A* Positive
x x A Positive
x x B Positive
x C False Positive
x x D False Negative
x F False Negative
A
B C CG14036
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membrane (IMM). Some of the subunits of NADH are translated from mtDNA 
transcripts (Burman et al. 2014), but CG32230 is a nuclear gene encoded peptide 
(Sardiello 2003). It would be very interesting to investigate whether CG32230 in 
involved with the effect on neurodegeneration as can be seen for mutants of NADH 
complex 1 in flies (Burman et al. 2014). RNAi against CG33199 shows a very strong 
phenotype (55.34±11.24%, 3 repeats, P≤0.0001) and there are no previously known 
phenotypes or biological processes associated with this transcript or the peptide that it 
encodes. This makes CG33199 a particularly interesting hit to follow up, as it is 
completely uncharacterised and may be playing a significant role in the mitochondria. 
RNAi targeting CG14036 also has a very strong phenotype, 54.26±13.22%, 3 repeats, 
P≤0.0001). Although the subcellular distribution of the CG14036 peptide appears as 
cortical in the subcellular distribution study, the peptide shows significant overlap to 
MitoTracker-Red at a level above the cut-offs. Upon re-examination of the images, the 
CG14036 peptide appears as a stronger Cortical staining, but can also be found in a 
reticular distribution in the cytoplasm(Figure 5.11C). CG14036 is annotated to have a 
function in copper-ion homeostasis (Norgate 2007), and there is evidence in the 
literature that it may be directly related to mitochondrial function in a Parkinson’s 
disease associated study (Cox and Spradling 2009).  
CG33714 is annotated as a Steroid receptor RNA activator (SRA) Stem-loop-interacting 
RNA-binding protein (SLIRP) encoding gene, which encodes a peptide of 90aa in 
Drosophila. The CG33714 SEP is a homolog of SLIRP found in human breast cancer 
cells (Hatchell et al. 2006), and this gene encodes a highly conserved, 109aa peptide in 
mammalian cells. This peptide is localised to the mitochondria, but has been shown to 
function as a regulator of hormone-responsive gene expression. CG14014 
(42.92±8.34%, 3 repeats, P≤0.01) is annotated in FlyBase to be have ‘protein 
dimerisation activity’ and was identified by sequence or structural homology to Basic 
region-leucine zipper (B-ZIP) transcription factors. These peptides dimerise and bind to 
sequence-specific DNA to regulate gene expression in response to cellular signals 
(Fassler et al. 2002).  
RNAi against the translated lncRNAs encoding mitochondrial SEPs, CR43144 (41.88 
±4.65%, 3 repeats,  P ≤ 0.01) and CR43250 (38.36±9.99, 3 repeats, P ≤ 0.05) showed a 
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significant effect on mitochondrial morphology. The functions of CR43144 and 
CR43250 are completely unknown, and the fact that these lncRNA smORFs encode for 
functional peptides is a very promising result that brings some functional insight: to the 
extremely challenging task of discerning between ‘real’ lncRNA genes and mis-
annotated smORF genes. There are two smORF dsRNAs (CG12384 and CG34200) that 
display a positive phenotype in this screen, but were not localised to the mitochondria. 
CG12384 (47.18±12.00%, 4 repeats,P≤0.0001) has a strong phenotype but there are no 
indications that this homolog of Death-Associated-Protein localises to the mitochondria. 
Programmed cell death and apoptosis occurs on mitochondrial membranes, so it can be 
argued that CG12384 is actually a positive in the screen, but for robustness of the assay, 
it is has been considered a false positive result. CG34200 (35.64±2.76%, 4 repeats, 
P≤0.05) has a marginally significant phenotype, and no indication of mitochondrial 
localisation or function and therefore can be considered a true false positive in the 
screen. It could also be that the dsRNA designed against CG34200 exhibited off-target 
effects, though no off target effects were predicted for any of the dsRNAs that we 
designed for this experiment (Snapdragon dsRNA design tool, www.flyrnai.org). There 
is one last hit, CG11686 that shows a very strong effect on mitochondrial morphology 
(64.69±7.70, 3 repeats, P≤0.0001), but in the absence of any localisation or functional 
data, CG11686 has been classified as a false-positive in this screen until further 
information is available regarding the subcellular localisation of the peptide. Overall, 
the mitochondrial morphology  RNAi screen is successful at detecting a mitochondrial 
phenotype from the knock-down of a mitochondria localised smORF peptide with a 
52% detection rate. According to the scoring system developed to differentiate 
functional mito-SEPs from false-positives and false negatives, the screen has a false 
positive rate of 13% (Figure 5.12A). Figure 5.12B gives an overview of the pipeline 
used to identify the 12/37 functional mito-SEPs in the RNAi mitochondrial screen, 
according to their phenotype and localisation. The functional mito-SEPs identified in 
this screen are summarised, along with a description in Figure 5.12C.
The false negatives from this screen are the 8 mitochondrial SEPs that do not show a 
phenotype (Figure 5.13A). Three of these have annotated mitochondrial functions, such 
as the cytochrome b-c1 complex subunit (CG14482), and mitochondrial-ribosomal sub-
units CG33155 and CG44242. Since dsRNA treatment against these mitochondrial
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Figure 5.12: Analysis of mitochondrial morphology RNAi screen results A) The 
number of smORFs in each result category, smORFs in categories A*-B (12) are 
considered High-confidence positive hits as they localise to the mitochondria. C-class 
results (3) are False-Positives as they show a RNAi phenotype but the SEP does not 
localise to mitochondria. D&F class results (8) are considered False-Negatives as they 
are mito-SEPs but do not display a mitochondrial phenotype after dsRNA treatment. B) 
Flow chart showing the pipeline used to categorise Functional mito-SEPs. Boxes in red 
show the numbers that were discarded at each step C) Summary table showing the SEP 
length, alpha helix prediction, smORF class, subcellular distribution, localisation and 
any GO terms for the 12 high confidence hits and 3 False-Positive hits. 
Gene ID aa length TMMHM Description
Subcellular 
Distribution
Subcellular 
localisation GO Term 
CR43144 91 0 lncRNA smORF Reticular Mitochondrial unknown function
CR43250 73 0 lncRNA smORF Reticular Mitochondrial unknown function
CG43194 
CG43210
88 1 Polycistronic smORF Cortical F-actin/ 
Endosomes 
mTP (TargetP)
unknown function
59 1 Polycistronic smORF Cortical unknown function
CG42497
CG9878 (Tim10)
65 0 Polycistronic smORF Reticular
Mitochondrial
Mitochondrial import
92 1 Polycistronic smORF Other Cytoplasmic inner membrane translocase (Tim10)
CG15386
CG42371
77 0 Polycistronic smORF Other Cytoplasmic
Mitochondrial
unknown function
87 0 Polycistronic smORF Reticular unknown function
CG32736
CG43208
79 1 Polycistronic smORF Reticular
Mitochondrial
unknown function
61 1 Polycistronic smORF Reticular unknown function
CG7630 90 1 Monocistronic smORF Reticular Mitochondrial Lipid droplet proteome
CG32230 83 1 Monocistronic smORF Reticular Mitochondrial NADH dehydrogenase MLRQ subunit
CG33199 79 0 Monocistronic smORF Reticular Mitochondrial unknown function
CG14036 93 0 Monocistronic smORF Cortical Mitochondrial copper ion homeostasis
CG14014 68 0 Monocistronic smORF Other Cytoplasmic Mitochondrial protein dimerisation activity
CG33714 90 0 Monocistronic smORF Reticular Mitochondrial stem-loop-interacting RNA-binding protein
CG12384 96 0 Monocistronic smORF Cortical F-actin Death-Associated protein1 (DAP1)
CG34200 52 0 Monocistronic smORF Limited Unknown unknown function
CG11686 70 1 Monocistronic smORF not tagged Unknown unknown function
A* A B C D F
5 6 1 3 5 3
52% 13% 35%
Positive mitochondrial 
hits in the screen 
False 
Positives False Negatives
smORFs tested 
in RNAi screen
 (37)
Mitochondrial 
Localisation data 
(23)
smORFs with 
phenotype 
(15)
Negatives 
(14)
False 
Negative 
mitoSEPs (8)
False 
Positives 
(3)
Functional 
mito-SEPs
(12)
A B
C
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smORFs did not cause a mitochondrial stress response, it implies that either the RNAi 
duplex is inefficient or that there is redundancy between these mitochondrial SEP’s and 
other  peptides.  The latter  does  not  seem to  be  the  case  with  CG14482,  which is  a 
subunit of cytochrome c, an essential component of the electron transport chain; if it 
were  being  effectively  knocked-down,  it  would  most  likely  show  an  effect  in  the 
mitochondrial morphology screen. It may also be the case that the mitochondrial SEPs 
which did not show an effect in the mitochondrial morphology screen, are not needed 
for  normal  mitochondrial  function but  their  requirement  is  heightened under  certain 
conditions  such  as  stress.  Another  possibility  is  that  the  effect  of  knocking  down 
mitochondrial ribosomal sub-units CG33155 and CG44242 may take a longer time to 
manifest. Analysis of amino acid lengths between the different groups (RNAi Screen 
hits, False positives and False negatives) shows that there is no significant difference 
(P=0.3128) between the functional  mito-SEPs (Average=79.69 ± 2.876aa) and False 
negatives (mitochondrial localised SEP’s with no phenotype (Average=66.38±5.487aa) 
in regards to amino acid length. There is a significant difference (P ≤0.01) between the 
amino acid lengths of the functional mito-SEPs and the amino acid lengths of the screen 
‘Negatives’ (Average=58.81±7.102aa), which indicates the robustness of this screen as 
it shows there is a distinct difference between the set of smORFs which are functional, 
or  should  be,  and  those  that  are  not. Whether  or  not  a  SEP contains  a  predicted 
transmembrane alpha helix does not seem to suggest mitochondrial function, as only 
40%  of  the  functional  mito-SEPs  have  transmembrane  alpha  helix  prediction  as 
compared to 63% in the ‘real negative’ SEPs. The subcellular distributions of all the 
Real negatives in the screen are either Other cytoplasmic, Limited, or unknown with the 
exception of CG33774 which was found to localise to mitochondria. A few of them also 
contain Signal Peptide motif predictions from TargetP (Figure 5.13C).  The clear-cut 
differences between hits  and non-hits in this screen indicates that  the Mitochondrial 
morphology RNAi screen is a reliable assay for detecting the function of peptides that 
are involved specifically in mitochondrial function. 
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Figure 5.13: False-Negatives and Negatives in the mitochondrial morphology RNAi 
screen A) Summary table showing different properties of the False-Negative smORFs 
in the RNAi screen showing SEP length, alpha helix prediction, smORF class, 
subcellular distribution, localisation and any GO terms. B) SEP length analysis of 
Functional mito-SEPs (RNAi screen hits), False-Negatives and Negative classes. There 
is a statistically significant difference between the peptide lengths of Functional mito-
SEPs (79.69aa ±2.876) and Negatives (58.81aa ±7.102) (P<0.01), and no significant 
difference between Functional mito-SEPs and False-Negative (66.38aa ±5.487) classes. 
C) Summary table showing the properties of the Negatives in this screen along with 
SEP length, alpha helix prediction, smORF class, subcellular distribution, localisation 
and any GO terms group of genes. 
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Gene ID aa length TMMHM Description Subcellular Distribution
Subcellular 
localisation
GO Term 
CR30055 2-53, 4-17, 
5-56
- lncRNA smORF Reticular + Limited Mitochondrial unknown function
CR32582 52 0 lncRNA smORF Reticular Mitochondrial unknown function
CG17680 97 1 Monocistronic smORF Unknown mTP (TargetP) Positive regulation of immune response
CG32276 64 1 Monocistronic smORF Reticular Mitochondrial Stress-associated ER protein
CG14482 57 0 Monocistronic smORF Reticular Mitochondrial cytochrome b-c1 complex subunit
CG44242 70 0 Monocistronic smORF Reticular Mitochondrial mitochondrial Ribosomal protein S36
 CG34242 58 1 Monocistronic smORF Reticular Mitochondrial unknown function
CG17278 80 0 Monocistronic smORF Reticular Mitochondrial unknown function
A
B C
Negatives in 
RNAi screen
aa 
length TMMHM
Subcellular 
Distribution
Subcellular 
Localisation GO Term 
pncr009 22/30/3
3
- Other Cytoplasmic + Limited Unknown unknown function
Rox2 38/17 - Limited Unknown unknown function
CG18622 94 1 Unknown Unknown unknown function
CG33170 71 0 Reticular Unknown unknown function
CG4101 87 1 Unknown Unknown unknown function
CG33774 40 1 Other Cytoplasmic Mitochondrial unknown function
CG33155 60 1 Limited Unknown mitochondrial Ribosomal protein L53
CG18343 99 2 Unknown Unknown unknown function
CG13784 67 2 Unknown SP(TargetP) unknown function
CG31360 98 1 Unknown Unknown unknown function
CG9669 78 2 Unknown SP(TargetP) unknown function
CG32248 82 1 Unknown Unknown unknown function
CG32267 49 1 Other Cytoplasmic Unknown unknown function
CG6770 69 0 Cortical F-actin Nuclear phosphoprotein p8, response to oxidative stress
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Discussion
The Poly-Ribo-Seq experiments conducted by our lab were performed in the Drosophila 
S2 cell line, which is derived from late-stage Drosophila embryos (Schneider 1972). 
The catalog of Poly-Ribo-Seq smORFs translated in our S2 cells gave us a candidate 
pool of genes to target using RNAi, as we had already observed that these smORF 
mRNAs undergo active translation. The independent proof of translation provided in 
Chapter IV also corroborates that these smORF genes are producing peptide products, 
which can localise specifically to distinct organelles. The use of RNAi in S2 cells, 
which is a method of Post-transcriptional gene silencing, could potentially be used to 
discern smORF function on a genome-wide level, since we now have a better 
understanding of  smORF translation at this scale.  
The previous chapter of this thesis described several smORF peptides being localised to 
the mitochondria. Mitochondria themselves contain a small circular genome containing 
mitochondrial DNA (mtDNA) and much of this mitochondrial genome encodes peptides 
from genes which are the size of SEPs (Lane and Martin 2010; Nunnari et al. 2012). A 
mammalian mitochondrion can contain over 1500 proteins, expressed in a tissue 
dependent manner. 13 of those proteins are encoded by mtDNA, which has reduced in 
size over the course of evolution due to gene transfer events to the host-cell nucleus. 
Therefore the maintenance and function of the mitochondria are heavily dependent on 
nuclear-encoded proteins, which are actively shuttled into mitochondrial compartments 
from the cytosol. Nuclear and mtDNA derived protein subunits are combined into 
macromolecular complexes, which perform the various roles of a mitochondrion 
(Schmidt et al. 2010).  
Drosophila mtDNA encodes 13 polypeptides involved in oxidative phosphorylation, 22 
tRNAs, and two ribosomal subunits (Garesse 1988; Torres et al. 2009;); therefore much 
of the mitochondrial proteome is encoded by nuclear genes in the fruit fly. Neurological 
and cardiac diseases, as well as metabolic syndrome, obesity and cancers can be linked 
to mitochondrial disfunction and have been investigated using the fruit fly as a model 
(Nunnari et al. 2012). In this chapter are described the results of two different RNAi 
screens that I conducted which led to the discovery of a unique way to screen for 
smORFs encoding functional peptides that may be playing a role in the mitochondria. 
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The mitochondrial morphology screen detects mito-SEP function 
Mitochondria are dynamic organelles that are constantly undergoing division and 
fusion. Most major regulators of mitochondrial dynamics are conserved from flies to 
humans. Cell death pathways are regulated through the mitochondrial fission/fusion 
machinery. By imaging mitochondria in S2 cells, a classification system was made to 
describe healthy and sick cells based upon the morphologies of the mitochondria. It has 
been well characterised that mitochondrial aggregation precedes a cell’s commitment to 
apoptosis (Haga et al. 2003; Haga et al. 2005) by treatment of cells with various 
apoptotic stimuli. Mitochondrial aggregation has also been attributed to genetic 
mutation of mitochondrial fission and fusion machinery (GandreBabbe and van der 
Bliek 2008; Ishihara et al. 2003; Qian et al. 2012). Interestingly, neurodegenerative 
diseases can be associated with mitochondrial translocation phenotypes. Parkinson’s 
neurodegenerative disease is known to be associated with mitochondrial defects of 
perinuclear clustering and there has been a race to characterise the other proteins that 
may be interacting with the parkin disease locus (Greene et al. 2003; Park 2009; Okatsu 
et al. 2010; Grünewald et al. 2010; DeCastro et al. 2011; Wang et al. 2012; Ivatt et al. 
2014; Norris et al. 2015).  
I decided to observe the effect on S2 cell mitochondrial morphology upon RNAi 
treatment of a small subset of smORFs from the list of S2 cell translated smORFs 
generated by the Poly-Ribo-Seq data. The majority of the pool of smORFs selected for 
this experiment had already been tested in the tagging-transfection assay, so we already 
had an indication of where these peptides may be functioning. We designed dsRNAs 
against several smORFs as well as various controls of cell death, and regulators of 
mitochondrial morphology. In this screen, I was able to establish the functionality of 
several smORFs by imaging RNAi treated S2 cells labeled with MitoTracker-Red to 
characterise the mitochondrial aggregation phenotype in order to compare smORF loss-
of-function phenotypes with the wild-type and diseased S2 cell mitochondrial 
populations.  
The experiment was verified by the positive controls DIAP1, reaper and 14-3-3, which 
had a significant effect on the morphology of mitochondria as reflected by the high 
proportion of abnormal mitochondria in these samples, especially that of DIAP1, which 
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is known to induce apoptosis upon knock-down. Reaper is an inducer of apoptosis when 
expressed at high levels, but it also plays a role in regulating mitochondrial fusion and 
can be found localised to the mitochondria (Thomenius et al. 2011), and is therefore 
justified to shows an effect in this screen. Knocking down 14-3-3ζ has been shown to 
have an effect on phagocytosis (Ulvila et al. 2011), but this screen also reveals the 
majority of the treated cells exhibiting mitochondrial aggregation upon 14-3-3ζ RNAi, 
showing that when a master regulator of the cell is knocked down, the mitochondria will 
be affected. 14-3-3ζ knockdown in human cell lines has been shown to reduce cell 
growth and confer sensitivity of cells to apoptosis, whilst over-expression of 14-3-3ζ 
can define a risk of breast cancer as it promotes cell survival (Neal et al. 2009).  
There is a high positive hit-rate for mitochondrial SEPs in this screen (12/23, 52%) as 
well as a high overall hit rate as 15 of the total 37 smORFs tested show a positive 
phenotype. Mitochondrial SEPs are highly enriched in the hit-list of the RNAi screen 
(80% of positive hit smORFs), which suggests that this screen directly reflects 
mitochondrial function. Therefore, it also emerged that the subcellular localisation of a 
smORF peptide is a precondition and hypothesis to be tested by the functional screen. 
That this screen more favourably detects phenotypes of mitochondrial SEPs, gives us an 
edge at determining which smORFs have a similar effect on mitochondria as proteins 
like DIAP1 and Drp1 which are directly related to apoptosis and mitochondrial 
function.  
Some of the positive hits in this screen could be playing very important mitochondrial 
roles. Drosophila mutants of NADH complex 1 exhibit phenotypes that resemble a 
mitochondrial disease called Leigh syndrome. This disease is associated with decreased 
lifespan, seizures, heat intolerance, movement problems and progressive 
neurodegeneration (Burman et al. 2014). It would be very interesting to see whether the 
SEP from the smORF CG32230, which is a subunit peptide of NADH complex 1 and 
therefore also integral to metabolism, is involved in the prognosis of these symptoms. 
Another hit in this screen, which supports this hypothesis is Tim10, which is encoded by 
the dicistronic transcript consisting of the two mitochondrial SEPs, CG9878/CG42497. 
Tim10 is known to function as an inter-membrane translocase that transports molecules 
from the outer mitochondrial membrane to various processing enzymes on the inner 
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mitochondrial membrane (Schmidt et al. 2010). This helps me to conclude that this 
screen is reliably detecting the function of annotated smORF encoded peptides with a 
high level of reproducibility across repeats, despite the double-blind method of analysis 
and scoring the phenotype.  
Knocking down Hemotin has quite a significant effect on mitochondrial morphology,            
even though there is substantial evidence to show that the Hemotin peptides are not 
generally found in the mitochondria. Hemotin contains a mitochondrial targeting motif 
(TargetP) in the peptide sequence, and Stannin has been found to localise to 
mitochondria in mammalian cells. This study shows that Hemotin may also be involved 
directly with the mitochondria, and this role has been previously unexplored by anyone.  
Another interesting hit that emerges in this screen is CG14036, which may be important 
as it can be traced back to a study conducted on a genetic interactor of the parkin gene 
(Cox and Spralding 2009). The Drosophila gene ‘clueless’ encodes a CluA orthologue 
that is 53% identical to Clu in human. Mutations in Drosophila clu elicits mitochondrial 
dysfunction and clustering in a fashion similar to parkin mutants. Clu null mutants have 
a decreased life span, sterility and mitochondrial abnormality in flight muscles. 
Drosophila Clu interacts genetically with parkin and CG14036 is shown to be down-
regulated in Clu heterozygous deficiency mutants (Cox and Spralding 2009). In my 
study, I have concluded that CG14036 deficiency also elicits a mitochondrial clustering 
response. As in the case with most of the hits in this screen, it may be that more 
mitochondrial SEPs are involved in the mitochondrial functional machinery, and by 
removing these smORFs may lead to mitochondrial phenotypes as severe as those found 
for canonical genes. Mutations in these smORFs would inevitably affect long term 
viability of the animal in which they are found, and could be involved in many 
pathways related to mitochondrial disease. 
Preliminary results from new Poly-Ribo-Seq experiments in our lab show that several 
smORFs translated in embryos overlap with those being expressed in S2 cells. The 
interesting fact about these overlapping smORFs is that they are expressed throughout 
embryogenesis (Personal communication MAS Mumtaz). The smORFs that are unique 
to translation in embryos are temporally regulated in their expression, and analysing 
those will most likely reveal smORFs involved in development and differentiation of 
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the embryo. As for the smORFs expressed throughout embryogenesis, their overall 
functions are probably involved in processing energy, cell survival, and overall cellular 
homeostasis. This is probably what the functions of S2 cell smORFs are related to, as 
these cells are not hindered by the patterning boundaries of the embryo or signalled to 
from other tissues to die or change, and their main purpose is to survive. In this way, 
cell lines are almost like tumours, as given enough media and time, they will grow until 
nutrients run out or when stress is applied experimentally.  
Though this assay was more time consuming than a generic cell viability assay 
conducted in a 96-well plate, it resulted in a large number of hits out of the small 
number of smORFs that were tested. This assay is robust and reliable at what could be 
considered a low N number for a typical cellular study which may employ automated 
imaging and high content microscopy to image hundreds of cells per repeat. In my 
screen, 50-100 cells were imaged per repeat and resulted in consistent and reproducible 
results. Therefore, this screen should be applied to the larger pool of translated smORFs 
in S2 cells because a potentially large proportion of these smORFs could be localised to 
the mitochondria. This screen could also theoretically be used to verify the effect of 
smORF over-expression on mitochondrial morphology in S2 cells using the tagging-
transfection method. This may lead to the discovery of other smORFs like Reaper, 
which, upon over-expression in S2 cells, leads to mass cell death (Thomenius et al. 
2011). 
The Alamar Blue assay does not detect smORF RNAi phenotypes 
The AB assay was conducted in order to observe whether knocking down of smORF 
peptide transcripts would result in a decrease in cell viability through measurement of 
cellular metabolism. Cell viability can be interpreted by comparing wild-type and 
mutant percentage reduction of AB reagent which is read by fluorescence signal derived 
from AB reagent incubated with the dsRNA-treated cells. AB is reduced by the 
Hydrogen transport molecules found in the mitochondrial matrix (NADH, FADH) 
which conduct a constant process that occurs in healthy cells. The severity of the 
smORF loss-of-function phenotype could then be assessed by comparing it to AB 
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reduction of samples treated with RNAi against known genes affecting cell viability, in 
this case DIAP1 and cdc2.  
At this stage, although we lacked the information of mitochondrial subcellular 
localisation and distribution of SEPs from the tagging-transfection assay, we did have 
the Poly-Ribo-Seq results showing that the smORFs tested in the AB assay were 
translated in our lab S2 cell population. The assumption that was been exercised at this 
at this initial stage was that these smORFs are probably not involved in ‘life or death’ 
processes as this would have led to discovery and investigation of these smORFs 
already. More likely, these smORFs are involved in homeostatic cellular processes, such 
as intracellular transport, like Hemotin, or transport of ions across membranes, such as 
Sarcolamban as they were expressed at high levels in a cell culture system. In this vein, 
AB appeared to be a good assay for smORF functional read-out, as knocking down 
proteins which shuttle nutrients or small molecules, would surely have an impact on the 
overall cellular metabolic process. However, the results from the AB experiment were 
difficult to discern.  
Knocking down DIAP1 by RNAi induces apoptosis (Wang et al. 1999; Steller 2008) 
and RNAi of cdc2 is known to decrease cell number (Björklund et al. 2006). Though 
knock-down of DIAP1 and cdc2 was verified by RT-PCR, the RNAi against these 
transcripts in the AB assay did not show a reproducible or significantly different change 
in AB reduction than the negative control and wild type samples. Though this may have 
been due to not choosing the correct positive controls to show an effect on the reduction 
of AB, and perhaps a better control would be one that effects the metabolic pathways 
directly. Cells treated with DIAP1 dsRNA, may have been respiring at wild-type rates 
despite the induction of apoptosis, but as DIAP1 is a commonly used positive control in 
cell viability screens, it should have technically shown some effect of a decrease in cell 
viability (Boutros et al. 2004). Since we observe knock-down of DIAP1, it is likely that 
cells in the DIAP1 RNAi sample are lowered in viability but the assay fails to pick up 
this change. In addition, two mitochondrial SEPs (CG32230 and CG7630) which show 
an effect in the mitochondrial morphology RNAi screen do not show an effect in the AB 
assay, even though CG32330 is annotated as a NADH complex 1 subunit. This dsRNA 
would target a direct metabolic function yet does not show an effect in the AB assay.  
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Even though the experiments were repeated with more dsRNA and longer incubation 
times to allow cells to show a significant effect of the knockdown of controls, the AB 
screen was not fruitful in detecting any of the smORFs tested as significantly functional. 
The two positive hits that come out in 2 or 3 repeats of the Pilot AB study do not have 
functions related to mitochondria, or cell death pathways according to their annotation, 
therefore I cannot conclude whether these are real hits or false positives in the screen. 
As we hoped to conduct the RNAi screen in a high-throughput fashion, it would not 
have been feasible to verify the knock-down of all the smORFs that were tested, 
therefore the AB screen was abandoned due to lack of success. However, I able to gain 
valuable knowledge from these experiments about the process of conducting an RNAi 
experiment and that the knock-down of controls is successful by this method in my 
hands. 
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Chapter VI - Discussion & Conclusions
smORF encoded peptides (SEPs) are gradually being shown to be involved in various 
physiological and developmental processes. DNA and RNA sequencing data has 
revealed that there is the potential for translation of hundreds or even thousands of 
smORFs in almost all multicellular model organisms, as well as in lower eukaryotes like 
yeast. Though some smORF genes are now being annotated as protein coding genes in 
genomes, SEPs are generally difficult to detect due to the limitations of standard 
biochemical techniques, leaving them largely uncharacterised in terms of their broader 
functions.  
The current definition of a smORF gene is characterised by the presence of one or more 
ORFs in it’s transcript that is 2-99 codons in length,  thereby encoding a peptide which 
is <100 amino acids (Basrai et al. 1997). Given that there are hundreds-of-thousands of 
smORFs present in most genomes that may potentially encode functional peptides 
(Basrai et al. 1997; Ladoukakis et al. 2011), it is essential to differentiate between 
smORFs that are translated and those that are not. Due to low rates of peptide detection, 
it is not yet well understood whether all of these smORF sequences are translated. 
However, examples exist in Drosophila of functional SEPs as small as 11 or 29 amino 
acids that play key roles in the development and physiology of the fruit fly (Galindo et 
al. 2007; Magny et al. 2013). The implementation of Poly-Ribo-Seq in Drosophila S2 
cells allowed us to asses which smORFs are translated in S2 cell transcriptome (Aspden 
et al. 2014). This study showed that annotated smORFs are translated in a similar 
proportion as standard protein coding genes (~85%), therefore we ended up with a list 
of at least 228 SEPs for which we need to ascertain function. This number exceeds the 
scope of the single-gene genetic analysis and in-depth characterisation approach used by 
our laboratory in whole organism studies. 
The hypothesis tested in this thesis is whether smORF functionality can be assessed at 
the cellular level, which would provide a new method by which to assess SEP functions 
at higher throughput than the single-gene studies used previously. The results reported 
here show that this is indeed possible and that by studying subcellular localisation and 
loss-of-function phenotypes in cell culture, we can start to identify the specific functions 
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of a larger number of SEPs. This study brings forward novel functional data on a 
significantly larger number of Drosophila SEPs than has ever been collectively studied 
before. 
The Hemotin SEP is involved in intracellular trafficking 
My investigation into smORF function at the cellular level began with hemotin, 
(Chapter III) which is a dicistronic smORF gene that encodes two peptides of 88aa 
(ORF1) and 59aa (ORF2) in size. Other members of our lab characterised the temporal 
expression of hemotin through semi quantitative RT-PCR, to show increased expression 
at the developmentally significant pupal stage and in adult flies. In embryos, in situ 
hybridisation showed that the pattern of expression of hemotin mRNA was similar to 
that of haemocyte markers, suggesting that Hemotin could play a role in haemocytes. In 
Haemocytes are actively involved in early Drosophila development in addition to their 
better characterised later functions in the immune system. Haemocytes are highly 
phagocytic and motile cells, which perform chemotaxis during wound healing and in 
response to infection (Wood and Jacinto 2007; Moreira et al. 2011). Since hemotin 
mRNA can be detected in embryonic haemocytes, they were used as the system in 
which to study the function of this SEP. These cells were an ideal system to study the 
function of Hemotin, as they can be assayed both in vivo and ex vivo .  
In order to prove that hemotin is present at the protein level, I attempted to detect the 
Hemotin peptide using some of the different approaches discussed below. On the 
expectation that Hemotin is expressed and functioning in haemocytes, a UAS-Hemotin-
GFP fusion protein plasmid was used to explore the subcellular localisation of Hemotin 
peptides with haemocyte-specific GAL4s to target the expression of this construct. This 
expression was readily detected by labelling with GFP specific antibodies, showing that 
the hemotin ORF1 is capable of producing a stable peptide product. I also attempted to 
detect endogenous expression of Hemotin in embryos and L3 and WPP haemocytes 
using a polyclonal antibody raised against Hemotin. Fluorescent antibody staining was 
used to verify endogenous Hemotin expression in embryos, and to test whether it can be 
detected in ex vivo haemocytes extracted from the animal at life stages where expression 
of the hemotin transcript has been detected by RT-PCR, and RNA-Seq by the 
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modENCODE project (L3 and WPP). Persisting signal from the antibody in the 
negative control samples (Hemotin null-mutant embryos and haemocytes) reinforced 
prior suspicions by our lab that antibodies raised against smORF peptides are generally 
inefficient. Direct antibody labelling has proven to be an experimental method that fails 
to detect endogenous smORF-encoded peptides. In the case of tarsal-less, the specific 
antibody also did not detect the endogenous peptide, but did manage to detect the much 
larger Tal-GST fusion protein. In the case of Hemotin, the Hemotin antibody staining 
did not colocalise to the signal from Hemotin-GFP expressed in haemocytes. Although 
this prevents us from knowing whether endogenous Hemotin protein is found in any 
other organs in the fly, the use of the tagged-construct provides proof of translation of 
Hemotin-ORF1 (CG43194). This also allowed us to move forward in characterising the 
function Hemotin performing in haemocytes through alternative techniques. 
Using the Hemotin-GFP fusion protein, I carried out colocalisation analysis with 
antibodies and markers of ER, Golgi and transport vesicles (anti-KDEL), mitochondria 
(anti-GRP75) and acidic organelles such as Lysosomes and lysosome precursors 
(LysoTracker-RED). These experiments revealed that Hemotin-GFP colocalises 
strongly to KDEL and Lysotracker at both L3 and WPP stages. This suggests that 
Hemotin is performing a role in intracellular trafficking or endocytosis based on the 
knowledge that these are the main functions related to the organelles where Hemotin-
GFP localises in haemocytes.  
This discovery led to a series of phenotypic studies to confirm the role of Hemotin in 
these processes. In order to achieve this, I had to search for a phenotype related to these 
functions in haemocytes in which hemotin is removed from the flies using genetics. If 
this phenotype occurs specifically due to the lack of Hemotin being expressed, it can 
then be used to find the pathways or interacting partners of Hemotin function by 
comparing Hemotin mutant phenotypes to wild type animals or known mutants of that 
specific function. A Hemotin-deficiency mutant (Df A4) was created by E.G. Magny, 
who had observed that flies develop into morphologically wild-type looking adults 
under normal growth conditions. With no overt phenotype related to the hemotin 
mutation, more in-depth work was required to discern the function of this smORF.  
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The following work was conducted to see what would happen to the functioning of 
haemocytes in the absence of Hemotin expression. The target of these assays were the 
processes of intracellular trafficking or immunity, which could be related to the possible 
functions of a peptide localised to KDEL and Lysotracker-specific organelles in 
haemocytes. First, I conducted viability studies to see whether these flies have similar 
life-spans to wild type flies. Df A4 flies have decreased viability at late adult stages and 
this effect is exacerbated upon infection with a large load of inert bacteria. Wild type 
flies survive this non-pathogenic bacterial immune challenge and live almost as long as 
untreated flies. Df A4 homozygous flies begin to show signs of trouble much earlier 
than wild type flies. This result supports a role for Hemotin in the correct functioning of 
haemocytes in immunity.   
The phagocytic/endocytic role of haemocytes is not just needed for immunity but comes 
into a developmental context for the clearance of apoptotic cell debris during embryonic 
and pupal stages (Wood and Jacinto 2007). These stages are characterised by the 
differentiation and re-modelling of body tissue as various organs are prepared for the 
next stage of life, therefore many cells undergo apoptosis at these times and leave 
behind cellular debris. Imaging the haemocytes in live embryos and pupae of Df A4 
mutants revealed that there are significantly larger vacuoles, or cellular inclusions, in 
hemotin deficient haemocytes. Live-imaging of pre-pupal haemocytes cultured ex vivo 
revealed that these cells contain significantly larger Lysotracker-labelled organelles than 
wild type pre-pupal haemocytes. Lysotracker labels late-endosomes and lysosomal 
compartments in the cell that have an acidic pH due to the acidifying enzymes 
responsible for breaking down phagocytised material in haemocytes (Watts 2012). In 
hemotin mutants, larger lysosomes persist in size, while wild type cells display a cyclic 
increase and decrease of lysosomal size in the same length of time. These data support a 
role for Hemotin in endocytosis and intracellular trafficking, along with the 
colocalisation of Hemotin-GFP to Lysotracker and KDEL markers. 
Ex vivo characterisation of hemotin mutant haemocytes could help to provide an easily 
quantifiable phenotype for Hemotin. This study shows that hemotin mutant haemocytes 
display a largely non-motile population of cells at WPP stage, unlike wild type cells 
which are mostly motile at this stage. Previous characterisation of  haemocytes showed 
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that they are active at this stage and display directional motility (Sampson et al. 2013). 
A non-motile profile has been observed in haemocytes that are mutant for cytoskeleton-
regulators and phagocytic pathway genes. These cells cannot move because they 
struggle to recycle internalised membrane from phagosomes to the cell edge in order to 
extend filopodia and lamellipodia (Velichkova et al. 2010; Sampson and Williams 
2012). The hemotin mutant cellular profile could only be partially rescued by expressing 
UAS-hemotin-ORF1 and UAS-hemotin-full length constructs with haemocyte-specific 
GAL4s in the null mutant background. It was later found that this motility phenotype 
could also be attributed to the removal of another gene (CG7691) in the hemotin-null 
(Df A4) line (C.J. Sampson). As the non-motility of hemotin mutant haemocytes was not 
exclusively due to loss of Hemotin, it explained why only a partial rescue of the 
phenotype could be observed by expressing hemotin in a null background. Therefore we 
could not use this  assay as a test for Hemotin function.  
Based on the colocalisation studies, the large vacuoles in mutant embryo and pupal 
haemocytes, and the large lysosomes in ex vivo haemocytes, the focus remained on the 
role for Hemotin in intracellular trafficking,. Work done by J.I Pueyo in the laboratory 
using ex vivo cultured haemocytes showed that the enlarged vacuole phenotype is 
specific to Hemotin by rescuing expression of hemotin in a null background (A4 Df). 
The decrease in viability after infection shows that there is a role for Hemotin in overall 
immunity of the fly, and that this is not attributed to CG7691 (Chapter III; Figure 3.7). I 
postulate that by removing Hemotin, we hamper intracellular trafficking, which in turn 
leads to the cell being overwhelmed and unable to digest pathogens that have been 
phagocytised. There is no obvious developmentally relevant morphological phenotype 
of Hemotin in the fly but studying it at a cellular level has led us to understand the 
function of this SEP. The role of Hemotin would be important in any cell type which is 
capable of performing endocytosis, especially in times of infection or when the cells are 
undergoing apoptosis, as intracellular trafficking mediates the removal of the by-
products of these processes. 
Running the peptide sequence of Hemotin through a homology-prediction software 
called PHYRE2 revealed a putative homologue for Hemotin called Stannin (Snn). Snn 
is an 88aa peptide similar to HemotinORF1. J.P. Couso has confirmed by sequence 
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alignment of this peptide across different phyla that the Hemotin peptide is conserved 
from Drosophila to mammals. Stannin was isolated from organotin toxin Trimethyltin 
(TMT) exposed cells in rat brain tissue (Toggas et al. 1992). Snn-FLAG fusion 
constructs expressed in rat cell lines showed that Snn colocalises to mitochondria and 
endoplasmic reticulum markers. Snn has also been isolated from the peroxisomal 
fraction of mammalian cells. Snn can be found (from high to low levels) in the spleen, 
brain, midbrain, kidney and lungs. It is widely expressed in the developing rat embryo 
then localises to the spleen and immune cells in the adult (Toggas et al. 1992; Dejneka 
et al. 1997). TMT exposure causes cell death specifically in cells that express this 
peptide and in this way, Snn confers toxin-sensitivity upon the tissue in which it is 
expressed. Snn expressing cells show increased vacuole formation in tubular epithelial 
cells. When lymphocytes lack Snn, this impairs immune function, causes splenic 
atrophy and results in altered cell cycle kinetics in mice (Billingsley et al. 2006). This 
indicates that there may be functional homology between Snn and Hemotin through 
vacuole formation and immunity.  
Stannin expression is up-regulated by the cytokine TNF-alpha, which is expressed in 
human cell lines and tissue upon stress and inflammation (Horrevoets et al. 1999). The 
peptide sequence of Snn contains a conserved CXC metal-binding motif (cytokine 
receptor) as well as a putative 14-3-3ζ binding domain. 14-3-3ζ is a soluble, dimeric 
protein with known binding to the RXS+(pS/G)XP and RSESEE motif, which is found 
in the Snn peptide sequence. 14-3-3ζ co-immunoprecipitates with Snn-FLAG expressed 
in PC-12 rat cells, showing that these peptides are interacting physically (Davidson et 
al. 2005). Hemotin-GFP overlap to a pan-14-3-3 antibody could be observed in my 
experiments, supporting the homology between Hemotin and Snn. Full functional 
analysis has now characterised the interaction between 14-3-3ζ and Hemotin (Pueyo et 
al. 2016, in press). Hemotin represents yet another smORF peptide characterised in 
Drosophila that acts as a regulator of a specific process (endocytosis) by interaction 
with a larger molecule (14-3-3ζ) in a specific tissue (haemocytes), similar to 
Sarcolamban which interacts with SERCA in heart muscle (Magny et al. 2013). The 
study of Hemotin function shows that a lack of an overall body morphology phenotype 
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does not equal to a lack of smORF functionality at the cellular level, which was the case 
for Sarcolamban as well.  
Understanding the functional role of a smORF by using fly genetics is currently 
dependent on the ability to detect the peptide in a particular tissue or developmental 
stage, such as haemocytes, and then characterise the loss-of-function phenotype in 
processes related to those clues, such as immunity or phagocytosis in this case. In 
addition to the challenge of defining smORF peptide translation, the wide range of 
functions (as seen by GO term analysis of translated smORFs) (Ladoukakis et al. 2011; 
Aspden et al. 2014) predicted for smORFs means that straightforward, high-throughput 
genetic analysis was not considered possible. However, by attempting smORF 
functional characterisation in cells and then using the information gathered to explore 
their function in the fly, can facilitate a more in-depth characterisation of SEP function 
on a wider scale.  
Subcellular localisation of Poly-Ribo-Seq smORF peptides reveals mito-SEPs 
The tagging-transfection assay (Chapter IV) corroborated the translation of the entire 
pool of smORFs tested (45 smORFs), which is 20% of the total high-confidence 
smORFs found translated by Poly-Ribo-Seq (228) in S2 cells. The tagging-transfection 
assay used heterologous gene expression in S2 cells to express FLAG-tagged smORF 
DNA under the actin 5c promoter. This method is considerably convenient to conduct in 
tissue culture, as it only requires the mixing of DNA and cells in the media. Creating a 
transgenic fly line with a fusion construct plasmid requires much more work, and three 
generations must pass before experiments can be conducted. Embryos must first be 
injected with the UAS construct, and then a stable fly line is created by mapping the 
insertion to a chromosome in order to further cross it to flies containing  specific GAL4s 
to drive expression of the construct. Transient cell transfection bypasses all these steps 
by allowing transfection and assays to be conducted on a single population of cells in a 
plate. Given the challenge of generating efficient antibody against SEPs, alternative 
methods such as these have been used so far provide proof of translation and label the 
peptide (Galindo et al. 2007; Magny et al. 2013; Slavoff et al. 2012; Vanderperre et al. 
2013; Slavoff 2014;). 
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The use of fluorescent imaging to detect the presence of FLAG-tagged peptide in the 
cells provided an opportunity to visualise the subcellular distribution and localisation of 
the SEPs. I observed four distinct categories of SEP distribution: ‘Reticular’, ‘Cortical’, 
‘Limited’ and ‘Other cytoplasmic’. This variety supports the robustness of the tagging-
transfection assay to assess SEP localisation and shows that this method is probably not 
creating an artifactual bias to localisation. Categorising tagged-SEPs into subcellular 
distribution classes allows a quick preliminary assessment of potential localisation of 
SEPs, and could be used as an initial tool for assessing smORF function in a semi-high-
throughput manner. The largest group of subcellular distribution are the ‘Reticular’ 
SEPs, which localise completely to the mitochondria (Colocalisation to MitoTracker-
Red, Chapter IV). ‘Other cytoplasmic’ SEPs also show a medium level of colocalisation 
to the mitochondria, and have Mander’s coefficients similar to Sarcolamban-ORFA 
(Scl-A) in this experiment. The ‘Other cytoplasmic’ SEP’s have similar subcellular 
distributions to Scl-A, which suggests that they could be localised to the ER. The 
perceived overlap to MitoTracker could be due to the close-knit juxtaposition of the ER 
and mitochondria in S2 cells. ‘Cortical’ SEPs could be observed to localise near the 
plasma membrane edge of the cell, where filamentous actin forms a scaffolding around 
the cytoplasm. ‘Cortical’ SEPs show a partial overlap to F-actin at the edge of the 
cytoplasm, but the average pixel-to-pixel overlap of these SEPs to Phalloidin-
Rhodamine was too low to conclude that they are  predominantly found at the F-actin 
periphery. This shows that not all of the peptide is localising to the cell edge, but could 
also be involved in another cytoskeletal-associated or intracellular capacity. For 
example, in this assay both tagged ORFs of Hemotin appear to be Cortical SEPs, but I 
and others have shown that the role of Hemotin is in intracellular organelles. This raises 
the question of whether the high levels of expression due to the the actin 5c promoter 
may be distorting the localisation of ‘Cortical’ SEP’s by spreading their expression 
beyond their actual sites of wild-type function, which may also mean that the amount of 
expression of the other tagged-SEPs may be similar to this scenario. ‘Limited’ SEPs 
show colocalisation to F-actin at similar levels to ‘Cortical’ SEPs, though their observed 
subcellular localisation is very different to the eye. Studies on the ‘Limited’ SEP’s 
should be followed up by quantifying co-localisation with internalised membrane 
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markers such as FM464, to show whether or not this is true. The partial overlap of 
‘Limited’ smORFs to F-actin could be because these SEPs are in intracellular vesicles 
and they may have a role in digestion.  
Amino acid length distributions of the different subcellular distribution classes showed 
that ‘Reticular’ and ‘Cortical’ SEPs tend to be near the upper-limit of SEP size (>50 
amino acids), whilst ‘Other Cytoplasmic’ smORFs have a wide distribution of amino 
acid lengths. ‘Limited’ smORFs are distinctly smaller in size than all the other 
distribution types and most of the ‘Limited’ SEP’s are derived from smORF sequences 
found within ncRNAs. It would be interesting to test whether the amino acid length of 
an SEP can predict the subcellular distribution of SEPs, using a size-selected sample of 
smORFs from the translated pool. The amino acid sizes of Limited SEPs falls at the 
range of what are called ‘dwarf smORFs’ which are approximately 20aa. Dwarf-
smORFs are predominantly found in 5’UTRs and ncr_ORFs. They are not well 
conserved and there is generally no bioinformatic indicators of peptide function 
(Aspden et al. 2014).  
As the Reticular smORFs were over-represented in the tagged-smORF pool, they 
became the focus of further functional characterisation. The overlap of Reticular SEPs 
to the mitochondrial marker MitoTracker-Red was even higher than the overlap between 
the positive control (UAS-mito-GFP expressed in haemocytes) and MitoTracker dye. If 
the results of the tagging-transfection assay are extrapolated to the larger pool, it 
appears that a very large proportion of S2 cell SEPs have mitochondrial localisation 
(44%). This is more than the proportion of canonical mitochondrial protein-coding 
genes, which are placed around 10-15% of total protein coding genes (Neupert and 
Herrmann 2007). GO term molecular annotations of the Poly-Ribo-Seq smORFs show 
an enrichment of catalytic activity (oxidoreductase) and transmembrane transporters, 
though the number of SEPs with annotation is low (Aspden et al. 2014). It is possible 
that Poly-Ribo-Seq smORFs actually contain very high numbers of mitochondrial SEPs, 
but TargetP (Emanuelsson et al. 2007) only accurately predicted these half of the time 
when compared to experimental verification by the tagging-transfection assay.  
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Subcellular localisation to functional assessment   
Understanding why so many smORFs are mitochondrial can place us one step ahead in 
characterising the important cellular function of SEPs, but in order to do that, we need 
confirmation of which smORFs actually elicit a mitochondrial stress response when 
they are removed from the cell. Therefore, it would be beneficial to know whether they 
localise to the inner or outer mitochondrial membranes. Even though both the inner and 
outer mitochondrial membranes are composed of a phospholipid bilayer, they are 
unique in protein composition and permeability, which relates to their distinct functions. 
Conventional laser confocal microscopy does not provide enough resolution to 
determine whether these peptides are embedded in the membranes of these organelles, 
but it could be very likely that some SEPs are localised there. The outer mitochondrial 
membrane (OMM) has a 50/50 ratio of proteins to phospholipid, whilst the inner 
membrane (IMM) is composed mainly of proteins (80%) (Krauss 2001). The OMM is 
permeable to ions and peptides of about 50aa and smaller (Lodish 2008; Park et al. 
2010). The median length of our Reticular SEPs is higher than this 50aa limit 
(66.79±22.19aa), showing that most of the Reticular SEPs cannot just passively diffuse 
into the mitochondria from the cytosol and must be localised there for a specific 
purpose. Required molecules that are larger than 50aa are actively transported to the 
inner membrane by Voltage Dependent Anion-selective Channels (VDAC) porins of the 
OMM (Young et al. 2007). Porins are conserved from bacterial to eukaryotic cells and 
studying them has revealed a common structurally property of VDAC porins; they 
consist of B-barrel structures and generally lack membrane-spanning alpha helices. 
Porins also allow the exchange of small molecules and ions like NADH and ATP across 
the OMM (Young et al. 2007; Park et al. 2010).  
The IMM has very low permeability for ions and molecules, allowing for the discrete 
separation of the cellular cytoplasm and the mitochondrial matrix, where electron and 
proton transport occur and a membrane potential is required for cellular metabolism. 
The IMM contains the OXPHOS enzymes and ion transporters to only allow specific 
molecules to cross the IMM, such as the nuclear-encoded phosphate-OH2 exchanger, 
the adenine nucleotide translocase (which exchanges ADP for ATP) as well as fatty acid 
transporters and aspartate/glutamate shuttles (Krauss 2001). Our tagged-smORF pool 
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contains three annotated SEPs which have GO terms that place them on the inner 
membrane: Tim10 peptides CG42497 (65aa) and CG9878 (92aa) are part of an inner 
membrane translocase complex and CG32230 (83aa) is a NADH dehydrogenase 
subunit. Another interesting common feature of these SEP’s is that they contain 
transmembrane alpha-helices and it could be possible that they play a role similar to the 
79aa MTGM (mitochondrial targeting GxxxG motif) SEP recently characterised in 
mammals and conserved throughout eukaryotes. MTGM is a mitochondrial inner 
membrane protein, and contains a transmembrane alpha-helical domain (Zhao et al. 
2009). The expression of this peptide increased reactive oxygen species (ROS) levels 
and caused DNA damage. MTGM depletion results in elongated mitochondria, 
decreased cell proliferation and resistance to apoptosis upon staurosporine exposure. 
The expression of this SEP confers a type of sensitivity to stress factors in the 
mitochondria, and regulates mitochondrial dynamics for optimal growth of both human 
brain tumour cell lines and tumour tissues (Zhao et al. 2009). The 63aa mitochondrial-
located SEP, Boymaw also seems to perform a similar role in cells, where the SEP 
translated from ORF3 is translocated to the mitochondria after increased expression 
during stress (Ji et al. 2015). In the mitochondria, Boymaw inhibits oxidoreductase 
activity in order to promote cell survival. The small size of this peptide allows it to be 
quickly degraded after permissive levels of stress are achieved. Few SEP’s have been 
previously linked to be directly impacting the function of mitochondria in Drosophila, 
but the precedence in mammalian cells makes the study of more mito-SEPs very 
valuable.  
Mitochondria are very complex organelles and there are still many processes that occur 
on or inside the mitochondria that are not yet completely understood. Besides their 
primary role in energy production, mitochondria can serve as reaction centres for signal 
transduction of cell survival, death and proliferation (Tait and Green 2012). This makes 
sense as they are constantly monitoring the external and internal energy requirements of 
the cell. Mitochondria cannot be created de novo and each cell in an organism inherits 
mitochondria from predecessor cells, which themselves have been donated by the 
maternal parent (Jornayvaz and Shulman 2010). This has implications related to 
longevity and ageing as well as stress and infection, and older mitochondria are known 
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to cause a decrease in viability (Finkel 2015). Mitochondria dynamically respond to 
stress, and mitochondrial stress can be elicited by a variety of stimuli, such as 
toxification by paraquat (Ivatt et al. 2014), chemotherapy drugs, UV irradiation, Ca2+ 
misregulation (Frieden et al. 2004), starvation (Rambold et al. 2011), inhibition of 
cytoskeletal dynamics and a variety of genetic factors (Park et al. 2010; Westermann 
2010; Westrate et al. 2014; Zemirli et al. 2014; Norris et al. 2015). Tubular elongation 
and clumping protects the mitochondria from autophagy and preserves mtDNA while 
still allowing respiration to occur in times of duress (Rambold et al. 2011; Gomes et al. 
2011). When the stress is removed, the system should potentially return to normal. 
However, when the stress is prolonged, as it would be in the case of a genetic disease, 
this translocation response of mitochondria eventually leads to increased generation of 
oxygen radicals from oxidative stress (Redpath et al. 2013) leading to mtDNA damage. 
Eventually, this results in decreased ATP production as enzyme subunits encoded by 
mtDNA would not be efficiently translated. ATP is required for the continued function 
of all the other organelles in the cell. In neurodegenerative diseases, this could 
potentially lead to the accumulation of mis-folded proteins due to lack of available 
energy to remove them, which result in the plaques that are observed in neurons (Chen 
and Chan 2009). These plaques are the cause of synaptic loss in patients suffering from 
neurodegenerative disease, and mitochondrial dynamics can be related to several 
neurodegenerative diseases (Chen and Chan 2009; Su et al. 2010; Itoh et al. 2013). No 
matter what the organ, if imposed factors lead to mitochondrial stress in a certain tissue, 
it would eventually cause damage to that organ through the effect on mitochondria. 
When enough damage has been done to mitochondria and mtDNA to push the cells over 
the edge, mitochondrial fission occurs, leading to the release of apoptotic factors, which 
signal the transcription of cell death factors such as reaper, and leads to cell death(Suen 
et al. 2008; Westermann et al. 2010; Westrate 2014).  
The discovery of several mito-SEPs made us question which specific characteristics of 
these peptides may cause them to localise to this organelle. As so many mitochondrial 
functions occur on membranes, it could be possible that SEPs are found in the 
mitochondrial membrane, acting as regulators of larger proteins, such as Sarcolamban 
or Hemotin. Approximately 30% of the total pool of tagged-smORFs contain high 
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confidence TMHMM alpha-helix predictions and overall, 32.3% of the Poly-Ribo-Seq 
translated smORFs have one or more predicted transmembrane alpha-helices, similar to 
the proportion of TMHMM in the total annotated FlyBase smORFs (32.2%). CG32230, 
CG7630, CG32276, CG34242 and  the  dicistronic CG15386 and CG9878 (Tim10) are 
mito-SEPs with TMHMM motifs. However, there are 2 examples of annotated mito-
SEPs that localise to the mitochondria, but do not contain a predicted alpha-helix, 
namely CG14482 (57aa), a cytochrome b-c1 complex subunit which would potentially 
be found on the IMM and CG44242 (70aa), a mitochondrial ribosomal subunit, which 
would reside in the mitochondrial matrix. In addition, there are mito-SEPs with no 
TMHMM or functional prediction: CG33199 (79aa), CG33714 (90aa), CR43250 
(73aa), CR43144 (91aa), CG14036 (93aa), CG14014 (68aa), CR32582 (52aa), and the 
dicistronic CG15386 (77aa) and CG42371 (87aa). Though subcellular localisation does 
indicate where these SEPs are found, there are very few other indicators of what 
function these latter mito-SEPs are involved in. Their sizes show that they cannot 
passively diffuse across the OMM, so they are probably playing a specific role in the 
mitochondria, but this needs to be verified by further functional testing.  
Mitochondrial morphology RNAi screen reveals Functional mito-SEPs 
The results from the tagging-transfection assay allow us to focus functional screening 
on specific cellular processes in which they may be involved. This led to the targeted 
testing of the function of these S2 cell Poly-Ribo-Seq translated smORFs in the 
mitochondria of S2 cells. The dynamic nature of mitochondria can be used as a 
reflection of the internal state of cellular health. Since the mitochondrial aggregation 
phenotype could be observed in our S2 cells, and so many of the tagged SEPs localised 
to the mitochondria I decided to design a screen based upon the mitochondrial stress 
response (Chapter V). Oxidative stress has been shown to lead to mitochondrial 
perinuclear clumping in cells (Redpath et al. 2013). The RNA-interference method 
degrades mRNA transcripts, leading to an indirect decrease in the peptide product of a 
target gene. This method became viable for the testing of smORF function after 
obtaining proof of translation of smORFs through Poly-Ribo-Seq (Aspden et al. 2014) 
and the tagging-transfection assay described in this thesis. Using the pool of tagged-
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smORFs as a starting point, several dsRNAs were designed to knockdown expression of 
these smORFs.  
This key phenotype exhibited by mitochondria under stress, is generally referred to as 
mitochondrial hyper-fusion or aggregation (Tondera et al. 2009). By screening for 
mitochondrial aggregation phenotypes after smORF RNAi, I hoped to see the effects of 
smORF knockdown on the organelle where so many are localised to and may be 
functioning in. The mitochondrial aggregation phenotype could be observed in our S2 
cells at a basal level in about 12–20% of the cells that were imaged from wild type 
samples. The induction of a non-specific RNAi response by targeting the BlueScript 
plasmid resulted in mitochondrial phenotypes similar to dsRNA-untransfected cells. 
Positive controls of cell death, such as DIAP1 and reaper (inhibits mitochondrial 
fragmentation; 68aa SEP (Thomenius et al. 2011)), caused levels of abnormal 
mitochondria to rise to a significantly higher level when compared to negative-control 
treated cells. Several major regulators of mitochondrial dynamics have been identified 
and the key players in these processes have been studied in high detail (Karbowski  and 
Youle 2003). Knocking down one of these major regulators, Dynamic-Related-Protein 
(Drp-1), is known to induce a mitochondrial hyper-fusion response (Qian et al. 2012). 
This was also the case in my screen, as the dsRNA designed against Drp1 raised the 
level of aggregated mitochondria to more than 60% of the imaged cells in these 
samples, offering a reliable positive control in the screen. RNAi against 14-3-3zeta, a 
major regulator of the cell cycle and intracellular trafficking resulted in similar 
phenotypes to dsRNA-Drp1. This duplex is targeted to a region common to all the 
isoforms of 14-3-3 which would also be very detrimental to the cell.  
Now that an upper and lower limit of mitochondrial aggregation phenotypes had been 
established, the results from knocking down smORFs could be interpreted. Of the 37 
smORFs tested in this screen, 15 showed a significant mitochondrial phenotype when 
compared to dsRNA-BlueScript treated cells. The effect on mitochondria may be due to 
knocking down SEPs that contain a TMHMM prediction, which could compromise 
membrane integrity of the mitochondria as opposed to having a direct effect on 
mitochondrial function. However, the opposite is true, of the positive hits in the screen, 
43.47% contain TMHMM predictions; while 81.81% of the negatives in the screen 
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contain TMHMM predictions. We can clearly observe that there is an enrichment of 
mito-SEP hits in the positive hits of the screen as 12 of the 15 positive hits have some 
evidence of mitochondrial localisation. Together, this information supports the idea that 
this screen is not biased towards smORF peptides which contain TM-alpha helical 
structures. Taken along with the fact that 80% of the hits are mito-SEPs, we can 
conclude that this screen detects mitochondrial morphological phenotypes as a direct 
response of removing mitochondrial-associated SEPs. This result is supported by 
examining the known data for these ‘Functional mito-SEPs'. ORF2 of the CG42497/
CG9878 dicistronic smORF transcript is annotated as Tim10 and the Tim9-Tim10 
complex is responsible for the transfer of peptides through the mitochondrial inter-
membrane space (Schmidt et al. 2010). Knocking down this transcript must have a 
direct effect on an important mitochondrial peptide, and the strong phenotype of RNAi 
against Tim10 is an internal proof of concept for this screen. Another positive control 
for a functional mitochondrial SEP is the RNAi against CG32230, which is homologous 
to NADH complex 1 subunit peptide, and therefore playing a role in the electron 
transport chain on the IMM. CG32330 also shows a phenotype in this screen. 
All four dicistronic smORFs tested, of which three are Reticular SEPs directly observed 
to localise to the mitochondria, showed a phenotype in this screen. Surprisingly, RNAi 
against Hemotin (Chapter III) shows a strong phenotype in this assay. Although I did 
not observe Hemotin-ORF1 localising to mitochondrial markers (GRP75, MitoTracker), 
ORF2 of Hemotin (CG43210-59aa) contains a predicted mTP sequence (ORF1 
(CG43194-88aa) has a predicted SP motif). Since the the entire hemotin transcript 
would be knocked down by the dsRNA, this result highlights that there could be a 
potential role for Hemotin-ORF2 in mitochondria. This is supported from the 
subcellular distribution of FLAG-tagged Hemotin-ORF2, where we could observe some 
punctate expression in the cytoplasm as well as a Cortical distribution near the F-actin 
periphery. Overlap to MitoTracker-Red is higher for Hemotin-ORF2 (Mander’s 
Coefficient = 0.37±0.14) than Hemotin-ORF1 (0.07±0.13). The other two novel 
dicistronic smORFs (CG32736/CG42308 and CG15386/CG42371) have no annotated 
function and could be very interesting for further study in the fly. Both of these 
dicistronic mitochondrial smORF transcripts are expressed ubiquitously in embryos, 
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larvae and adult flies and organs at quite high levels (modENCODE). These mito-SEPS 
could potentially be very important for cellular homeostasis based upon their 
localisation, phenotype and expression data. In addition, the monocistronic smORFs 
CG7630, CG33199, CG14036, CG14014, CR43144, CR43250 and CG33714 are 
positive hits in the mitochondrial morphology screen, with Reticular distribution and 
mitochondrial localisation, but their mitochondrial functions have never been verified in 
Drosophila or higher animals. The fact that two of these are annotated ncRNA 
transcripts containing translated smORFs also makes them good candidates for further 
study. The mitochondrial morphology RNAi screen detects  mitochondrial function of 
32% of the smORFs that were tested in the screen. Considering that the results are quite 
consistent between repeats for both test and control samples, it seems very likely that 
these smORFs are inducing a genuine stress response from the mitochondria, due to a 
direct functional link to this organelle.  
Characterising loss-of-function phenotypes using a sensitive read-out is important, 
especially in the case of smORFs, as I discovered in my initial attempt at an RNAi 
screen with the fluorometric reagent called Alamar Blue (AB). AB measures the 
reducing environment of cells and would theoretically allow us to monitor the effects of 
knocking down a smORF by the perturbations that would occur in the metabolic state of 
the dsRNA-treated cells after inducing RNAi. The candidate smORFs for this screen 
were those found in the Peptide Atlas database (Desiere et al. 2006), but lacked 
information for the subcellular localisation of these peptides. Though two positive 
controls of cell viability (DIAP1 and cdc2) were chosen, neither gave a significant result 
in the many repeats of the AB assay. The results from smORF dsRNA samples were 
also inconsistent and it was concluded that our AB assay was not reliable. The two 
smORF hits (CG11985 and CG17059) that emerged as statistically different to wild type 
samples, across three AB experiments, were not predicted to have any function that is 
related to metabolic functions or the mitochondria. Furthermore, CG7630 and CG33714 
which are now known mito-SEPs, do not show a phenotype in this screen. These results 
imply that wide-spread metabolic failure seems to be the last response to cellular stress, 
and may only occur as a consequence of a very strong phenotypic response from RNAi. 
This can be related to the result observed in DIAP1-dsRNA treated cells, which should 
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be undergoing apoptosis due to the removal of DIAP1. However, these cells exhibit 
wild type levels of reduction of the Alamar Blue reagent in the assay despite verified 
knock-down of DIAP1 by RT-PCR of DIAP1-dsRNA treated S2 cells. However, the 
mitochondrial morphology screen also produces some false negatives (mitochondrial-
localised SEPs that do not show a phenotype), this implies that the RNAi technique 
itself may require further optimisation. It could also be that some target genes require a 
larger amount of or a longer incubation time with the dsRNA to effectively knock down 
the targeted smORF gene product. Ideally, we would verify this for individual smORFs 
by quantitative RT-PCR.  
Mitochondrial morphological changes are involved in phenotypes observed in 
Alzheimer’s Disease, Huntington’s disease, Parkinson’s disease, cerebellar 
degeneration, and peripheral nerve dysfunction (Charcot-Marie-Tooth disease) (Chen 
and Chan 2009; Grünewald et al. 2010; Itoh et al. 2013). Mitochondria play a 
significant role in the neuropathy of all the major neurodegenerative diseases, for which 
many of the genetic-risk loci currently have not been identified. All of these diseases 
have been linked to the induction of oxidative stress in the cells that are affected (Lin 
2006; Federico et al. 2012). Could it be that old-age related diseases can be caused by 
genomic elements as small as smORFs? If true, this would change the way that we look 
for markers of these diseases, and could present novel therapeutic targets to alleviate 
symptoms. The smORF peptides that are positive hits in the RNAi screen may be 
performing functions of cellular homeostasis in wild type animals, but when they are 
removed, they cause mitochondria to translocate in a similar fashion as knock-down of 
very important proteins such as DIAP1, reaper, Drp1 and 14-3-3. 
Cellular characterisation of smORF function: a pipeline in progress 
The results in this thesis, from the initial characterisation of Hemotin to the discovery of 
20 mitochondrial-SEPs in S2 cells, and the functional verification of 12 of those mito-
SEPs by RNAi, highlights the advantages of studying smORF function at the cellular 
level prior to carrying out a full scale organismal study (Figure 6.1). These studies 
provide preliminary results and hypotheses to be corroborated by further study in the 
whole fly. Though these results are based on a small subset of the potential peptide 
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encoding smORFs in the Drosophila genome, they represent almost 20 percent of the 
total smORFs that are translated in S2 cells, and thus can be considered a representative 
sample. The Hemotin study showed that the use of epitope-tagged smORFs in 
haemocytes can help unravel its function through imaging. Though this thesis focused 
on the Reticular mito-SEPs, the staining technique allows labelling of different 
organelles, and using markers for the ER, Golgi and lysosomes. Therefore we could 
potentially confirm whether ‘Other Cytoplasmic’ SEPs are found in the ER, or whether 
‘Limited’ SEPs are localised to intracellular vesicles and whether or not there is a 
pattern to these SEP containing a Signal-Peptide (SP) motif, as is the case for Hemotin-
ORF1. There are published methods by which to assay whether or not a peptide is 
involved in the secretory pathway or the organisation of Golgi bodies using RNAi (Bard 
et al. 2006; Kondylis et al. 2011).  
In order to truly expand our knowledge of the proteome on a higher-throughput basis, I 
believe that the cellular characterisation of smORF peptides is necessary and valuable. 
The developmental biology field has been saturated by the identification of novel 
developmental genes in the past two or three decades. However, in recent years, there is 
a trend towards the detection and characterisation of smaller genomic elements, which 
play subtle roles in the way that developed organisms and cells are being impacted by 
their environment. Micro-RNAs have been shown to regulate adaptive responses by 
affecting the expression and repression of important genes according to the environment 
(Diawara et al. 2014; Ma et al. 2011). Small peptides encoded by smORF genes in 
5’UTR’s (uORFS) play regulatory roles in the translation of downstream proteins (Child 
et al. 1999; Zhang 2005). The peptides encoded by sarcolamban and Hemotin also seem 
to be involved in regulatory roles with other proteins, acting upon specific organelles at 
the cell or tissue level. This thesis therefore contributes significantly to expanding the 
small pool of functional SEPs. These results can also aid in the definition of novel 
sequence motifs to aid the identification of more smORFs or SEPs. 
Arising from my studies, I propose that the cellular characterisation of smORFs would 
use a pipeline of semi high-throughput techniques: 1) evidence of translation by Poly-
Ribo-Seq; 2) confirmation of translation and study of subcellular localisation by the 
tagging-transfection assay; and 3) based upon subcellular localisation, assessment of 
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organelle-related loss-of-function phenotypes by RNAi screening. Using this pipeline 
can help to gather functional information about smORFs on a much wider scale than 
before. This data could result in smORFs and their SEPs being considered by others to 
unravel their animal physiological function in more detail. 
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Figure 6.1 Summary of Cellular characterisation of smORF functions in 
Drosophila melanogaster 
smORF Length (aa)
Tm 
alpha 
helix
Poly Ribo 
Seq 
Tranlated
Peptidomic 
Evidence
FLAG-tag 
translation TargetP Distribution
Phalloidin-
Rhodamine 
Overlap 
MitoTracker-Red 
Overlap Phenotype
CG9878 92 1 Yes No Yes Signal Other Cytoplasmic Low High Yes
CG42308 61 1 Yes No Yes Signal Reticular Low High Yes
CG7630 90 1 Yes Pep. Atlas Yes Mito Reticular Low High Yes
CG33199 79 0 Yes Pep. Atlas Yes Mito Reticular Low High Yes
CG33714 90 0 Yes Pep. Atlas Yes Mito Reticular Low High Yes
CG42371 87 0 Yes No Yes Mito Reticular Low High Yes
CG32736 79 1 Yes No Yes Mito Reticular Low High Yes
CG32230 83 1 Yes Pep. Atlas Yes -  Reticular Low High Yes
CG14104 68 0 Yes No Yes - Other Cytoplasmic Low High Yes
CG14036 93 0 Yes Pep. Atlas Yes - Cortical Medium High Yes
CR43144 91 0 Yes No Yes - Reticular Low High Yes
CR43250 73 0 Yes No Yes - Reticular Low High Yes
CG42497 65 0 Yes No Yes - Reticular Low High Yes
CG43194 88 1 Yes Pep. Atlas Yes Signal Cortical Medium Low Yes
CG12384 96 0 Yes Pep. Atlas Yes - Cortical Medium Low Yes
CG43210 59 1 Yes Pep. Atlas Yes Mito Cortical Medium Medium Yes
CG34200 52 0 Yes Pep. Atlas Yes - Limited Low Medium Yes
CG15386 77 0 Yes No Yes Signal Other Cytoplasmic Low Not tested Yes
CG11686 70 1 Yes Pep. Atlas Not Tagged - Unknown Unknown Unknown Yes
CG34242 58 1 Yes No Yes Signal Reticular Low High No
CG44242 70 0 Yes Couso Lab Yes Mito Reticular Low High No
CG14482 57 0 Yes Pep. Atlas Yes Mito Reticular Low High No
CG32276 64 1 Yes No Yes Mito Other Cytoplasmic Low High No
CR32582 52 0 Yes No Yes Mito Reticular Low High No
CG17278 80 0 Yes No Yes - Reticular Low High No
CR30055 2-53, 4-17, 5-56 0 Yes No Yes - Reticular + Limited Low (ORF1) High (ORF1) No
CG33155 60 1 Yes Pep. Atlas Yes - Limited Low Low No
CG33170 71 0 Yes No Yes Signal Reticular Low Medium No
CG33774 40 1 Yes Pep. Atlas Yes Signal Other Cytoplasmic Low Medium No
CG32267 49 1 Yes Pep. Atlas Yes Mito Other Cytoplasmic Low Not tested No
CG6770 69 0 Yes Pep. Atlas Yes - Cortical Medium Not tested No
pncr009:3L 1-21, 2-20 3 - 33 0 Yes No Yes -
Other Cytoplasmic + 
Limited Low Not tested No
Rox2 1 - 38, 2-17 0 Yes No Yes - Limited - Not tested No
CG13784 67 2 Yes Pep. Atlas Not Tagged Signal Unknown Unknown Unknown No
CG17680 97 1 Yes Pep. Atlas Not Tagged Mito Unknown Unknown Unknown No
CG4101 87 1 Yes Pep. Atlas Not Tagged - Unknown Unknown Unknown No
CG18343 99 2 Yes Pep. Atlas Not Tagged - Unknown Unknown Unknown No
CG31360 98 1 Yes Pep. Atlas Not Tagged - Unknown Unknown Unknown No
CG9669 78 2 Yes Pep. Atlas Not Tagged - Unknown Unknown Unknown No
CG32248 82 1 Yes Pep. Atlas Not Tagged - Unknown Unknown Unknown No
CG15456 95 0 Yes Pep. Atlas Yes - Cortical Medium Medium -
Scl-A 28 1 No Yes Yes - Other Cytoplasmic not tested Medium -
CG11985 85 0 Yes Pep. Atlas Not Tagged - Unknown Unknown Unknown Yes - AB
CG17059 57 0 Yes Pep. Atlas Not Tagged - Unknown Unknown Unknown Yes - AB
CG11284 16 NA Yes No Yes - Cortical Medium Not tested -
CrebA 16 NA Yes No Yes - Reticular - Not tested -
FBtr0072084 14 NA Yes No Yes - Reticular Low Not tested -
FBtr0072210 13 NA Yes No Yes - Other Cytoplasmic Low Not tested -
FBtr0081720 11 NA Yes No Yes - Limited Low Not tested -
tal-B 49 0 No No Yes - Other Cytoplasmic Low Not tested No
tal full length 49 0 No No No - N/A not tested Not tested No
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Appendix 1 
RT-PCR primers  
DIAP1 forward primer: TGTGTGAAGTACATGCCGGT 
DIAP1 reverse primer:  TTCAGAGGAAAGGAGCCAGA 
Product: 288bp 
TGTGTGAAGTACATGCCGGTttgggccaattggcgtttatccagccagtccagcggccagtcggtgaaggt
ctttaatcgcgtctcctcgcggtttaaatcgttcattctggttttgtttatattatttttgaatagctgggtcgcgttcgtgttgttatccac
ctgatcaaaagcgataggtccataagacggaagatcagctacaacagatgccattttgtgttctggttgttagctcctttgtttgcc
tgactcttaatttcttcTCTGGCTCCTTTCCTCTGAA 
Cdc2 forward primer: ACCAGATATCGACGGGACAG  
Cdc2 reverse primer: GCTGCCAGTTGATAAGCACA 
Product: 287bp  
ACCAGATATCGACGGGACAGgaataccggggtgaacccagtagcacctccggcgctctgtaccacaaggt
aacaatctcgtgcgtataaatgcgcaccggaatgccaaaggatcggccaagtccaaagtcggcgacttttatgaggccac 
tcttgtcgattagtaagttctgcggcttaagatcacggtgaagtactcgccgacgatggcagaaaagaatggcgctagttatttg
gtacaaatagctacggaccaattcactctccaTGTGCTTATCAACTGGCAGC 
Rp49 forward primer: CCAGTCGGATCGATATGCTAA 
Rp49 reverse primer: GAGGTCCTGCTCATGCAGA 
Product:268bp 
CCAGTCGGATCGATATGCTAAGCTGTCGGTGAGTGCCAACGAGGATTGTGCC
AAATTGTACCCGTGTTTAATCAACATGTCTCCTTGCAGCACAAATGGCGCAAG
CCCAAGGGTATCGACAACAGAGTGCGTCGCCGCTTCAAGGGACAGTATCTGA
TGCCCAACATCGGTTACGGATCGAACAAGCGCACCCGCCACATGCTGCCCAC
CGGATTCAAGAAGTTCCTGGTGCACAACGTGCGCGAGCTGGAGGTCCTGCT
CATGCAGA 
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Appendix 2 
dsRNA primers  
(T7 polymerase priming sequence underlined)  
Diap1Fw TAATACGACTCACTATAGGGAGCCTGTTGAACCACGATTTT 
Diap1Rv TAATACGACTCACTATAGGGATCTCATGGATTGGAACGACA 
Drp1Fw TAATACGACTCACTATAGGGATTGAGAACCCGAACTCCATC 
Drp1Rv TAATACGACTCACTATAGGGATAAGATCTGGCAGGCAGTCC 
Pi3K68DFw TAATACGACTCACTATAGGGAGGCAAGCGCATATCGACTACGACA 
Pi3K68DRvTAATACGACTCACTATAGGGAGGGTGGAAAGCCGTATTGAGGAGG  
14-3-3Fw TAATACGACTCACTATAGGGAGGGGGACAACCTGACTCTCTGGAC  
14-3-3Rv TAATACGACTCACTATAGGGAGGACTGTGAAGCATTCTGCCCTCA  
CG33714Fw TAATACGACTCACTATAGGGAGGACTACAAGCAGGCCACGAAT 
CG33714Rv TAATACGACTCACTATAGGGAGGCTCCGCACCAGGAACTGTAT 
CG32276Fw TAATACGACTCACTATAGGGAGGAGGCTTCACCTCGCATAAGA 
CG32276Rv TAATACGACTCACTATAGGGAGGATTTAAAACTGCGCCGAGAA 
CG14104Fw TAATACGACTCACTATAGGGAGGAAGAAAAAGTCGCGCAAAAC 
CG14104Rv TAATACGACTCACTATAGGGAGGACAAACTTTATTCGTCGCGG
  
CG14036Fw TAATACGACTCACTATAGGGAGGTTTTGACAAACGGCTCTTGA 
CG14036Rv TAATACGACTCACTATAGGGAGGGGATGCCTGCTTGTCTTAGC 
CG6770Fw TAATACGACTCACTATAGGGAGGCAAAAAGCAGACACCAACCA 
CG6770Rv TAATACGACTCACTATAGGGAGGAGCTTGGTCAGAATCTTGCG
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CG34242Fw TAATACGACTCACTATAGGGAGGTGGTTGGAGATTCGTTGGAT 
CG34242Rv TAATACGACTCACTATAGGGAGGGGAGTTCATGCTGTCAGGGT 
CR43250Fw TAATACGACTCACTATAGGGAGGGAGCGGCTAAAAATATCCGA 
CR43250Fw TAATACGACTCACTATAGGGAGGGGGTTCTGTGAAAAAGCGAA 
CG9878Fw TAATACGACTCACTATAGGGAGGACGCATTTGTGCTGTCAAAG 
CG9878Rv TAATACGACTCACTATAGGGAGGTTTCGATCTCCATTTCCTGC  
CG42371Fw TAATACGACTCACTATAGGGAGGAAAATTGGTGAAATCGTCGG 
CG42371Fw TAATACGACTCACTATAGGGAGGAAGCCAATCAGCCACAAAAC
  
CG32736Fw TAATACGACTCACTATAGGGAGGATGCCCGCCGGAGTTT  
CG32736Rv TAATACGACTCACTATAGGGAGGCTTTGCGGTGGGATCCAC 
CG17278Fw TAATACGACTCACTATAGGGAGGACTCCTTGTCGCTGATTTTTT    
CG17278Rv TAATACGACTCACTATAGGGAGGGACACGCAGGAGTACCGATC 
HemotinFw TAATACGACTCACTATAGGGAGGTTCAATCGGAAATCAATCCCTTA  
HemotinRv TAATACGACTCACTATAGGGAGGGTCATCGTGATGCACTGTCCAA  
CG11686Fw TAATACGACTCACTATAGGGACGCTCTGAACAAACAACACC 
CG11686Rv TAATACGACTCACTATAGGGAGCAAATGCGTAGACCCAGAT 
CG34293Fw TAATACGACTCACTATAGGGACTTTTGTGCCACATAGGCTG 
CG34293Rv TAATACGACTCACTATAGGGACCCTGGGAAAAGAAGCTGAT 
CG12012Fw TAATACGACTCACTATAGGGATGCATCAGGGAGCACCTAGT  
CG12012Rv TAATACGACTCACTATAGGGATAGAAAACCGTTCCGCAGTT 
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CG32448Fw:TAATACGACTCACTATAGGGATGCTCCCAATTCGACTTCTT  
CG32448Rv TAATACGACTCACTATAGGGACAAGATTATCATGGGCCTGG 
CG18343Fw TAATACGACTCACTATAGGGAAGGAAATGTCCCATTTGTCG  
CG18343RvTAATACGACTCACTATAGGGAACAGATGTGATGTCGACGGA 
CG31360Fw TAATACGACTCACTATAGGGACGCCTTATTTTCCAAATCCA  
CG31360Rv TAATACGACTCACTATAGGGATCCAGAGGTTTCGCTTGTCT 
CG32267Fw TAATACGACTCACTATAGGGAAGGATTTGGGTACATTGCCA 
CG32267RvTAATACGACTCACTATAGGGATTTTTGGGCTGAAAGGTACG 
CG9669Fw TAATACGACTCACTATAGGGATATGTTAACGCCCCCc 
CG9669Rv TAATACGACTCACTATAGGGACTACGTATCGCCCGTGAAC 
CG13784FwTAATACGACTCACTATAGGGACCAGGCACACGTACAGAGAG 
CG13784Rv TAATACGACTCACTATAGGGAAATGATGAGATGGGCCTGAC 
CG17680Fw TAATACGACTCACTATAGGGAAATATATGGCCGTGAGCTGG 
CG17680Rv TAATACGACTCACTATAGGGACCACATGTCCAGCGTGTACT 
CG4101Fw TAATACGACTCACTATAGGGAATGTGGGTGCTCTCTTCCAG 
CG4101Rv TAATACGACTCACTATAGGGACGTCGCTTCTTCTTCTCCAG 
CG18622Fw TAATACGACTCACTATAGGGATCTCCATCAAATACCAGGGC 
CG18622Rv TAATACGACTCACTATAGGGAAAGGACTCTCCGGAGTCGAA 
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Appendix 3 - Papers published 
